However	O
,	O
only	O
complete	B
DnaJ	I
can	O
cooperate	O
with	O
DnaK	B
and	O
a	O
third	O
protein	O
,	O
GrpE	B
,	O
in	O
refolding	O
denatured	B
firefly	I
luciferase	I
.	O

Binding	O
of	O
LPS	O
-	O
LPS	B
binding	I
protein	I
(	I
LBP	I
)	I
complexes	I
to	O
CD14	B
,	O
a	O
surface	B
receptor	I
that	O
mediates	O
many	O
LPS	O
responses	O
,	O
was	O
found	O
to	O
be	O
crucial	O
,	O
as	O
pretreatment	O
of	O
THP	O
-	O
1	O
cells	O
with	O
the	O
monoclonal	B
antibody	I
60b	I
,	O
which	O
blocks	O
this	O
binding	O
,	O
inhibited	O
JNK	B
activation	O
.	O

The	O
cell	B
cycle	I
-	I
dependent	I
transcription	I
factor	I
,	O
E2F	B
-	I
1	I
,	O
regulates	O
the	O
cyclin	B
-	O
like	O
species	O
of	O
the	O
DNA	B
repair	I
enzyme	I
uracil	B
-	I
DNA	I
glycosylase	I
(	I
UDG	I
)	I
gene	I
in	O
human	O
osteosarcoma	O
(	O
Saos	O
-	O
2	O
)	O
cells	O
.	O

Based	O
on	O
our	O
observations	O
,	O
we	O
propose	O
a	O
model	O
whereby	O
inactive	O
precursor	O
molecules	O
produced	O
from	O
the	O
PEP4	B
gene	I
self	O
-	O
activate	O
within	O
the	O
yeast	O
vacuole	O
and	O
subsequently	O
activate	O
other	O
vacuolar	B
hydrolases	I
.	O

Nucleolin	B
is	O
one	O
component	O
of	O
the	O
B	B
cell	I
-	I
specific	I
transcription	I
factor	I
and	O
switch	B
region	I
binding	I
protein	I
,	O
LR1	B
.	O

Structure	O
of	O
the	O
EMAPII	B
domain	I
of	O
human	B
aminoacyl	I
-	I
tRNA	I
synthetase	I
complex	I
reveals	O
evolutionary	O
dimer	O
mimicry	O
.	O

The	O
cellular	B
oncogene	I
c	B
-	I
myb	I
can	O
interact	O
synergistically	O
with	O
the	O
Epstein	B
-	I
Barr	I
virus	I
BZLF1	I
transactivator	I
in	O
lymphoid	O
cells	O
.	O

Our	O
analysis	O
of	O
nonsense	O
mutations	O
indicates	O
that	O
the	O
C	O
terminus	O
of	O
eIF2Bepsilon	B
(	I
residues	I
518	I
to	I
712	I
)	I
is	O
required	O
for	O
both	O
catalytic	O
activity	O
and	O
interaction	O
with	O
eIF2	B
.	O

G28	B
-	I
5	I
IgG	I
partially	O
blocked	O
,	O
whereas	O
G28	B
-	I
5	I
sFv	I
augmented	O
CD40	B
responses	O
during	O
stimulation	O
with	O
natural	B
ligand	I
(	O
gp39	B
-	I
CD8	I
fusion	I
protein	I
)	O
.	O

The	O
human	B
myeloid	I
nuclear	I
differentiation	I
antigen	I
(	O
MNDA	B
)	O
is	O
expressed	O
specifically	O
in	O
maturing	O
cells	O
of	O
the	O
myelomonocytic	O
lineage	O
and	O
in	O
monocytes	O
and	O
granulocytes	O
.	O

To	O
identify	O
cis	O
-	O
acting	O
elements	O
that	O
target	O
c	B
-	I
myc	I
mRNA	I
for	O
downregulation	O
during	O
myogenesis	O
,	O
we	O
stably	O
transfected	O
C2C12	O
cells	O
with	O
mutant	B
myc	I
genes	I
or	O
chimeric	O
genes	O
in	O
which	O
various	O
myc	B
sequences	I
were	O
fused	O
to	O
the	O
human	B
beta	I
-	I
globin	I
gene	I
or	O
to	O
the	O
bacterial	B
chloramphenicol	I
acetyltransferase	I
(	O
CAT	B
)	O
gene	O
.	O

The	O
carboxyl	O
-	O
terminal	O
portion	O
of	O
UKLF	B
contains	O
three	O
zinc	O
fingers	O
of	O
the	O
Cys2	O
-	O
His2	O
type	O
and	O
binds	O
in	O
vitro	O
to	O
the	O
CACCC	O
motif	O
of	O
the	O
beta	B
-	I
globin	I
promoter	I
and	O
to	O
the	O
Sp1	B
recognition	I
sequence	I
.	O

We	O
present	O
here	O
a	O
detailed	O
genomic	O
sequencing	O
analysis	O
of	O
the	O
cytosine	O
methylation	O
patterns	O
of	O
the	O
transposase	B
binding	O
sites	O
within	O
both	O
Ac	B
ends	O
in	O
the	O
wx	B
-	I
m9	I
:	O
:	O
Ac	B
allele	I
,	O
where	O
Ac	B
is	O
inserted	O
into	O
the	O
tenth	O
exon	O
of	O
the	O
Waxy	B
gene	I
.	O

By	O
multimerizing	O
the	O
regulatory	B
elements	I
of	O
the	O
GM	B
-	I
CSF	I
promoter	I
,	O
we	O
found	O
that	O
one	O
of	O
the	O
target	B
sites	I
for	O
the	O
CN	B
action	O
is	O
the	O
conserved	B
lymphokine	I
element	I
0	I
(	O
CLE0	B
)	O
,	O
located	O
at	O
positions	O
between	O
-	O
54	O
and	O
-	O
40	O
.	O

mod	B
(	O
mdg4	B
)	O
,	O
also	O
known	O
as	O
E	B
(	I
var	I
)	I
3	I
-	I
93D	I
,	O
is	O
involved	O
in	O
a	O
variety	O
of	O
processes	O
,	O
such	O
as	O
gene	O
silencing	O
in	O
position	O
effect	O
variegation	O
(	O
PEV	O
)	O
,	O
the	O
control	O
of	O
gypsy	B
insulator	I
sequences	I
,	O
regulation	O
of	O
homeotic	B
gene	I
expression	O
,	O
and	O
programmed	O
cell	O
death	O
.	O

A	O
single	O
MEF	B
-	I
2	I
site	I
is	O
a	O
major	O
positive	O
regulatory	O
element	O
required	O
for	O
transcription	O
of	O
the	O
muscle	O
-	O
specific	O
subunit	O
of	O
the	O
human	B
phosphoglycerate	I
mutase	I
gene	I
in	O
skeletal	O
and	O
cardiac	O
muscle	O
cells	O
.	O

Identification	O
of	O
the	O
plakoglobin	B
-	O
binding	O
domain	O
in	O
desmoglein	B
and	O
its	O
role	O
in	O
plaque	O
assembly	O
and	O
intermediate	O
filament	O
anchorage	O
.	O

We	O
demonstrate	O
that	O
this	O
part	O
of	O
the	O
BCL6	B
molecule	I
contains	O
an	O
autonomous	B
transrepressor	I
domain	I
and	O
that	O
two	O
noncontiguous	B
regions	I
,	O
including	O
the	O
POZ	B
motif	I
,	O
mediate	O
maximum	O
transrepressive	O
activity	O
.	O

We	O
have	O
previously	O
demonstrated	O
that	O
a	O
mutated	O
form	O
of	O
the	O
human	B
CIITA	I
gene	I
,	O
coding	O
for	O
a	O
protein	O
lacking	O
the	O
amino	B
terminal	I
151	I
amino	I
acids	I
,	O
acts	O
as	O
a	O
potent	O
dominant	O
-	O
negative	O
suppressor	O
of	O
HLA	B
class	I
II	I
expression	O
.	O

Both	O
GATA	B
-	I
1	I
and	O
CACCC	B
-	I
binding	I
proteins	I
are	O
critical	O
for	O
the	O
developmentally	O
regulated	O
expression	O
of	O
erythroid	B
-	I
specific	I
genes	I
.	O

Molecular	O
and	O
genetic	O
analysis	O
of	O
the	O
yeast	B
early	I
meiotic	I
recombination	I
genes	I
REC102	I
and	O
REC107	B
/	O
MER2	B
.	O

Sequence	O
analysis	O
of	O
the	O
47	B
-	I
kilodalton	I
major	I
integral	I
membrane	I
immunogen	I
of	I
Treponema	I
pallidum	I
.	O

Taken	O
together	O
,	O
our	O
data	O
suggest	O
that	O
the	O
antagonistic	O
effects	O
of	O
CRP	B
and	O
KdgR	B
on	O
the	O
expression	O
of	O
the	O
pectinolysis	B
genes	I
occur	O
by	O
different	O
mechanisms	O
,	O
including	O
direct	O
competition	O
between	O
the	O
two	O
regulators	O
or	O
between	O
the	O
repressor	O
and	O
RNA	B
polymerase	I
for	O
the	O
occupation	O
of	O
a	O
common	O
DNA	O
region	O
on	O
the	O
target	O
genes	O
.	O

In	O
the	O
cytoplasm	O
it	O
acts	O
as	O
a	O
dehydratase	B
in	O
the	O
regeneration	O
of	O
tetrahydrobiopterin	B
,	O
the	O
cofactor	O
for	O
aromatic	B
amino	I
acid	I
hydroxylases	I
.	O

Expression	O
of	O
various	O
FAK	B
mutants	I
in	O
the	O
FAK	B
-	O
cells	O
showed	O
that	O
FAK	B
kinase	I
activity	O
,	O
the	O
Tyr	B
-	I
397	I
/	I
SH2	I
domain	I
binding	I
site	I
,	O
and	O
the	O
first	O
proline	O
-	O
rich	O
SH3	B
binding	I
region	I
in	O
the	O
FAK	B
C	I
-	I
terminal	I
domain	I
were	O
individually	O
needed	O
to	O
promote	O
full	O
FAK	B
-	O
mediated	O
FAK	B
-	O
cell	O
migration	O
to	O
FN	B
whereas	O
direct	O
paxillin	B
binding	O
to	O
FAK	B
was	O
not	O
required	O
.	O

Rhombotin	B
-	I
2	I
(	O
RBTN	B
-	I
2	I
)	O
is	O
a	O
proto	B
-	I
oncogene	I
only	O
in	O
the	O
context	O
of	O
T	O
lymphocytes	O
.	O

The	O
interacting	O
surfaces	O
are	O
located	O
on	O
the	O
catalytic	B
domain	I
of	O
the	O
calcineurin	B
A	I
chain	I
and	O
on	O
an	O
86	B
-	I
amino	I
acid	I
fragment	I
of	O
the	O
NFAT	B
regulatory	I
domain	I
.	O

In	O
this	O
report	O
we	O
address	O
the	O
contribution	O
of	O
the	O
regulatory	B
and	I
catalytic	I
domains	I
of	O
pp56	B
(	I
lck	I
)	I
to	O
another	O
function	O
of	O
this	O
enzyme	O
independent	O
of	O
CD4	B
:	O
TCR	O
-	O
induced	O
IL	B
-	I
2	I
production	O
.	O

However	O
,	O
a	O
cosmid	O
clone	O
containing	O
the	O
entire	O
mouse	B
alpha	I
1	I
(	I
I	I
)	I
gene	I
,	O
including	O
3	O
.	O
7	O
kb	O
of	O
5	O
'	O
-	O
and	O
4	O
kb	O
of	O
3	O
'	O
-	O
flanking	O
DNA	O
,	O
was	O
expressed	O
at	O
reduced	O
levels	O
in	O
fibroblasts	O
overexpressing	O
oncogenic	B
ras	I
.	O

However	O
,	O
the	O
same	O
U1A	B
peptide	I
,	O
when	O
conjugated	O
to	O
BSA	B
,	O
inhibits	O
vertebrate	B
PAP	I
.	O

We	O
demonstrate	O
here	O
that	O
STAT	B
protein	I
heterocomplexes	I
exist	O
prior	O
to	O
cytokine	B
treatment	O
.	O

The	O
behavior	O
of	O
suf12	B
-	I
null	I
/	I
SUF12	I
+	I
heterozygotes	I
indicates	O
that	O
suf12	B
is	O
co	O
-	O
dominantly	O
expressed	O
and	O
suggests	O
that	O
suf12	B
allele	O
-	O
specific	O
suppression	O
may	O
result	O
from	O
functionally	O
distinct	O
mutant	O
proteins	O
rather	O
than	O
variation	O
in	O
residual	O
wild	B
-	I
type	I
SUF12	I
+	I
activity	O
.	O

The	O
E2A	B
-	I
HLF	I
(	I
for	I
hepatic	I
leukaemia	I
factor	I
)	I
fusion	I
gene	I
,	O
formed	O
by	O
action	O
of	O
the	O
t	B
(	I
17	I
;	I
19	I
)	I
(	I
q22	I
;	I
p13	I
)	I
chromosomal	O
translocation	O
,	O
drives	O
the	O
leukaemic	O
transformation	O
of	O
early	O
B	O
-	O
cell	O
precursors	O
,	O
but	O
the	O
mechanism	O
of	O
this	O
activity	O
remains	O
unknown	O
.	O

We	O
suggest	O
that	O
this	O
gene	O
cluster	O
codes	O
for	O
(	O
parts	O
of	O
)	O
a	O
multisubunit	B
cytochrome	I
c	I
haem	I
lyase	I
.	O

Induction	O
of	O
the	O
enhancer	B
may	O
have	O
a	O
role	O
in	O
the	O
increase	O
in	O
globin	B
gene	I
transcription	O
that	O
characterizes	O
erythroid	O
maturation	O
.	O

Cytomegalovirus	B
immediate	I
early	I
genes	I
upregulate	O
interleukin	B
-	I
6	I
gene	O
expression	O
.	O

Transcriptional	O
regulation	O
of	O
lysosomal	B
acid	I
lipase	I
in	O
differentiating	O
monocytes	O
is	O
mediated	O
by	O
transcription	B
factors	I
Sp1	B
and	O
AP	B
-	I
2	I
.	O

Expression	O
cloning	O
with	O
this	O
region	O
of	O
DNA	O
now	O
shows	O
that	O
tegument	B
protein	I
VP22	B
and	O
the	O
viral	B
dUTPase	I
,	O
encoded	O
by	O
genes	B
UL49	I
and	I
UL50	I
,	O
respectively	O
,	O
are	O
T	B
-	I
cell	I
antigens	I
.	O

However	O
,	O
an	O
induction	O
of	O
the	O
human	B
CIITA	I
gene	I
was	O
observed	O
in	O
mouse	O
macrophage	O
and	O
fibrosarcoma	O
cell	O
lines	O
,	O
when	O
the	O
cells	O
were	O
transfected	O
with	O
a	O
cosmid	B
containing	O
the	O
human	B
CIITA	I
gene	I
,	O
but	O
lacking	O
the	O
1	B
.	I
8	I
kb	I
promoter	I
described	O
above	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
investigated	O
whether	O
maltolyl	B
p	I
-	I
coumarate	I
could	O
improve	O
cognitive	O
decline	O
in	O
scopolamine	B
-	O
injected	O
rats	O
and	O
in	O
amyloid	B
beta	I
peptide	I
(	I
1	I
-	I
42	I
)	I
-	O
infused	O
rats	O
.	O

The	O
swa2	B
-	I
1	I
allele	I
recovered	O
from	O
the	O
original	O
screen	O
carries	O
a	O
point	O
mutation	O
in	O
its	O
tetratricopeptide	O
repeat	O
(	O
TPR	O
)	O
domain	O
,	O
a	O
motif	O
not	O
found	O
in	O
auxilin	B
but	O
known	O
in	O
other	O
proteins	O
to	O
mediate	O
interaction	O
with	O
heat	B
-	I
shock	I
proteins	I
.	O

Differential	O
interaction	O
of	O
nuclear	B
factors	I
with	O
the	O
leukocyte	B
-	I
specific	I
pp52	I
promoter	I
in	O
B	O
and	O
T	O
cells	O
.	O

In	O
vivo	O
protection	O
of	O
dna	O
damage	O
associated	O
apoptotic	O
and	O
necrotic	O
cell	O
deaths	O
during	O
acetaminophen	B
-	O
induced	O
nephrotoxicity	O
,	O
amiodarone	B
-	O
induced	O
lung	O
toxicity	O
and	O
doxorubicin	B
-	O
induced	O
cardiotoxicity	O
by	O
a	O
novel	O
IH636	B
grape	I
seed	I
proanthocyanidin	I
extract	I
.	O

To	O
study	O
the	O
functional	O
differences	O
between	O
cutaneous	O
HPV5	O
and	O
HPV8	O
E7s	B
and	O
genital	B
HPV16	I
E7	I
,	O
we	O
cloned	O
each	O
of	O
the	O
E7	B
open	O
reading	O
frames	O
and	O
tested	O
their	O
immortalizing	O
and	O
transforming	O
activities	O
,	O
the	O
binding	O
ability	O
of	O
their	O
products	O
with	O
retinoblastoma	B
protein	I
(	O
RB	B
)	O
and	O
their	O
complementation	O
activity	O
of	O
a	O
RB	B
-	I
nonbinding	I
adenovirus	I
E1A	I
mutant	I
.	O

Spi	B
-	I
1	I
/	I
PU	I
.	I
1	I
is	O
a	O
hematopoietic	B
transcription	I
factor	I
of	O
the	O
Ets	B
family	I
.	O

Light	B
regulatory	I
unit	I
1	I
(	O
LRU1	B
)	O
is	O
necessary	O
for	O
and	O
sufficient	O
to	O
mediate	O
light	O
-	O
dependent	O
activation	O
of	O
the	O
chalcone	B
synthase	I
(	I
CHS	I
)	I
minimal	I
promoter	I
in	O
Petroselinum	O
crispum	O
.	O

The	O
1	B
.	I
955	I
-	I
kb	I
viral	I
segment	I
includes	O
a	O
dyad	O
symmetry	O
region	O
located	O
between	O
two	O
small	B
nuclear	I
RNA	I
genes	I
and	O
is	O
located	O
upstream	O
of	O
the	O
dihydrofolate	B
reductase	I
gene	I
homolog	I
.	O

The	O
mEmBP	B
-	I
1	I
protein	I
can	O
activate	O
transcription	O
from	O
a	O
truncated	O
promoter	O
containing	O
a	O
pentamer	O
of	O
the	O
O2	B
site	I
in	O
yeast	O
cells	O
;	O
however	O
,	O
it	O
inhibited	O
regulated	O
transcription	O
of	O
a	O
22	B
kDa	I
zein	I
promoter	I
in	O
a	O
transient	O
expression	O
assay	O
using	O
cultured	O
maize	O
endosperm	O
cells	O
.	O

Comparison	O
of	O
the	O
structural	O
characteristics	O
of	O
Cu	B
(	I
2	I
+	I
)	I
-	O
bound	O
and	O
unbound	O
alpha	B
-	I
syn12	I
peptide	I
obtained	O
in	O
simulations	O
using	O
different	O
force	O
fields	O
.	O

EBNA	B
-	I
2	I
trans	O
-	O
activates	O
cellular	B
and	I
viral	I
genes	I
like	O
CD23	B
,	O
c	B
-	I
fgr	I
,	O
latent	B
membrane	I
protein	I
1	I
(	O
LMP1	B
)	O
and	O
terminal	B
protein	I
1	I
(	O
TP1	B
)	O
.	O

The	O
transforming	O
gene	O
of	O
the	O
avian	B
sarcoma	I
virus	I
CT10	I
encodes	O
a	O
fusion	O
protein	O
(	O
p47gag	B
-	O
crk	B
or	O
v	B
-	I
Crk	I
)	O
containing	O
viral	B
Gag	I
sequences	I
fused	O
to	O
cellular	O
sequences	O
consisting	O
primarily	O
of	O
Src	B
homology	I
regions	I
2	I
and	I
3	I
(	O
SH2	B
and	O
SH3	B
sequences	I
)	O
.	O

Involvement	O
of	O
AP1	B
and	O
PEA3	B
binding	I
sites	I
in	O
the	O
regulation	O
of	O
murine	B
tissue	I
inhibitor	I
of	I
metalloproteinases	I
-	I
1	I
(	O
TIMP	B
-	I
1	I
)	O
transcription	O
.	O

The	O
coexpression	O
of	O
full	O
-	O
length	O
expression	O
constructs	O
for	O
both	O
DBP	B
and	O
hepatic	B
leukemia	I
factor	I
resulted	O
in	O
a	O
dramatic	O
increase	O
in	O
activation	O
mediated	O
by	O
the	O
GAL4	B
-	O
DBP	B
fusion	O
proteins	O
,	O
suggesting	O
the	O
involvement	O
of	O
a	O
regulated	O
coactivator	O
in	O
this	O
process	O
.	O

CONCLUSION	O
:	O
Mutated	B
human	I
CIITA	I
constructs	I
are	O
potent	O
suppressors	O
of	O
porcine	O
MHC	B
class	I
II	I
expression	O
.	O

The	O
onset	O
of	O
apoptosis	O
in	O
both	O
cell	O
types	O
can	O
be	O
delayed	O
by	O
hemopoietins	B
and	O
inflammatory	B
mediators	I
.	O

The	O
demonstration	O
that	O
nucleolin	B
is	O
a	O
component	O
of	O
a	O
B	B
cell	I
-	I
specific	I
complex	I
that	O
binds	O
switch	O
region	O
sequences	O
suggests	O
that	O
the	O
G	B
-	I
rich	I
switch	I
regions	I
may	O
have	O
evolved	O
from	O
rDNA	B
.	O

The	O
c	B
-	I
myc	I
and	O
skeletal	B
alpha	I
-	I
actin	I
gene	I
promoters	I
contain	O
YY1	B
binding	I
sites	I
thought	O
to	O
act	O
either	O
as	O
positive	O
or	O
negative	O
cis	O
-	O
acting	O
elements	O
.	O

Consistent	O
with	O
this	O
finding	O
,	O
wild	B
-	I
type	I
SAGA	I
inhibits	O
TBP	B
binding	O
to	O
the	O
HIS3	B
promoter	I
in	O
vitro	O
,	O
while	O
SAGA	B
lacking	O
Spt3	B
or	O
Spt8	B
is	O
not	O
inhibitory	O
.	O

The	O
receptor	B
for	I
hyaluronan	I
mediated	I
motility	I
(	B
RHAMM	I
)	I
gene	I
expression	O
is	O
markedly	O
elevated	O
in	O
fibrosarcomas	O
exposed	O
to	O
transforming	B
growth	I
factor	I
-	I
beta1	I
(	O
TGF	B
-	I
beta1	I
)	O
.	O

Previous	O
work	O
has	O
demonstrated	O
that	O
SLP	B
-	I
76	I
,	O
a	O
Grb2	B
-	I
associated	I
tyrosine	I
-	I
phosphorylated	I
protein	I
,	O
augments	O
Interleukin	B
-	I
2	I
promoter	I
activity	O
when	O
overexpressed	O
in	O
the	O
Jurkat	O
T	O
cell	O
line	O
.	O

Based	O
upon	O
these	O
results	O
we	O
propose	O
that	O
alpha	B
-	I
interferon	I
through	O
its	O
receptor	O
initiates	O
phosphatidic	O
acid	O
dependent	O
signalling	O
which	O
in	O
turn	O
regulates	O
the	O
affinity	O
of	O
47	B
kDa	I
sterol	I
regulatory	I
element	I
binding	I
factor	I
as	O
well	O
as	O
LDL	B
-	I
receptor	I
gene	I
transcription	O
in	O
lymphocytes	O
from	O
CML	O
patients	O
.	O

Anti	B
-	I
Ro	I
(	I
SSA	I
)	I
autoantibodies	I
are	O
associated	O
with	O
T	B
cell	I
receptor	I
beta	I
genes	I
in	O
systemic	O
lupus	O
erythematosus	O
patients	O
.	O

B	O
cell	O
-	O
specific	O
mb	B
-	I
1	I
and	O
B29	B
genes	I
encode	O
the	O
alpha	O
/	O
beta	O
components	O
of	O
the	O
BCR	B
-	I
associated	I
complex	I
in	O
mature	O
sIgM	B
+	I
B	O
cells	O
.	O

By	O
using	O
several	O
HBD	B
subfragments	I
,	O
the	O
mAb	B
18C7	I
epitope	I
was	O
located	O
in	O
the	O
N	B
-	I
terminal	I
region	I
of	O
the	O
HBD	B
from	O
Thr729	B
to	I
Leu765	I
.	O

The	O
mutant	O
receptors	O
,	O
as	O
well	O
as	O
sBMPR	B
-	I
IA	I
,	O
were	O
expressed	O
as	O
fusion	O
proteins	O
with	O
thioredoxin	B
in	O
Escherichia	O
coli	O
,	O
and	O
purified	O
using	O
reverse	O
phase	O
high	O
performance	O
liquid	O
chromatography	O
(	O
RP	O
-	O
HPLC	O
)	O
after	O
digestion	O
with	O
enterokinase	B
.	O

The	O
p53	B
-	I
homolog	I
p73beta	B
also	O
activated	O
the	O
PIG3	B
promoter	I
,	O
but	O
in	O
contrast	O
to	O
p53	B
,	O
the	O
proline	O
-	O
rich	O
domain	O
of	O
p73beta	B
(	I
residues	I
81	I
-	I
113	I
)	I
was	O
dispensable	O
to	O
induce	O
the	O
PIG3	B
promoter	I
.	O

Here	O
we	O
show	O
that	O
the	O
lymphoid	B
lineage	I
-	I
determining	I
factors	I
Ikaros	B
and	O
Aiolos	B
can	O
function	O
as	O
strong	B
transcriptional	I
repressors	I
.	O

EBNA	B
-	I
2	I
and	O
the	O
cis	O
-	O
acting	O
CD23	B
element	I
increased	O
TK	B
-	O
promoted	O
mRNA	O
and	O
did	O
not	O
alter	O
the	O
herpes	B
simplex	I
virus	I
TK	I
promoter	I
transcription	I
start	I
site	I
.	O

Inhibition	O
of	O
monoamine	B
oxidase	O
by	O
phthalide	B
analogues	O
.	O

Fetal	O
murine	O
thymus	O
exhibited	O
a	O
striking	O
concordance	O
of	O
endogenous	O
c	B
-	I
myb	I
expression	O
with	O
that	O
of	O
mouse	B
ADA	I
and	O
human	B
ADA	I
LCR	I
-	O
directed	O
transgene	O
expression	O
.	O

Cloning	O
of	O
murine	B
TCF	I
-	I
1	I
,	O
a	O
T	O
cell	O
-	O
specific	O
transcription	B
factor	I
interacting	O
with	O
functional	B
motifs	I
in	O
the	O
CD3	B
-	I
epsilon	I
and	I
T	I
cell	I
receptor	I
alpha	I
enhancers	I
.	O

We	O
propose	O
that	O
mutations	O
of	O
MDS1	B
/	I
EVI1	I
either	O
by	O
gene	O
truncation	O
resulting	O
in	O
the	O
transcription	B
repressor	I
EVI1	I
or	O
by	O
gene	O
fusion	O
to	O
AML1	B
lead	O
to	O
an	O
altered	O
cellular	O
response	O
to	O
growth	O
and	O
differentiation	B
factors	I
that	O
could	O
result	O
in	O
leukemic	O
transformation	O
.	O

Previously	O
we	O
demonstrated	O
that	O
heterologous	B
activation	I
domains	I
can	O
fully	O
substitute	O
for	O
the	O
ZEBRA	B
activation	I
domain	I
.	O

Interestingly	O
,	O
the	O
RNA	O
sequences	O
selected	O
by	O
the	O
mutated	O
zinc	B
knuckle	I
9G8	I
variant	I
are	O
efficiently	O
recognized	O
by	O
SRp20	B
,	O
in	O
agreement	O
with	O
the	O
fact	O
that	O
the	O
RBD	O
of	O
9G8	B
and	O
SRp20	B
are	O
similar	O
.	O

However	O
,	O
all	O
20	O
cases	O
lacked	O
the	O
t	O
(	O
15	O
;	O
17	O
)	O
and	O
17	O
cases	O
tested	O
lacked	O
the	O
promyelocytic	B
/	I
retinoic	I
acid	I
receptor	I
alpha	I
(	I
RAR	I
alpha	I
)	I
fusion	I
transcript	I
in	O
RT	O
-	O
PCR	O
assays	O
;	O
12	O
cases	O
had	O
46	O
,	O
XX	O
or	O
46	O
,	O
XY	O
karyotypes	O
,	O
whereas	O
2	O
cases	O
had	O
abnormalities	O
of	O
chromosome	B
17q	I
:	O
1	O
with	O
del	B
(	I
17	I
)	I
(	I
q25	I
)	I
and	O
the	O
other	O
with	O
t	B
(	I
11	I
;	I
17	I
)	I
(	I
q23	I
;	I
q21	I
)	I
and	O
the	O
promyelocytic	B
leukemia	I
zinc	I
finger	I
/	I
RAR	I
alpha	I
fusion	I
transcript	I
.	O

A	O
novel	O
human	B
homeobox	I
gene	I
distantly	O
related	O
to	O
proboscipedia	B
is	O
expressed	O
in	O
lymphoid	O
and	O
pancreatic	O
tissues	O
.	O

Myosin	B
light	I
chain	I
kinase	I
functions	O
downstream	O
of	O
Ras	B
/	O
ERK	B
to	O
promote	O
migration	O
of	O
urokinase	B
-	I
type	I
plasminogen	I
activator	I
-	O
stimulated	O
cells	O
in	O
an	O
integrin	B
-	O
selective	O
manner	O
.	O

Our	O
findings	O
demonstrate	O
that	O
truncated	B
TSG101	I
and	I
FHIT	I
transcripts	I
are	O
commonly	O
detected	O
in	O
both	O
normal	O
and	O
malignant	O
tissues	O
and	O
that	O
a	O
significant	O
fraction	O
of	O
these	O
are	O
likely	O
to	O
be	O
the	O
result	O
of	O
aberrant	O
splicing	O
.	O

A	O
triple	B
-	I
mutant	I
TBP	I
(	O
R231E	O
+	O
R235E	O
+	O
R239S	O
)	O
had	O
greatly	O
reduced	O
activity	O
for	O
yeast	B
U6	I
snRNA	I
gene	I
transcription	O
while	O
remaining	O
active	O
for	O
Pol	B
II	I
basal	O
transcription	O
.	O

Such	O
alleles	O
have	O
not	O
been	O
observed	O
among	O
more	O
than	O
900	O
normal	O
and	O
SBMA	B
X	I
-	I
chromosomes	I
that	O
have	O
been	O
examined	O
.	O

Sialoadhesin	B
is	O
a	O
macrophage	B
-	I
restricted	I
member	I
of	O
the	O
Ig	B
superfamily	I
that	O
mediates	O
adhesion	O
with	O
lymphoid	O
and	O
myeloid	O
cells	O
.	O

To	O
further	O
explore	O
the	O
involvement	O
of	O
PI3	B
-	I
K	I
in	O
T	O
cell	O
activation	O
,	O
we	O
created	O
a	O
set	O
of	O
potentially	O
dominant	B
negative	I
PI3	I
-	I
K	I
constructs	I
comprising	O
individual	O
or	O
tandem	B
domains	I
of	O
the	O
regulatory	B
p85	I
subunit	I
and	O
tested	O
their	O
effect	O
on	O
downstream	O
signaling	O
events	O
like	O
Erk2	B
activation	O
and	O
transcription	O
from	O
an	O
NFAT	B
(	I
nuclear	I
factor	I
of	I
activated	I
T	I
cells	I
)	I
element	I
taken	O
from	O
the	O
interleukin	B
-	I
2	I
promoter	I
.	O

Human	B
Duo	I
contains	O
a	O
guanine	B
nucleotide	I
exchange	I
factor	I
(	O
GEF	B
)	O
domain	O
that	O
is	O
likely	O
to	O
be	O
rac1	B
-	O
specific	O
,	O
a	O
pleckstrin	B
homology	I
(	O
PH	B
)	O
domain	O
and	O
spectrin	B
-	I
like	I
repeat	I
units	I
.	O

Expression	O
of	O
an	O
active	O
form	O
of	O
Ras	B
,	O
Ras	B
(	I
G12V	I
)	I
,	O
suppressed	O
the	O
IL	B
-	I
2	I
-	O
induced	O
beta	B
-	I
casein	I
and	O
OSM	B
gene	O
expression	O
,	O
and	O
the	O
negative	O
effect	O
of	O
Ras	B
is	O
mediated	O
by	O
the	O
region	O
between	O
-	B
105	I
and	I
-	I
193	I
in	O
the	O
beta	B
-	I
casein	I
promoter	I
.	O

Glutathione	B
-	I
S	I
-	I
transferase	I
(	I
GST	I
)	I
-	I
Grb2	I
fusion	I
proteins	I
have	O
been	O
used	O
to	O
identify	O
the	O
potential	O
role	O
of	O
Grb2	B
-	I
binding	I
proteins	I
in	O
platelet	O
activation	O
by	O
the	O
platelet	B
low	I
-	I
affinity	I
IgG	I
receptor	I
,	O
Fc	B
gamma	I
RIIA	I
.	O

MDS1	B
/	I
EVI1	I
,	O
located	O
on	O
chromosome	B
3	I
band	I
q26	I
,	O
encodes	O
a	O
zinc	B
-	I
finger	I
DNA	I
-	I
binding	I
transcription	I
activator	I
not	O
detected	O
in	O
normal	O
hematopoietic	O
cells	O
but	O
expressed	O
in	O
several	O
normal	O
tissues	O
.	O

DNA	O
sequence	O
and	O
functions	O
of	O
the	O
actVI	B
region	I
of	O
the	O
actinorhodin	B
biosynthetic	I
gene	I
cluster	I
of	I
Streptomyces	I
coelicolor	I
A3	I
(	I
2	I
)	I
.	O

PrpB	B
showed	O
homology	O
to	O
carboxyphosphonoenolpyruvate	B
phosphonomutase	I
of	I
Streptomyces	I
hygroscopicus	I
and	O
to	O
its	O
homolog	O
in	O
the	O
carnation	O
Dianthus	O
caryophyllus	O
;	O
PrpC	B
was	O
homologous	O
to	O
both	O
archaeal	B
and	I
bacterial	I
citrate	I
synthases	I
;	O
PrpD	B
showed	O
homology	O
to	O
yeast	O
and	O
Bacillus	O
subtilis	O
proteins	O
of	O
unknown	O
function	O
;	O
PrpE	B
showed	O
homology	O
to	O
acetyl	B
coenzyme	I
A	I
synthetases	I
.	O

By	O
Southern	O
hybridization	O
analyses	O
of	O
somatic	O
cell	O
hybrid	O
panels	O
with	O
murine	B
cDNA	I
probe	I
,	O
fluorescence	O
chromosomal	O
in	O
situ	O
hybridization	O
(	O
FISH	O
)	O
of	O
human	B
genomic	I
clones	I
,	O
and	O
analysis	O
of	O
recombinant	O
inbred	O
mouse	O
strains	O
,	O
we	O
have	O
found	O
single	O
sites	O
for	O
EBF	B
homologous	I
sequences	I
on	O
human	O
Chromosome	O
(	O
Chr	O
)	O
5	O
,	O
band	B
q34	I
,	O
and	O
on	O
proximal	B
mouse	I
Chr	I
11	I
,	O
in	O
an	O
evolutionarily	B
conserved	I
region	I
.	O

The	O
mutated	B
human	I
CIITA	I
constructs	I
were	O
,	O
therefore	O
,	O
tested	O
in	O
the	O
pig	O
.	O

Our	O
results	O
provide	O
the	O
first	O
evidence	O
that	O
both	O
GATA	B
-	I
1	I
and	O
C	B
/	I
EBPbeta	I
synergistically	O
transactivate	O
the	O
promoter	B
of	O
an	O
eosinophil	B
-	I
specific	I
granule	I
protein	I
gene	I
and	O
that	O
FOG	B
may	O
act	O
as	O
a	O
negative	O
cofactor	O
for	O
the	O
eosinophil	O
lineage	O
,	O
unlike	O
its	O
positively	O
regulatory	O
function	O
for	O
the	O
erythroid	O
and	O
megakaryocyte	O
lineages	O
.	O

A	O
regulatory	B
element	I
in	O
the	O
human	B
interleukin	I
2	I
gene	I
promoter	I
is	O
a	O
binding	B
site	I
for	O
the	O
zinc	B
finger	I
proteins	I
Sp1	B
and	O
EGR	B
-	I
1	I
.	O

Mutation	O
of	O
Aiolos	B
-	I
binding	I
sites	I
within	O
the	O
Bcl	B
-	I
2	I
promoter	I
inhibits	O
transactivation	O
of	O
the	O
reporter	B
gene	I
luciferase	I
,	O
suggesting	O
direct	O
control	O
of	O
Bcl	B
-	I
2	I
expression	O
by	O
Aiolos	B
.	O

Erythropoietin	B
induces	O
tyrosine	O
phosphorylation	O
of	O
Jak2	B
,	O
STAT5A	B
,	O
and	O
STAT5B	B
in	O
primary	O
cultured	O
human	O
erythroid	O
precursors	O
.	O

The	O
genomic	O
structure	O
of	O
the	O
human	B
SPEC1	I
gene	I
reveals	O
complex	O
splicing	O
and	O
close	O
promoter	O
proximity	O
to	O
the	O
AF1q	B
translocation	I
gene	I
.	O

PU	B
.	I
1	I
(	O
spi	B
-	I
1	I
)	O
,	O
a	O
member	O
of	O
the	O
Ets	B
transcription	I
factor	I
family	I
,	O
is	O
predominantly	O
expressed	O
in	O
myeloid	O
and	O
B	O
cells	O
,	O
activates	O
many	O
B	B
cell	I
and	I
myeloid	I
genes	I
,	O
and	O
is	O
critical	O
for	O
development	O
of	O
both	O
of	O
these	O
lineages	O
.	O

Calmodulin	B
-	I
binding	I
peptide	I
(	O
CBP	B
)	O
,	O
a	O
peptide	O
of	O
26	O
amino	O
acids	O
derived	O
from	O
muscle	B
myosin	I
light	I
chain	I
kinase	I
(	O
MLCK	B
)	O
,	O
binds	O
to	O
calmodulin	B
with	O
nanomolar	O
affinity	O
.	O

Comparison	O
of	O
the	O
deduced	O
amino	B
acid	I
sequence	I
of	I
gamma	I
-	I
kafirin	I
with	O
the	O
published	O
sequences	B
of	I
gamma	I
-	I
prolamins	I
of	I
maize	I
,	I
and	I
Coix	I
revealed	O
highly	O
conserved	O
domains	O
.	O

Molecular	O
cloning	O
of	O
the	O
human	O
homolog	O
of	O
a	O
striatum	B
-	I
enriched	I
phosphatase	I
(	B
STEP	I
)	I
gene	I
and	O
chromosomal	O
mapping	O
of	O
the	O
human	O
and	O
murine	O
loci	O
.	O

Wild	O
-	O
type	O
and	O
chimeric	B
HLF	I
proteins	I
also	O
bound	O
closely	O
related	O
sites	O
identified	O
previously	O
for	O
bZIP	B
proteins	I
of	O
both	O
the	O
proline	B
-	O
and	O
acidic	O
amino	O
acid	O
-	O
rich	O
(	O
PAR	B
)	O
and	O
C	B
/	I
EBP	I
subfamilies	I
;	O
however	O
,	O
E2A	B
-	I
HLF	I
proteins	O
were	O
significantly	O
less	O
tolerant	O
of	O
certain	O
deviations	O
from	O
the	O
HLF	B
consensus	I
binding	I
site	I
.	O

Cardiac	B
myosin	I
-	I
binding	I
protein	I
C	I
(	O
MyBP	B
-	I
C	I
)	O
:	O
identification	O
of	O
protein	B
kinase	I
A	I
and	O
protein	B
kinase	I
C	I
phosphorylation	O
sites	O
.	O

Functional	O
characterization	O
of	O
the	O
murine	B
homolog	I
of	O
the	O
B	B
cell	I
-	I
specific	I
coactivator	I
BOB	B
.	I
1	I
/	I
OBF	I
.	I
1	I
.	O

Here	O
,	O
we	O
show	O
that	O
the	O
Duffy	B
antigen	I
/	I
chemokine	I
receptor	I
gene	I
(	O
DARC	B
)	O
is	O
composed	O
of	O
a	O
single	O
exon	B
and	O
that	O
most	O
Duffy	O
-	O
negative	O
blacks	O
carry	O
a	O
silent	B
FY	I
*	I
B	I
allele	I
with	O
a	O
single	O
T	O
to	O
C	O
substitution	O
at	O
nucleotide	O
-	O
46	O
.	O

The	O
co	O
-	O
existence	O
of	O
TE	B
domains	I
within	O
modular	O
PKSs	B
along	O
with	O
physically	O
separated	O
,	O
monofunctional	O
TEs	B
(	O
TE	B
IIs	I
)	O
has	O
been	O
reported	O
for	O
a	O
number	O
of	O
modular	O
polyketide	O
and	O
non	B
-	I
ribosomal	I
peptide	I
synthases	I
(	O
NRPS	B
)	O
.	O

Human	B
erythroid	I
5	I
-	I
aminolevulinate	I
synthase	I
:	O
promoter	B
analysis	O
and	O
identification	O
of	O
an	O
iron	B
-	I
responsive	I
element	I
in	O
the	O
mRNA	B
.	O

This	O
study	O
can	O
help	O
us	O
to	O
understand	O
the	O
mechanisms	O
through	O
which	O
Cu	B
(	I
2	I
+	I
)	I
participates	O
in	O
the	O
fibrillation	O
of	O
alpha	B
-	I
syn12	I
peptide	I
at	O
the	O
atomic	O
level	O
,	O
which	O
in	O
turn	O
represents	O
a	O
step	O
towards	O
elucidating	O
the	O
nosogenesis	O
of	O
Parkinson	O
'	O
s	O
disease	O
.	O

This	O
enhancer	B
is	O
inducible	O
in	O
K562	O
human	O
erythroleukemia	O
cells	O
,	O
increasing	O
linked	O
gamma	B
-	I
globin	I
promoter	I
/	B
luciferase	I
gene	O
expression	O
to	O
170	O
-	O
fold	O
over	O
an	O
enhancerless	B
construct	I
.	O

The	O
caprine	B
arthritis	I
-	I
encephalitis	I
virus	I
(	I
CAEV	I
)	I
long	I
terminal	I
repeat	I
(	O
LTR	B
)	O
is	O
activated	O
by	O
gamma	B
interferon	I
(	O
IFN	B
-	I
gamma	I
)	O
in	O
promonocytic	O
cells	O
.	O

Thus	O
,	O
overall	O
,	O
our	O
results	O
demonstrate	O
that	O
a	O
PTPase	B
is	O
involved	O
either	O
directly	O
or	O
indirectly	O
in	O
the	O
pathway	O
leading	O
to	O
the	O
induction	O
of	O
endothelial	B
cell	I
adhesion	I
molecules	I
by	O
TNF	B
.	O

Constitutively	B
active	I
SHP1	I
-	I
DeltaSH2	I
had	O
a	O
more	O
pronounced	O
effect	O
on	O
ZAP	B
-	I
70	I
and	O
Syk	B
,	O
even	O
when	O
expressed	O
at	O
near	O
physiological	O
levels	O
.	O

In	O
apparent	O
contradiction	O
,	O
expression	O
of	O
a	O
dominant	O
negative	O
form	O
of	O
Ras	B
,	O
RasN17	B
,	O
also	O
inhibited	O
IL	B
-	I
2	I
-	O
induced	O
activation	O
of	O
the	O
promoter	O
containing	O
the	O
minimal	O
beta	B
-	I
casein	I
STAT5	I
element	I
as	O
well	O
as	O
the	O
promoters	O
of	O
CIS	B
and	O
OSM	B
.	O

Cross	O
-	O
linking	O
FcalphaR	B
on	O
wt	B
-	I
ITAM	I
or	O
IIA	B
-	I
ITAM	I
cells	O
triggered	O
equivalent	O
PI	B
3	I
-	I
kinase	I
-	O
dependent	O
activation	O
of	O
PKBalpha	B
.	O

SLP	B
-	I
76	I
(	O
SH2	B
domain	I
leukocyte	I
protein	I
of	O
76	O
kDa	O
)	O
is	O
a	O
recently	O
identified	O
substrate	O
of	O
the	O
TCR	B
-	I
stimulated	I
protein	I
tyrosine	B
kinases	I
that	O
functions	O
in	O
the	O
signal	O
transduction	O
cascade	O
linking	O
the	O
TCR	B
with	O
IL	B
-	I
2	I
gene	O
expression	O
.	O

Taken	O
together	O
,	O
our	O
results	O
suggest	O
that	O
OCA	B
-	I
B	I
is	O
a	O
tissue	B
-	I
,	I
promoter	I
-	I
,	I
and	I
factor	I
-	I
specific	I
coactivator	I
and	O
that	O
OCA	B
-	I
B	I
may	O
be	O
a	O
major	O
determinant	O
for	O
B	O
cell	O
-	O
specific	O
activation	O
of	O
immunoglobulin	B
promoters	I
.	O

ICSAT	B
(	O
Interferon	B
Consensus	I
Sequence	I
binding	I
protein	I
for	I
Activated	I
T	I
cells	I
)	O
is	O
a	O
lymphocyte	O
-	O
specific	O
member	O
of	O
the	O
interferon	B
regulatory	I
factor	I
(	I
IRF	I
)	I
family	I
of	O
transcription	O
factors	O
,	O
originally	O
identified	O
through	O
Southwestern	O
screening	O
of	O
the	O
ATL	B
(	I
Adult	I
T	I
-	I
cell	I
leukemia	I
)	I
-	I
16T	I
expression	I
library	I
.	O

Expression	O
and	O
role	O
of	O
PML	B
gene	I
in	O
normal	O
adult	O
hematopoiesis	O
:	O
functional	O
interaction	O
between	O
PML	B
and	I
Rb	I
proteins	I
in	O
erythropoiesis	O
.	O

Selection	O
was	O
based	O
on	O
expression	O
of	O
an	O
integrated	O
DNA	O
fragment	O
containing	O
the	O
con	B
-	I
10	I
promoter	I
-	I
regulatory	I
region	I
followed	O
by	O
the	O
initial	O
segment	O
of	O
the	O
con	B
-	I
10	I
open	I
reading	I
frame	I
fused	O
in	O
frame	O
with	O
the	O
bacterial	B
hygromycin	I
B	I
phosphotransferase	I
structural	I
gene	I
(	O
con10	B
'	I
-	I
'	I
hph	I
)	O
.	O

To	O
investigate	O
the	O
inhibitory	O
mechanisms	O
,	O
we	O
constructed	O
a	O
secreted	B
-	I
type	I
placental	I
alkaline	I
phosphatase	I
(	I
PLAP	I
)	I
reporter	I
gene	I
whose	O
transcription	O
is	O
controlled	O
by	O
a	O
1	B
.	I
4	I
-	I
kb	I
human	I
TNF	I
-	I
alpha	I
promoter	I
.	O

The	O
protein	O
predicted	O
by	O
the	O
sequence	O
of	O
the	O
human	B
pim	I
-	I
1	I
proto	I
-	I
oncogene	I
shares	O
extensive	O
homology	O
with	O
known	O
serine	B
/	I
threonine	I
protein	I
kinases	I
,	O
and	O
yet	O
the	O
human	B
Pim	I
-	I
1	I
enzyme	I
has	O
previously	O
been	O
reported	O
to	O
exhibit	O
protein	B
tyrosine	I
kinase	I
activity	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

Comparative	O
studies	O
showed	O
that	O
Fli	B
-	I
1	I
was	O
also	O
able	O
to	O
transactivate	O
the	O
GPIbalpha	B
and	O
,	O
to	O
a	O
lesser	O
extent	O
,	O
the	O
GPIIb	B
promoter	I
.	O

Ent	B
-	I
kaurene	I
synthase	I
from	I
the	I
fungus	I
Phaeosphaeria	I
sp	O
.	O

HIV	B
-	I
1	I
tat	I
induces	O
the	O
expression	O
of	O
a	O
new	O
hematopoietic	B
cell	I
-	I
specific	I
transcription	I
factor	I
and	O
downregulates	O
MIP	B
-	I
1	I
alpha	I
gene	I
expression	O
in	O
activated	O
T	O
-	O
cells	O
.	O

The	O
human	B
G0	I
/	I
G1	I
switch	I
gene	I
,	O
G0S2	B
,	O
has	O
potential	O
NFAT	B
-	I
binding	I
sites	I
in	O
the	O
5	B
'	I
flank	I
and	O
encodes	O
a	O
small	B
basic	I
potential	I
phosphoprotein	I
of	O
unknown	O
function	O
.	O

C	O
.	O
elegans	O
KLP	B
-	I
11	I
/	O
OSM	B
-	I
3	I
/	O
KAP	B
-	I
1	I
:	O
orthologs	O
of	O
the	O
sea	B
urchin	I
kinesin	I
-	I
II	I
,	O
and	O
mouse	O
KIF3A	B
/	O
KIFB	B
/	O
KAP3	B
kinesin	B
complexes	O
.	O

A	O
mutant	O
T	O
cell	O
line	O
was	O
isolated	O
that	O
lacked	O
expression	O
of	O
SLP	B
-	I
76	I
(	O
SH2	B
domain	I
-	I
containing	I
leukocyte	I
protein	I
of	O
76	O
kilodaltons	O
)	O
,	O
a	O
hematopoietically	B
expressed	I
adaptor	I
protein	I
and	O
PTK	B
substrate	I
.	O

A	O
fusion	B
complementary	I
DNA	I
in	O
the	O
T	O
cell	O
line	O
HSB	O
-	O
2	O
elucidates	O
a	O
provocative	O
mechanism	O
for	O
the	O
disruption	O
of	O
the	O
putative	O
hematopoietic	B
transcription	I
factor	I
SCL	B
.	O

The	O
ZEBRA	B
activation	I
region	I
was	O
replaced	O
with	O
the	O
potent	O
acid	B
activation	I
region	I
from	O
the	O
herpes	B
simplex	I
virus	I
VP16	I
protein	I
or	O
with	O
the	O
activation	B
region	I
of	O
the	O
EBV	B
R	I
protein	I
.	O

In	O
DNA	O
-	O
protein	O
binding	O
studies	O
,	O
we	O
detected	O
the	O
binding	O
of	O
transcription	B
factors	I
GABP	B
alpha	I
and	I
-	I
beta	I
to	O
a	O
dyad	B
symmetry	I
element	I
(	O
DSE	B
)	O
of	O
the	O
distal	B
enhancer	I
,	O
which	O
is	O
formed	O
by	O
palindromic	B
binding	I
sites	I
of	O
Ets	B
-	I
like	I
factors	I
.	O

Antisense	O
transcription	O
of	O
a	O
murine	B
FGFR	I
-	I
3	I
psuedogene	I
during	O
fetal	O
developement	O
.	O

Reverse	O
transcription	O
of	O
FMDV	B
RNA	O
was	O
carried	O
out	O
with	O
avian	B
myeloblastosis	I
virus	I
reverse	O
transcriptase	O
(	O
Promega	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
promega	O
.	O
com	O
)	O
or	O
Transcriptor	O
reverse	O
transcriptase	O
(	O
Roche	O
,	O
http	O
:	O
/	O
/	O
www	O
.	O
roche	O
.	O
com	O
)	O
,	O
and	O
PCR	O
amplification	O
was	O
performed	O
by	O
using	O
either	O
Ampli	O
-	O
Taq	O
polymerase	O
(	O
PerkinElmer	O
,	O
http	O
:	O
/	O
/	O
las	O
.	O
perkinelmer	O
.	O
com	O
)	O
or	O
an	O
Expand	O
High	O
Fidelity	O
polymerase	O
system	O
(	O
Roche	O
)	O
,	O
as	O
instructed	O
by	O
the	O
manufacturers	O
.	O

On	O
the	O
other	O
hand	O
,	O
the	O
3	B
'	I
NF	I
-	I
E2	I
/	I
AP1	I
motif	I
is	O
able	O
to	O
exert	O
both	O
positive	O
and	O
negative	O
regulatory	O
effects	O
on	O
the	O
zeta	B
2	I
-	I
globin	I
promoter	I
activity	O
in	O
K562	O
cells	O
,	O
and	O
this	O
dual	O
function	O
appears	O
to	O
be	O
modulated	O
through	O
differential	O
binding	O
of	O
the	O
ubiquitous	B
AP1	I
factors	I
and	O
the	O
erythroid	B
-	I
enriched	I
NF	I
-	I
E2	I
factor	I
.	O

When	O
the	O
high	O
affinity	O
hnRNP	B
A1	I
binding	I
site	I
was	O
inserted	O
into	O
the	O
beta	B
-	I
globin	I
reporter	I
,	O
Rev	B
was	O
able	O
to	O
increase	O
the	O
cytoplasmic	O
levels	O
of	O
unspliced	O
mRNAs	O
to	O
14	O
%	O
.	O

Moreover	O
,	O
the	O
catalytic	B
domain	I
of	O
pp56	B
(	I
lck	I
)	I
was	O
able	O
to	O
induce	O
IL	B
-	I
2	I
cytokine	B
production	O
to	O
an	O
extent	O
similar	O
to	O
that	O
of	O
wild	O
-	O
type	O
pp56	B
(	I
lck	I
)	I
.	O

A	O
noncatalytic	O
domain	O
conserved	O
among	O
cytoplasmic	B
protein	I
-	I
tyrosine	I
kinases	I
modifies	O
the	O
kinase	O
function	O
and	O
transforming	O
activity	O
of	O
Fujinami	B
sarcoma	I
virus	I
P130gag	I
-	O
fps	B
.	O

Accordingly	O
,	O
an	O
expanded	O
survey	O
in	O
lymphoid	O
malignancies	O
showed	O
that	O
BCL	B
-	I
6	I
mutations	O
are	O
restricted	O
to	O
B	O
cell	O
tumors	O
displaying	O
GC	O
or	O
post	O
-	O
GC	O
phenotype	O
and	O
carrying	O
mutated	B
Ig	I
variable	I
heavy	I
chain	I
sequences	I
.	O

Binding	O
of	O
SSP	B
to	O
the	O
stage	B
selector	I
element	I
(	O
SSE	B
)	O
in	O
the	O
proximal	O
gamma	B
-	I
globin	I
promoter	I
is	O
integral	O
to	O
the	O
competitive	O
silencing	O
of	O
a	O
linked	O
beta	B
-	I
promoter	I
in	O
embryonic	O
/	O
fetal	O
stage	O
erythroleukemia	O
(	O
K562	O
)	O
cells	O
.	O

3	O
.	O
7	O
kilobases	O
upstream	O
of	O
the	O
murine	B
hematopoietic	I
-	I
specific	I
GATA	I
-	I
1	I
IE	I
promoter	I
.	O

We	O
have	O
recently	O
identified	O
two	O
regulatory	O
elements	O
in	O
the	O
murine	B
immunoglobulin	I
heavy	I
-	I
chain	I
(	I
IgH	I
)	I
enhancer	I
,	O
pi	B
and	O
microB	B
,	O
which	O
exhibit	O
striking	O
similarity	O
to	O
binding	B
sites	I
for	O
ets	B
-	I
related	I
proteins	I
.	O

This	O
process	O
is	O
shown	O
to	O
evolve	O
independently	O
of	O
the	O
presence	O
of	O
TNF	B
,	O
lymphotoxin	B
alpha	I
,	O
or	O
the	O
p55TNF	B
-	I
R	I
,	O
although	O
coexpression	O
of	O
a	O
human	B
TNF	I
transgene	I
accelerated	O
pathology	O
.	O

This	O
study	O
assessed	O
the	O
ability	O
of	O
IH636	B
grape	I
seed	I
proanthocyanidin	I
extract	I
(	O
GSPE	B
)	O
to	O
prevent	O
acetaminophen	B
(	O
AAP	B
)	O
-	O
induced	O
nephrotoxicity	O
,	O
amiodarone	B
(	O
AMI	B
)	O
-	O
induced	O
lung	O
toxicity	O
,	O
and	O
doxorubicin	B
(	O
DOX	B
)	O
-	O
induced	O
cardiotoxicity	O
in	O
mice	O
.	O

We	O
demonstrate	O
that	O
the	O
p105	B
and	O
p98	B
precursors	O
share	O
functional	O
properties	O
with	O
the	O
I	B
kappa	I
B	I
proteins	I
,	O
which	O
also	O
contain	O
SWI6	B
/	I
ankyrin	I
repeats	I
.	O

Native	O
PTF	B
beta	I
,	O
in	O
either	O
protein	O
fractions	O
or	O
a	O
PTF	B
-	I
Oct	I
-	I
1	I
-	I
DNA	I
complex	I
,	O
can	O
be	O
recognized	O
by	O
polyclonal	B
antibodies	I
raised	O
against	O
recombinant	B
PTF	I
beta	I
.	O

Sequence	O
analysis	O
indicates	O
that	O
RBP21	B
shares	O
homology	O
with	O
other	O
retinoblastoma	B
-	I
binding	I
proteins	I
in	O
the	O
pRb	B
-	I
binding	I
motif	I
LxCxE	O
at	O
the	O
C	O
-	O
terminal	O
region	O
.	O

We	O
also	O
compared	O
the	O
sequence	O
with	O
the	O
partly	O
homologous	O
products	O
of	O
the	O
S	O
.	O
cerevisiae	O
genes	O
TPS2	B
and	O
TSL1	B
which	O
code	O
for	O
the	O
larger	O
subunits	O
of	O
the	O
trehalose	B
synthase	I
complex	I
and	O
with	O
a	O
TSL1	B
homologue	I
,	O
TPS3	B
,	O
of	O
unknown	O
function	O
.	O

Access	O
to	O
this	O
site	O
is	O
blocked	O
in	O
the	O
normal	B
silent	I
c	I
-	I
myc	I
allele	I
;	O
these	O
data	O
suggest	O
that	O
the	O
Nm23H2	B
protein	O
is	O
involved	O
in	O
deregulation	O
of	O
the	O
translocated	O
c	B
-	I
myc	I
allele	I
in	O
Burkitt	O
'	O
s	O
lymphoma	O
cells	O
.	O

The	O
remarkable	O
correlation	O
between	O
genomic	O
footprinting	O
data	O
and	O
the	O
mutagenesis	O
results	O
also	O
suggests	O
that	O
the	O
erythroid	O
lineage	O
-	O
and	O
developmental	O
stage	O
-	O
specific	O
regulation	O
of	O
human	B
alpha	I
-	I
like	I
globin	I
promoters	I
is	O
indeed	O
modulated	O
by	O
stable	O
binding	O
of	O
specific	B
nuclear	I
factors	I
in	O
vivo	O
.	O

The	O
PuF	B
site	I
on	O
the	O
silent	B
normal	I
c	I
-	I
myc	I
allele	I
was	O
unoccupied	O
.	O

This	O
study	O
was	O
designed	O
to	O
determine	O
the	O
potential	O
cis	B
-	I
elements	I
involved	O
in	O
transcriptional	O
regulation	O
of	O
the	O
mouse	B
perforin	I
gene	I
.	O

On	O
the	O
basis	O
of	O
these	O
unique	O
properties	O
,	O
the	O
newly	O
characterized	O
hemagglutinin	B
has	O
been	O
termed	O
Limulus	B
18K	I
agglutination	I
-	I
aggregation	I
factor	I
(	O
18K	B
-	I
LAF	I
)	O
.	O

We	O
analyzed	O
the	O
effects	O
of	O
hemin	O
or	O
TPA	O
induction	O
on	O
the	O
binding	O
and	O
activity	O
of	O
transcription	B
factors	I
at	O
a	O
regulatory	B
element	I
found	O
within	O
the	O
transcriptional	B
regulatory	I
sequences	I
of	O
many	O
erythroid	B
-	I
specific	I
genes	I
.	O

Isolation	O
and	O
characterization	O
of	O
murine	B
fra	I
-	I
1	I
:	O
induction	O
mediated	O
by	O
CD40	B
and	O
surface	B
Ig	I
is	O
protein	B
kinase	I
C	I
dependent	O
.	O

From	O
an	O
RNK	O
-	O
16	O
lambda	O
-	O
gt11	O
library	O
,	O
we	O
have	O
isolated	O
and	O
sequenced	O
a	O
novel	O
cDNA	O
rat	B
NK	I
cell	I
protease	I
1	I
(	O
RNKP	B
-	I
1	I
)	O
that	O
has	O
characteristics	O
unique	O
to	O
serine	B
proteases	I
.	O

Digestion	O
of	O
NF	B
-	I
IL6	I
with	O
endoprotease	B
Asp	I
-	I
N	I
produced	O
a	O
domain	O
smaller	O
than	O
the	O
TCD	B
(	O
NF	B
-	I
IL6	I
bZIP	I
domains	I
(	O
NFBD	B
)	O
(	O
272	O
-	O
345	O
)	O
)	O
,	O
a	O
domain	O
identified	O
either	O
in	O
the	O
absence	O
or	O
the	O
presence	O
of	O
DNA	O
.	O

In	O
both	O
shoots	O
and	O
roots	O
,	O
GT	B
-	I
2	I
protein	I
is	O
undetectable	O
in	O
meristematic	O
tissue	O
but	O
becomes	O
expressed	O
at	O
later	O
stages	O
of	O
cellular	O
development	O
,	O
consistent	O
with	O
a	O
role	O
in	O
contributing	O
to	O
the	O
pattern	O
of	O
phytochrome	B
A	I
gene	I
expression	O
.	O

Identification	O
of	O
an	O
ionomycin	B
/	I
cyclosporin	I
A	I
-	I
responsive	I
element	I
within	O
the	O
human	B
T	I
cell	I
receptor	I
gamma	I
enhancer	I
.	O

Northern	O
blot	O
analysis	O
showed	O
that	O
C3a	B
as	O
well	O
as	O
C3a	B
(	I
desArg	I
)	I
enhanced	O
LPS	O
-	B
induced	I
mRNA	I
levels	O
for	O
IL	B
-	I
6	I
.	O

An	O
element	B
upstream	O
from	O
the	O
human	B
delta	I
-	I
globin	I
-	I
encoding	I
gene	I
specifically	O
enhances	O
beta	B
-	I
globin	I
reporter	I
gene	I
expression	O
in	O
murine	O
erythroleukemia	O
cells	O
.	O

Analyses	O
of	O
hGMR	B
beta	I
subunit	I
mutants	I
revealed	O
two	O
cytoplasmic	O
regions	O
involved	O
in	O
activation	O
of	O
the	O
c	B
-	I
myc	I
promoter	I
,	O
one	O
is	O
essential	O
and	O
the	O
other	O
is	O
dispensable	O
but	O
enhances	O
the	O
activity	O
.	O

Transcriptional	O
regulation	O
of	O
the	O
pyruvate	B
kinase	I
erythroid	I
-	I
specific	I
promoter	I
.	O

In	O
the	O
majority	O
of	O
cases	O
,	O
RARalpha	B
translocates	O
and	O
fuses	O
with	O
the	O
promyelocytic	B
leukemia	I
(	I
PML	I
)	I
gene	I
located	O
on	O
chromosome	B
15	I
.	O

We	O
investigated	O
the	O
role	O
of	O
this	O
G	B
+	I
C	I
-	I
rich	I
region	I
in	O
augmenting	O
alpha	B
-	I
globin	I
promoter	I
activity	O
in	O
the	O
presence	O
of	O
the	O
far	B
-	I
upstream	I
alpha	I
-	I
globin	I
enhancer	I
,	O
HS	B
-	I
40	I
.	O

Interaction	O
was	O
apparently	O
determined	O
by	O
the	O
N	O
-	O
terminal	O
splice	O
region	O
of	O
RPDE	B
-	I
6	I
,	O
as	O
the	O
PDE4A	B
splice	O
variant	O
RPDE	B
-	I
39	I
,	O
which	O
differs	O
from	O
RPDE	B
-	I
6	I
at	O
the	O
extreme	O
N	O
-	O
terminus	O
,	O
failed	O
to	O
associate	O
with	O
v	B
-	I
Src	I
-	O
SH3	B
;	O
met26RD1	B
(	O
where	O
RD1	B
is	O
rat	B
'	I
dunc	I
-	I
like	I
'	I
PDE	I
)	O
,	O
which	O
has	O
the	O
N	O
-	O
terminal	O
splice	O
region	O
deleted	O
,	O
failed	O
to	O
associate	O
with	O
v	B
-	I
Src	I
-	O
SH3	B
,	O
and	O
the	O
association	O
of	O
RPDE	B
-	I
6	I
and	O
v	B
-	I
Src	I
-	O
SH3	B
was	O
blocked	O
by	O
a	O
fusion	O
protein	O
formed	O
from	O
the	O
N	O
-	O
terminal	O
splice	O
region	O
.	O

Thrombopoietin	B
also	O
induced	O
tyrosine	O
phosphorylation	O
of	O
Stat3	B
and	O
Stat5	B
in	O
FDCP	O
-	O
2	O
cells	O
genetically	O
engineered	O
to	O
constitutively	O
express	O
human	B
c	I
-	I
Mpl	I
.	O

In	O
this	O
study	O
,	O
we	O
have	O
cloned	O
a	O
region	O
that	O
complements	O
the	O
exoenzyme	B
S	I
-	O
deficient	O
phenotype	O
of	O
strain	O
388	O
exs1	B
:	O
:	O
Tn1	B
,	O
a	O
chromosomal	B
Tn1	I
insertional	I
mutation	I
.	O

ATF1	B
and	O
CREB	B
trans	O
-	O
activate	O
a	O
cell	B
cycle	I
regulated	I
histone	I
H4	I
gene	I
at	O
a	O
distal	B
nuclear	I
matrix	I
associated	I
promoter	I
element	I
.	O

Thrombopoietin	B
induces	O
tyrosine	O
phosphorylation	O
of	O
Stat3	B
and	O
Stat5	B
in	O
human	O
blood	O
platelets	O
.	O

However	O
,	O
Spi	B
-	I
C	I
may	O
represent	O
a	O
novel	O
subgroup	O
within	O
the	O
Ets	B
protein	I
family	I
,	O
as	O
it	O
differed	O
significantly	O
from	O
Spi	B
-	I
B	I
and	O
PU	B
.	I
1	I
within	O
helix	B
1	I
of	O
the	O
Ets	B
domain	I
.	O

The	O
predicted	O
protein	O
products	O
of	O
ORFs	B
N2417	I
and	O
N2403	B
present	O
similarities	O
with	O
domains	O
from	O
proteins	O
of	O
other	O
organisms	O
:	O
the	O
Candida	O
maltosa	O
cycloheximide	B
-	I
resistance	I
protein	I
,	O
the	O
human	O
interleukin	B
enhancer	I
-	I
binding	I
factor	I
(	O
ILF	B
-	I
2	I
)	O
.	O

Complexes	O
containing	O
wild	O
-	O
type	O
and	O
either	O
his175	B
or	I
his273	I
mutant	I
p53	I
proteins	I
are	O
completely	O
unable	O
to	O
bind	O
to	O
the	O
RGC	B
DNA	I
sequence	I
.	O

Bal	O
31	O
deletion	O
mapping	O
data	O
suggested	O
that	O
one	O
GATA	O
-	O
1	O
motif	O
,	O
one	O
GT	O
motif	O
,	O
and	O
two	O
NF	O
-	O
E2	O
/	O
AP1	O
motifs	O
together	O
formed	O
the	O
functional	O
core	O
of	O
HS	B
-	I
40	I
in	O
the	O
erythroid	O
-	O
specific	O
activation	O
of	O
the	O
zeta	B
2	I
globin	I
promoter	I
.	O

In	O
this	O
study	O
,	O
transient	O
cotransfection	O
of	O
several	O
GPIX	B
promoter	I
/	I
reporter	I
constructs	I
into	O
293T	O
kidney	O
fibroblasts	O
with	O
a	O
Fli	B
-	I
1	I
expression	I
vector	I
shows	O
that	O
the	O
oncogenic	O
protein	O
Fli	B
-	I
1	I
can	O
transactivate	O
the	O
GPIX	B
promoter	I
when	O
an	O
intact	O
GPIX	B
Ets	I
site	I
is	O
present	O
.	O

In	O
addition	O
,	O
stonin	B
2	I
binds	O
to	O
the	O
C2B	O
domains	O
of	O
synaptotagmins	B
I	I
and	I
II	I
.	O

Structure	O
and	O
function	O
analysis	O
of	O
the	O
human	B
myeloid	I
cell	I
nuclear	I
differentiation	I
antigen	I
promoter	I
:	O
evidence	O
for	O
the	O
role	O
of	O
Sp1	B
and	O
not	O
of	O
c	B
-	I
Myb	I
or	O
PU	B
.	I
1	I
in	O
myelomonocytic	O
lineage	O
-	O
specific	O
expression	O
.	O

Here	O
we	O
report	O
that	O
human	O
leukaemia	O
cells	O
carrying	O
the	O
translocation	O
t	B
(	I
17	I
;	I
19	I
)	I
rapidly	O
died	O
by	O
apoptosis	O
when	O
programmed	O
to	O
express	O
a	O
dominant	O
-	O
negative	O
suppressor	O
of	O
the	O
fusion	O
protein	O
E2A	B
-	I
HLF	I
,	O
indicating	O
that	O
the	O
chimaeric	B
oncoprotein	I
probably	O
affects	O
cell	O
survival	O
rather	O
than	O
cell	O
growth	O
.	O

As	O
an	O
initial	O
step	O
towards	O
the	O
characterization	O
of	O
replicative	O
DNA	B
polymerases	I
of	I
trypanosomes	I
,	O
we	O
have	O
cloned	O
,	O
sequenced	O
and	O
examined	O
the	O
expression	O
of	O
the	O
Trypanosoma	O
(	O
Trypanozoon	O
)	O
brucei	O
brucei	O
gene	O
that	O
encodes	O
the	O
DNA	B
polymerase	I
alpha	I
catalytic	I
core	I
(	O
pol	B
alpha	I
)	O
.	O

To	O
clarify	O
the	O
molecular	O
mechanisms	O
involved	O
in	O
the	O
developmental	O
control	O
of	O
hemoglobin	B
-	I
encoding	I
genes	I
we	O
have	O
been	O
studying	O
the	O
expression	O
of	O
these	O
genes	B
in	O
human	O
cells	O
in	O
continuous	O
culture	O
.	O

The	O
myeloid	B
-	I
cell	I
-	I
specific	I
c	I
-	I
fes	I
promoter	I
is	O
regulated	O
by	O
Sp1	B
,	O
PU	B
.	I
1	I
,	O
and	O
a	O
novel	O
transcription	B
factor	I
.	O

In	O
contrast	O
,	O
Y239	B
/	I
240F	I
Shc	I
,	O
but	O
not	O
Y317F	B
Shc	I
,	O
reduced	O
the	O
EGF	B
-	O
induced	O
c	B
-	I
myc	I
message	O
.	O

Initiation	B
binding	I
repressor	I
,	O
a	O
factor	O
that	O
binds	O
to	O
the	O
transcription	B
initiation	I
site	I
of	O
the	O
histone	B
h5	I
gene	I
,	O
is	O
a	O
glycosylated	B
member	I
of	O
a	O
family	O
of	O
cell	B
growth	I
regulators	I
[	O
corrected	O
]	O
[	O
published	O
erratum	O
appears	O
in	O
Mol	O
Cell	O
Biol	O
1996	O
Feb	O
;	O
16	O
(	O
2	O
)	O
:	O
735	O
]	O

Furthermore	O
,	O
using	O
DNA	B
templates	I
containing	O
two	O
copies	O
of	O
the	O
PRDII	B
domain	I
linked	O
to	O
the	O
rabbit	B
beta	I
globin	I
gene	I
,	O
the	O
purified	O
polypeptides	O
specifically	O
stimulated	O
NF	B
-	I
kappa	I
B	I
dependent	O
transcription	O
in	O
an	O
in	O
vitro	O
reconstitution	O
assay	O
as	O
heterodimers	O
but	O
not	O
as	O
p50	B
homodimers	I
.	O

SLP	B
-	I
76	I
and	O
Vav	B
,	O
two	O
hematopoietic	B
cell	I
specific	I
molecules	I
,	O
are	O
critical	O
for	O
T	O
cell	O
development	O
and	O
activation	O
.	O

When	O
tested	O
for	O
its	O
ability	O
to	O
block	O
calcineurin	B
-	O
dependent	O
signaling	O
in	O
Jurkat	O
cells	O
,	O
expression	O
of	O
this	O
`	B
`	I
B	I
-	I
subunit	I
knock	I
-	I
out	I
'	I
'	I
(	I
BKO	I
)	I
construct	I
suppressed	O
reporter	B
gene	I
activity	O
driven	O
by	O
NF	B
-	I
AT	I
,	O
the	O
pivotal	O
promoter	B
element	I
for	O
interleukin	B
(	I
IL	I
)	I
-	I
2	I
gene	I
induction	O
.	O

Our	O
investigations	O
have	O
focused	O
on	O
localizing	O
cis	B
-	I
elements	I
responsible	O
for	O
the	O
down	O
regulation	O
of	O
the	O
adult	B
beta	I
-	I
like	I
globin	I
genes	I
(	O
delta	B
and	O
beta	B
)	O
in	O
immature	O
,	O
or	O
primitive	O
erythroid	O
tissues	O
.	O

A	O
membrane	B
-	I
proximal	I
region	I
that	O
contains	O
the	O
BOX1	B
consensus	I
sequence	I
is	O
required	O
for	O
IL	B
-	I
9	I
-	O
induced	O
cell	O
proliferation	O
and	O
tyrosine	O
phosphorylation	O
of	O
Janus	B
kinases	I
(	O
JAKs	B
)	O
.	O

Mapping	O
of	O
RNA	O
-	O
temperature	B
-	I
sensitive	I
mutants	I
of	I
Sindbis	I
virus	I
:	I
complementation	I
group	I
F	I
mutants	I
have	O
lesions	O
in	O
nsP4	B
.	O

TPO	B
induced	O
tyrosine	O
phosphorylation	O
of	O
the	O
TPO	B
receptor	O
but	O
not	O
the	O
erythropoietin	B
(	I
EPO	I
)	I
receptor	I
.	O

To	O
understand	O
the	O
function	O
of	O
AML1	B
during	O
B	O
cell	O
differentiation	O
,	O
we	O
analyzed	O
regulatory	B
regions	I
of	O
B	B
cell	I
-	I
specific	I
genes	I
for	O
potential	O
AML1	B
-	I
binding	I
sites	I
and	O
have	O
identified	O
a	O
putative	O
AML1	B
-	I
binding	I
site	I
in	O
the	O
promoter	O
of	O
the	O
B	B
cell	I
-	I
specific	I
tyrosine	I
kinase	I
gene	I
,	I
blk	I
.	O

Cells	O
were	O
pretreated	O
with	O
maltolyl	B
p	I
-	I
coumarate	I
,	O
before	O
exposed	O
to	O
amyloid	B
beta	I
peptide	I
(	I
1	I
-	I
42	I
)	I
,	O
glutamate	B
or	O
H2O2	B
.	O

The	O
transcription	B
factor	I
,	O
Nm23H2	B
,	O
binds	O
to	O
and	O
activates	O
the	O
translocated	O
c	B
-	I
myc	I
allele	I
in	O
Burkitt	O
'	O
s	O
lymphoma	O
.	O

We	O
have	O
cloned	O
a	O
novel	O
protein	O
kinase	O
,	O
termed	O
hematopoietic	B
progenitor	I
kinase	I
1	I
(	O
HPK1	B
)	O
,	O
that	O
is	O
expressed	O
predominantly	O
in	O
hematopoietic	O
cells	O
,	O
including	O
early	O
progenitor	O
cells	O
.	O

Cotransfection	O
of	O
Sp3	B
along	O
with	O
CD11c	B
promoter	I
-	I
luciferase	I
constructs	I
into	O
Sp	O
-	O
deficient	O
Drosophila	O
Schneider	O
2	O
cells	O
showed	O
that	O
Sp3	B
could	O
activate	O
the	O
CD11c	B
promoter	I
.	O

A	O
subset	O
of	O
mutations	O
in	O
the	O
Psi	B
synthase	I
domain	I
impairs	O
association	O
of	O
the	O
altered	O
Cbf5p	B
proteins	I
with	O
selected	O
box	O
H	B
/	I
ACA	I
snoRNAs	I
,	O
suggesting	O
that	O
the	O
functional	O
catalytic	O
domain	O
is	O
essential	O
for	O
that	O
interaction	O
.	O

The	O
complement	B
C3a	I
anaphylatoxin	I
receptor	I
(	O
C3aR	B
)	O
is	O
a	O
seven	B
-	I
transmembrane	I
G	I
-	I
protein	I
coupled	I
chemoattractant	I
receptor	I
that	O
on	O
binding	O
the	O
C3a	B
peptide	I
ligand	I
mediates	O
numerous	O
cellular	O
responses	O
,	O
including	O
histamine	O
release	O
from	O
mast	O
cells	O
.	O
smooth	O
muscle	O
contraction	O
,	O
and	O
the	O
directed	O
migration	O
of	O
eosinophils	O
.	O

The	O
HB9	B
homeodomain	I
is	O
most	O
similar	O
to	O
that	O
of	O
the	O
Drosophila	B
melanogaster	I
homeobox	I
gene	I
proboscipedia	B
.	O

Analyses	O
of	O
hybrid	O
cells	O
show	O
that	O
TIMP	B
,	O
ZXDA	B
,	O
and	O
ZXDB	B
loci	I
on	O
the	O
proximal	B
short	I
arm	I
,	O
and	O
AR	B
and	O
PHKA1	B
loci	I
on	O
the	O
long	O
arm	O
,	O
are	O
well	O
expressed	O
from	O
the	O
tiny	B
ring	I
X	I
chromosome	I
lacking	O
XIST	B
DNA	I
.	O

The	O
recombinant	B
vaccinia	I
virus	I
-	I
expressed	I
mutant	I
P1	I
polyproteins	I
were	O
analyzed	O
for	O
proteolytic	O
processing	O
defects	O
in	O
cells	O
coinfected	O
with	O
a	O
recombinant	O
vaccinia	O
virus	O
(	O
VVP3	O
)	O
that	O
expresses	O
the	O
poliovirus	B
3CD	I
protease	I
and	O
for	O
processing	O
and	O
assembly	O
defects	O
by	O
using	O
a	O
trans	O
complementation	O
system	O
in	O
which	O
P1	B
-	O
expressing	O
recombinant	O
vaccinia	O
viruses	O
provide	O
capsid	B
precursor	I
to	O
a	O
defective	O
poliovirus	O
genome	O
that	O
does	O
not	O
express	O
functional	O
capsid	B
proteins	I
(	O
D	O
.	O

The	O
T	B
-	I
cell	I
oncogenic	I
protein	I
HOX11	I
activates	O
Aldh1	B
expression	O
in	O
NIH	O
3T3	O
cells	O
but	O
represses	O
its	O
expression	O
in	O
mouse	O
spleen	O
development	O
.	O

Fas	B
(	O
CD95	B
/	I
APO	I
-	I
1	I
)	O
is	O
a	O
transmembrane	B
protein	I
of	O
the	O
TNF	B
/	I
neuron	I
growth	I
factor	I
receptor	I
family	I
.	O

One	O
feature	O
of	O
this	O
chromatin	O
reorganization	O
is	O
the	O
formation	O
of	O
DNase	B
1	I
hypersensitive	I
sites	I
in	O
the	O
regions	O
of	O
active	B
globin	I
gene	I
promoters	I
.	O

Analysis	O
of	O
erythroblasts	O
co	O
-	O
expressing	O
Spi	B
-	I
1	I
and	O
the	O
wild	B
-	I
type	I
mouse	I
EpoR	I
showed	O
that	O
differentiation	O
arrest	O
and	O
inhibition	O
of	O
apoptosis	O
depended	O
on	O
specific	O
cooperation	O
between	O
Spi	B
-	I
1	I
and	O
EpoR	B
(	I
R129C	I
)	I
.	O

Moreover	O
,	O
glucan	B
synthase	I
activity	O
,	O
which	O
is	O
activated	O
by	O
Rho1p	B
,	O
was	O
significantly	O
reduced	O
in	O
the	O
deltabem4	B
mutant	I
.	O

Mutation	O
of	O
Ikaros	B
or	O
AP	B
-	I
1	I
binding	I
sites	I
in	O
the	O
context	O
of	O
the	O
granzyme	B
B	I
promoter	I
demonstrated	O
that	O
both	O
sites	O
participate	O
in	O
dexamethasone	O
-	O
mediated	O
inhibition	O
of	O
the	O
granzyme	B
B	I
promoter	I
activity	O
.	O

We	O
report	O
here	O
the	O
molecular	O
cloning	O
of	O
a	O
putative	O
adhesive	O
molecule	O
from	O
P	O
.	O
falciparum	O
that	O
shares	O
both	O
sequence	O
and	O
structural	O
similarities	O
with	O
a	O
sporozoite	O
surface	O
molecule	O
from	O
Plasmodium	O
termed	O
the	O
thrombospondin	B
-	I
related	I
anonymous	I
protein	I
(	O
TRAP	B
)	O
and	O
,	O
to	O
a	O
lesser	O
extent	O
,	O
with	O
the	O
circumsporozoite	B
(	I
CS	I
)	I
protein	I
.	O

Transcriptional	O
activity	O
of	O
core	B
binding	I
factor	I
-	I
alpha	I
(	I
AML1	I
)	I
and	I
beta	I
subunits	O
on	O
murine	B
leukemia	I
virus	I
enhancer	I
cores	I
.	O

Isolation	O
and	O
characterization	O
of	O
a	O
vinculin	B
cDNA	I
from	I
chick	I
-	I
embryo	I
fibroblasts	I
.	O

The	O
HTLV	B
-	I
I	I
transcriptional	I
activator	I
tax	I
was	O
used	O
to	O
gain	O
insight	O
into	O
the	O
mechanism	O
of	O
lymphotoxin	B
(	I
LT	I
;	I
TNF	I
-	I
beta	I
)	I
gene	I
induction	O
.	O

T	B
-	I
helper	I
-	I
cell	I
determinants	I
in	O
protein	B
antigens	I
are	O
preferentially	O
located	O
in	O
cysteine	B
-	I
rich	I
antigen	I
segments	I
resistant	O
to	O
proteolytic	O
cleavage	O
by	O
cathepsin	B
B	I
,	I
L	I
,	I
and	I
D	I
.	O

To	O
determine	O
if	O
platelet	O
thromboxane	B
receptors	I
are	O
under	O
transcriptional	O
control	O
,	O
we	O
isolated	O
and	O
characterized	O
human	B
genomic	I
DNA	I
clones	I
containing	O
the	O
5	B
'	I
flanking	I
region	I
of	O
the	O
thromboxane	B
receptor	I
gene	I
.	O

We	O
have	O
identified	O
a	O
cDNA	B
clone	I
,	O
DR	B
-	I
nm23	I
,	O
differentially	O
expressed	O
in	O
a	O
blast	B
-	I
crisis	I
cDNA	I
library	I
,	I
which	O
has	O
approximately	O
70	O
%	O
sequence	O
similarity	O
to	O
the	O
putative	B
metastatic	I
suppressor	I
genes	I
,	O
nm23	B
-	I
H1	I
and	O
nm23	B
-	I
H2	I
.	O

The	O
lysozyme	B
FEF	B
site	O
is	O
immediately	O
5	O
'	O
to	O
a	O
PU	B
.	O

BASH	B
becomes	O
tyrosine	O
-	O
phosphorylated	O
with	O
the	O
B	B
cell	I
Ag	I
receptor	I
(	O
BCR	B
)	O
cross	O
-	O
link	O
or	O
by	O
coexpression	O
with	O
Syk	B
and	O
Lyn	B
and	O
associates	O
with	O
signaling	B
molecules	I
including	O
Syk	B
and	O
a	O
putative	B
chicken	I
Shc	I
homologue	I
.	O

We	O
have	O
tested	O
several	O
subregions	O
of	O
the	O
DR	B
enhancer	I
B	B
domain	I
,	O
either	O
alone	O
or	O
in	O
combination	O
,	O
for	O
their	O
capacity	O
to	O
transmit	O
the	O
R	O
-	O
activating	O
signal	O
to	O
the	O
rabbit	B
beta	I
-	I
globin	I
promoter	I
.	O

The	O
extracellular	O
domain	O
of	O
the	O
murine	B
G	I
-	I
CSF	I
receptor	I
was	O
required	O
for	O
the	O
activity	O
of	O
SB	O
247464	O
,	O
suggesting	O
that	O
the	O
compound	O
acts	O
by	O
oligomerizing	B
receptor	I
chains	I
.	O

We	O
conclude	O
that	O
the	O
human	B
c	I
-	I
fes	I
gene	I
contains	O
a	O
strong	O
myeloid	B
-	I
cell	I
-	I
specific	I
promoter	I
that	O
is	O
regulated	O
by	O
Sp1	B
,	O
PU	B
.	I
1	I
,	O
and	O
a	O
novel	O
transcription	B
factor	I
.	O

Although	O
Micrococcus	B
luteus	I
UV	I
endonuclease	I
has	O
been	O
reported	O
to	O
be	O
an	O
18	O
-	O
kDa	O
enzyme	O
with	O
possible	O
homology	O
to	O
the	O
16	B
-	I
kDa	I
endonuclease	I
V	I
from	I
bacteriophage	I
T4	I
(	O
Gordon	O
,	O
L	O
.	O

Grf40	B
binds	O
to	O
the	O
SH2	B
domain	I
-	I
containing	I
leukocyte	I
protein	I
of	O
76	O
kD	O
(	O
SLP	B
-	I
76	I
)	O
via	O
its	O
SH3	O
domain	O
more	O
tightly	O
than	O
Grb2	B
.	O

We	O
find	O
that	O
in	O
the	O
absence	O
of	O
EKLF	B
,	O
while	O
human	B
beta	I
-	I
globin	I
expression	O
is	O
dramatically	O
reduced	O
,	O
gamma	B
-	I
globin	I
transcripts	I
are	O
elevated	O
approximately	O
5	O
-	O
fold	O
.	O

A	O
novel	O
form	O
of	O
the	O
myeloid	B
-	I
specific	I
zinc	I
finger	I
protein	I
(	O
MZF	B
-	I
2	I
)	O
.	O

Identification	O
of	O
dynein	B
heavy	I
chain	I
genes	I
expressed	O
in	O
human	O
and	O
mouse	O
testis	O
:	O
chromosomal	O
localization	O
of	O
an	O
axonemal	B
dynein	I
gene	I
.	O

From	O
a	O
murine	B
B	I
-	I
cell	I
cDNA	I
-	I
library	I
we	O
have	O
cloned	O
a	O
cDNA	B
encoding	O
the	O
murine	B
B	I
-	I
cell	I
specific	I
coactivator	I
mBob1	B
.	O

Recombinant	B
Leishmania	I
surface	I
glycoprotein	I
GP63	I
is	O
secreted	O
in	O
the	O
baculovirus	O
expression	O
system	O
as	O
a	O
latent	O
metalloproteinase	B
.	O

It	O
is	O
very	O
likely	O
that	O
these	O
domains	O
bind	O
megakaryocyte	B
-	I
specific	I
nuclear	I
proteins	I
acting	O
as	O
positive	B
transcription	I
factors	I
.	O

Parathyroid	B
hormone	I
regulation	O
of	O
bone	B
sialoprotein	I
(	O
BSP	B
)	O
gene	O
transcription	O
is	O
mediated	O
through	O
a	O
pituitary	B
-	I
specific	I
transcription	I
factor	I
-	I
1	I
(	O
Pit	B
-	I
1	I
)	O
motif	O
in	O
the	O
rat	B
BSP	I
gene	I
promoter	I
.	O

Recently	O
,	O
the	O
defective	B
gene	I
in	O
group	O
II	O
type	O
II	O
MHC	B
CID	O
has	O
been	O
isolated	O
and	O
termed	O
CIITA	B
.	O

The	O
composite	B
motif	I
binds	O
a	O
multi	B
-	I
protein	I
hematopoietic	I
-	I
specific	I
transcription	I
factor	I
complex	I
which	O
includes	O
GATA	B
-	I
1	I
,	O
SCL	B
/	I
tal	I
-	I
1	I
,	I
E2A	B
,	O
Lmo2	B
and	O
Ldb	B
-	I
1	I
.	O

Hematopoietic	B
growth	I
factors	I
have	O
already	O
had	O
an	O
enormous	O
impact	O
on	O
transfusion	O
practice	O
by	O
eliminating	O
or	O
reducing	O
the	O
need	O
for	O
red	O
blood	O
cell	O
transfusions	O
in	O
a	O
variety	O
of	O
anemic	O
states	O
characterized	O
by	O
an	O
absolute	O
or	O
relative	O
decrease	O
in	O
erythropoietin	B
.	O

In	O
previous	O
studies	O
,	O
we	O
identified	O
calcineurin	B
mutations	O
that	O
block	O
binding	O
by	O
the	O
cyclophilin	B
A	I
/	I
CsA	I
or	I
FKBP12	I
/	I
FK506	I
complexes	I
and	O
thereby	O
render	O
yeast	O
cells	O
resistant	O
to	O
the	O
antifungal	O
effects	O
of	O
CsA	O
or	O
FK506	O
.	O

The	O
loss	O
of	O
TNFRp55	B
function	O
renders	O
mice	O
resistant	O
to	O
lethal	O
dosages	O
of	O
either	O
lipopolysaccharides	O
or	O
S	B
.	I
aureus	I
enterotoxin	I
B	I
.	O

Analysis	O
at	O
the	O
phenotype	O
and	O
genetic	O
level	O
showed	O
that	O
lack	O
of	O
CD5	B
expression	O
was	O
due	O
neither	O
to	O
segregation	O
of	O
human	B
autosome	I
11	I
,	O
on	O
which	O
the	O
CD5	B
gene	I
has	O
been	O
mapped	O
,	O
nor	O
to	O
deletion	O
of	O
the	O
CD5	B
structural	I
gene	I
.	O

Together	O
,	O
our	O
data	O
show	O
that	O
bcl	B
-	I
xL	I
is	O
essential	O
for	O
normal	O
erythroid	O
development	O
and	O
suggest	O
a	O
regulatory	O
hierarchy	O
in	O
which	O
bcl	B
-	I
xL	I
is	O
a	O
critical	O
downstream	O
effector	O
of	O
GATA	B
-	I
1	I
and	O
erythropoietin	B
-	O
mediated	O
signals	O
.	O

These	O
data	O
show	O
that	O
human	B
PCD	I
/	I
DCoH	I
is	O
not	O
only	O
present	O
in	O
cells	O
where	O
tetrahydrobiopterin	B
is	O
synthesized	O
or	O
HNF1	B
is	O
present	O
but	O
is	O
a	O
widely	O
distributed	O
protein	O
.	O

We	O
hypothesize	O
that	O
this	O
110	B
-	I
kDa	I
protein	I
may	O
be	O
a	O
functionally	O
important	O
B	B
cell	I
-	I
specific	I
co	I
-	I
activator	I
of	O
A	B
-	I
MYB	I
.	O

In	O
support	O
of	O
a	O
role	O
at	O
the	O
spindle	O
,	O
two	O
-	O
hybrid	O
library	O
screening	O
with	O
HEF1	B
identifies	O
the	O
human	O
homolog	O
of	O
the	O
G2	B
/	I
M	I
spindle	I
-	I
regulatory	I
protein	I
Dim1p	I
as	O
a	O
specific	O
interactor	O
with	O
a	O
region	O
of	O
HEF1	B
encompassed	O
in	O
p55	B
(	O
HEF1	B
)	O
.	O

Lipopolysaccharide	O
-	O
induced	O
E	B
-	I
selectin	I
expression	O
requires	O
continuous	O
presence	O
of	O
LPS	O
and	O
is	O
inhibited	O
by	O
bactericidal	B
/	I
permeability	I
-	I
increasing	I
protein	I
.	O

A	O
novel	B
B	I
cell	I
-	I
derived	I
coactivator	I
potentiates	O
the	O
activation	O
of	O
immunoglobulin	B
promoters	I
by	O
octamer	B
-	I
binding	I
transcription	I
factors	I
.	O

Thus	O
,	O
we	O
have	O
identified	O
a	O
GRE	O
sufficient	O
to	O
account	O
for	O
full	O
glucocorticoid	O
inducibility	O
and	O
an	O
HNF	B
-	I
1	I
site	I
close	O
to	O
the	O
promoter	O
that	O
are	O
major	O
determinants	O
of	O
transcriptional	O
control	O
of	O
the	O
Xenopus	B
fibrinogen	I
B	I
beta	I
subunit	I
gene	I
in	O
cells	O
from	O
normal	O
liver	O
tissue	O
.	O

We	O
show	O
that	O
,	O
whereas	O
a	O
multimerized	B
response	I
element	I
from	O
the	O
germline	B
IgE	I
promoter	I
was	O
highly	O
induced	O
by	O
IL	B
-	I
4	I
in	O
Stat6	O
-	O
expressing	O
Jurkat	O
cells	O
,	O
the	O
intact	O
human	B
IL	I
-	I
4	I
promoter	I
was	O
repressed	O
under	O
similar	O
conditions	O
.	O

Bruton	B
'	I
s	I
agammaglobulinemia	I
tyrosine	I
kinase	I
(	O
Btk	B
)	O
is	O
a	O
cytoplasmic	B
tyrosine	I
kinase	I
involved	O
in	O
the	O
human	O
disease	O
X	O
-	O
linked	O
agammaglobulinemia	O
(	O
XLA	O
)	O
.	O

Gene	O
for	O
a	O
tissue	B
-	I
specific	I
transcriptional	I
activator	I
(	O
EBF	B
or	O
Olf	B
-	I
1	I
)	O
,	O
expressed	O
in	O
early	O
B	O
lymphocytes	O
,	O
adipocytes	O
,	O
and	O
olfactory	O
neurons	O
,	O
is	O
located	O
on	O
human	B
chromosome	I
5	I
,	O
band	B
q34	I
,	O
and	O
proximal	B
mouse	I
chromosome	I
11	I
.	O

We	O
report	O
here	O
that	O
the	O
nuclear	B
factor	I
of	O
activated	O
T	O
cells	O
(	O
NFATp	B
)	O
,	O
a	O
cyclosporin	B
A	I
(	I
CsA	I
)	I
-	I
sensitive	I
factor	I
that	O
regulates	O
the	O
transcription	O
of	O
several	O
cytokines	B
,	O
mediates	O
CD16	B
-	O
induced	O
activation	O
of	O
cytokine	B
genes	I
in	O
human	O
NK	O
cells	O
.	O

METHODS	O
:	O
Stable	O
transfectants	O
of	O
the	O
porcine	O
vascular	O
endothelial	O
cell	O
line	O
PIEC	O
with	O
mutated	O
CIITA	B
constructs	I
were	O
tested	O
for	O
SLA	B
-	I
DR	I
and	O
SLA	B
-	I
DQ	I
induction	O
by	O
recombinant	B
porcine	I
interferon	I
-	I
gamma	I
.	O

Our	O
experiments	O
suggest	O
that	O
the	O
SCL	B
gene	I
can	O
be	O
a	O
target	O
for	O
the	O
erythroid	B
transcription	I
factor	I
GATA	I
-	I
1	I
and	O
that	O
the	O
SCL	B
gene	I
product	I
serves	O
as	O
a	O
positive	O
regulator	O
of	O
erythroid	O
differentiation	O
.	O

Significantly	O
,	O
expression	O
of	O
the	O
newly	O
identified	O
Fas	B
-	I
regulatory	I
gene	I
,	O
TDAG51	B
,	O
was	O
found	O
to	O
be	O
dependent	O
upon	O
the	O
activity	O
of	O
PKC	B
.	O

The	O
adult	O
globin	O
expressing	O
cells	O
displayed	O
more	O
extensive	O
footprints	O
than	O
the	O
fetal	O
globin	O
expressing	O
cells	O
in	O
the	O
3	B
'	I
regulatory	I
sequences	I
of	O
both	O
the	O
Agamma	B
-	I
and	I
the	I
beta	I
-	I
globin	I
genes	I
,	O
suggesting	O
a	O
role	O
of	O
these	O
3	B
'	I
elements	I
in	O
beta	B
-	I
globin	I
gene	I
expression	O
.	O

The	O
capacity	O
of	O
Syk	B
to	O
reconstitute	O
the	O
MAPK	B
response	O
required	O
the	O
catalytic	O
activity	O
of	O
Syk	B
,	O
an	O
intact	O
autophosphorylation	B
site	I
(	O
Y518	O
and	O
Y519	O
)	O
,	O
both	O
Src	B
homology	I
2	I
domains	I
and	O
it	O
was	O
blocked	O
by	O
the	O
inhibitory	B
N17	I
-	I
mutated	I
dominant	I
-	I
negative	I
Ras	I
construct	I
.	O

A	O
series	O
of	O
aminopropylindenes	B
,	O
designed	O
as	O
mimics	O
of	O
a	O
cationic	O
high	O
energy	O
intermediate	O
in	O
the	O
oxidosqualene	B
cyclase	O
(	O
1	O
)	O
(	O
OSC	O
)	O
-	O
mediated	O
cyclization	O
of	O
2	B
,	I
3	I
-	I
oxidosqualen	I
to	O
lanosterol	B
was	O
prepared	O
from	O
Grundmann	B
'	I
s	I
ketone	I
.	O

The	O
v	B
-	I
erbA	I
oncogene	I
,	O
a	O
mutated	O
version	O
of	O
the	O
thyroid	B
hormone	I
receptor	I
alpha	I
(	O
c	B
-	I
erbA	I
/	I
TR	I
-	I
alpha	I
)	O
,	O
inhibits	O
erythroid	O
differentiation	O
and	O
constitutively	O
represses	O
transcription	O
of	O
certain	O
erythrocyte	B
genes	I
,	O
suggesting	O
a	O
normal	O
function	O
of	O
the	O
proto	B
-	I
oncogene	I
c	I
-	I
erbA	I
in	O
erythropoiesis	O
.	O

In	O
this	O
report	O
,	O
it	O
is	O
demonstrated	O
that	O
Elf	B
-	I
1	I
contains	O
a	O
sequence	O
motif	O
that	O
is	O
highly	O
related	O
to	O
the	O
Rb	B
binding	I
sites	I
of	O
several	O
viral	O
oncoproteins	B
and	O
binds	O
to	O
the	O
pocket	O
region	O
of	O
Rb	B
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

The	O
(	O
two	O
-	O
motif	O
)	O
domain	O
fold	O
contains	O
a	O
pair	O
of	O
calcium	O
binding	O
sites	O
very	O
similar	O
to	O
those	O
found	O
in	O
a	O
two	B
-	I
domain	I
prokaryotic	I
betagamma	I
-	I
crystallin	I
fold	I
family	I
member	I
,	O
Protein	B
S	I
.	O

SH2D1A	B
protein	I
levels	O
are	O
up	O
-	O
regulated	O
by	O
CD40	B
cross	O
-	O
linking	O
and	O
down	O
-	O
regulated	O
by	O
B	B
cell	I
receptor	I
ligation	O
.	O

Moreover	O
,	O
the	O
observation	O
of	O
enhanced	O
luteal	B
HSP	I
-	I
27	I
phosphorylation	O
in	O
vivo	O
,	O
in	O
late	O
pregnancy	O
,	O
when	O
PKC	B
-	I
delta	I
is	O
abundant	O
and	O
active	O
,	O
suggests	O
that	O
select	O
PKC	B
family	I
members	I
contribute	O
to	O
sHSP	B
phosphorylation	O
events	O
in	O
vivo	O
.	O

Gtx	B
mRNA	I
accumulates	O
in	O
parallel	O
with	O
the	O
RNAs	O
encoding	O
the	O
major	O
structural	O
proteins	O
of	O
myelin	O
,	O
myelin	B
basic	I
protein	I
(	O
MBP	B
)	O
,	O
and	O
proteolipid	B
protein	I
(	O
PLP	B
)	O
during	O
postnatal	O
brain	O
development	O
;	O
Gtx	B
mRNA	I
decreases	O
in	O
parallel	O
with	O
MBP	B
and	O
PLP	B
mRNAs	I
in	O
the	O
brains	O
of	O
myelin	O
-	O
deficient	O
rats	O
,	O
which	O
have	O
a	O
point	O
mutation	O
in	O
the	O
PLP	B
gene	I
.	O

A	O
survey	O
of	O
promoters	O
has	O
revealed	O
that	O
the	O
wild	B
-	I
type	I
,	I
unfused	I
EBNA3C	I
can	O
specifically	O
repress	O
expression	O
from	O
reporter	B
plasmids	I
containing	O
the	O
Epstein	O
-	O
Barr	O
virus	O
Cp	B
latency	I
-	I
associated	I
promoter	I
.	O

Involvement	O
of	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
pathways	O
in	O
interleukin	B
-	I
8	I
production	O
by	O
human	O
monocytes	O
and	O
polymorphonuclear	O
cells	O
stimulated	O
with	O
lipopolysaccharide	O
or	O
Mycoplasma	B
fermentans	I
membrane	I
lipoproteins	I
.	O

The	O
structure	O
of	O
the	O
free	O
SH2	B
domain	I
has	O
been	O
compared	O
to	O
that	O
of	O
the	O
SH2	B
complexed	O
with	O
a	O
doubly	O
phosphorylated	O
peptide	O
derived	O
from	O
polyomavirus	B
middle	I
T	I
antigen	I
(	O
MT	B
)	O
.	O

Collectively	O
,	O
these	O
results	O
show	O
that	O
the	O
differential	O
utilization	O
of	O
Staf	B
zinc	I
finger	I
1	I
represents	O
a	O
new	O
,	O
critical	O
determinant	O
of	O
the	O
transcriptional	O
activation	O
mechanism	O
for	O
the	O
Xenopus	B
tRNA	I
(	O
Sec	B
)	O
and	O
human	B
U6	I
snRNA	I
genes	I
.	O

Altogether	O
these	O
results	O
indicate	O
that	O
the	O
Syn	B
5	I
locus	I
segregates	O
from	O
the	O
gene	O
specifying	O
gH	B
,	O
to	O
a	O
region	O
encompassing	O
portions	O
of	O
the	O
TK	B
and	O
UL	B
24	I
genes	I
,	O
and	O
that	O
the	O
syn	B
mutation	I
does	O
not	O
affect	O
the	O
expression	O
or	O
activity	O
of	O
TK	B
.	O

Here	O
,	O
we	O
demonstrate	O
that	O
the	O
kappa	B
3	I
binding	I
factor	I
contains	O
NFATp	B
,	O
a	O
cyclosporin	B
-	I
sensitive	I
DNA	I
-	I
binding	I
protein	I
required	O
for	O
interleukin	B
-	I
2	I
gene	I
transcription	O
.	O

In	O
human	B
histiocytic	I
U937	I
cells	I
mRNA	I
of	O
clone	O
pAT	O
133	O
was	O
constitutively	O
expressed	O
,	O
whereas	O
mRNA	B
of	O
pAT	B
225	I
/	I
EGR1	I
was	O
induced	O
upon	O
induction	O
of	O
terminal	O
differentiation	O
.	O

Dexamethasone	O
inhibits	O
binding	O
to	O
the	O
Ikaros	B
and	O
AP	B
-	I
1	I
regulatory	I
elements	I
of	O
the	O
granzyme	B
B	I
promoter	I
.	O

Since	O
one	O
of	O
the	O
few	O
transcription	B
factors	I
which	O
have	O
been	O
implicated	O
in	O
the	O
regulation	O
of	O
monocyte	B
genes	I
is	O
the	O
macrophage	B
-	I
and	I
B	I
-	I
cell	I
-	I
specific	I
PU	I
.	I
1	I
transcription	B
factor	I
,	O
we	O
investigated	O
whether	O
PU	B
.	I
1	I
binds	O
and	O
activates	O
the	O
M	B
-	I
CSF	I
receptor	I
promoter	I
.	O

Cell	O
hemoglobinization	O
was	O
accompanied	O
by	O
the	O
increased	O
expression	O
of	O
genes	B
encoding	O
gamma	B
-	I
globin	I
and	I
porphobilinogen	I
deaminase	I
(	O
PBGD	B
)	O
,	O
an	O
enzyme	O
of	O
heme	O
synthesis	O
.	O

Cotransfection	O
of	O
the	O
C	B
/	I
EBP	I
-	I
epsilon	I
sense	O
and	O
antisense	O
expression	O
constructs	O
together	O
with	O
chloramphenicol	B
acetyltransferase	I
reporter	I
vectors	I
containing	O
myeloid	B
-	I
cell	I
-	I
specific	I
c	I
-	I
mim	I
and	I
human	I
myeloperoxidase	I
promoters	I
suggested	O
a	O
role	O
for	O
C	B
/	I
EBP	I
-	I
epsilon	I
transcription	B
factor	I
in	O
the	O
regulation	O
of	O
a	O
subset	O
of	O
myeloid	B
-	I
cell	I
-	I
specific	I
genes	I
.	O

However	O
,	O
IFN	B
(	I
alpha	I
)	I
does	O
not	O
have	O
any	O
effects	O
on	O
the	O
retinoid	O
-	O
dependent	O
regulation	O
of	O
the	O
myeloid	B
surface	I
markers	I
CD11b	B
and	O
CD33	B
.	O

Conformational	O
changes	O
of	O
the	O
ferric	B
uptake	I
regulation	I
protein	I
upon	O
metal	O
activation	O
and	O
DNA	O
binding	O
;	O
first	O
evidence	O
of	O
structural	O
homologies	O
with	O
the	O
diphtheria	B
toxin	I
repressor	I
.	O

Human	O
MHC	B
class	I
II	I
gene	I
transcription	O
directed	O
by	O
the	O
carboxyl	B
terminus	I
of	O
CIITA	B
,	O
one	O
of	O
the	O
defective	B
genes	I
in	O
type	O
II	O
MHC	B
combined	O
immune	O
deficiency	O
.	O

IL	B
-	I
4	I
induces	O
Cepsilon	B
germline	I
transcripts	I
and	O
IgE	B
isotype	I
switching	O
in	O
B	O
cells	O
from	O
patients	O
with	O
gammac	B
chain	I
deficiency	O
.	O

In	O
addition	O
,	O
the	O
erythroid	B
-	I
specific	I
transcription	I
factor	I
NF	B
-	I
E1	I
was	O
shown	O
to	O
be	O
expressed	O
coordinately	O
with	O
that	O
of	O
globin	B
in	O
embryoid	O
bodies	O
.	O

Next	O
,	O
in	O
an	O
effort	O
to	O
determine	O
critical	O
transcription	B
factors	I
that	O
regulate	O
CD95	B
ligand	I
expression	O
,	O
we	O
demonstrate	O
a	O
cyclosporin	B
A	I
-	I
sensitive	I
nuclear	I
factor	I
-	I
AT	I
response	I
element	I
in	O
the	O
promoter	B
region	I
of	O
this	O
gene	O
that	O
is	O
critical	O
for	O
optimal	O
CD95	B
ligand	I
reporter	O
activity	O
in	O
stimulated	O
T	O
cells	O
.	O

We	O
describe	O
18	O
patients	O
from	O
several	O
generations	O
of	O
12	O
unrelated	O
families	O
who	O
were	O
heterozygous	O
for	O
1	O
to	O
5	O
overlapping	B
IFNGR1	I
frameshift	I
small	I
deletions	I
and	O
a	O
wild	B
-	I
type	I
IFNGR1	I
allele	I
.	O

When	O
sequences	B
from	I
-	I
417	I
to	I
-	I
207	I
5	I
'	I
to	O
the	O
zeta	B
-	I
globin	I
mRNA	I
cap	I
site	I
were	O
deleted	O
,	O
up	O
to	O
95	O
%	O
of	O
the	O
zeta	B
-	I
globin	I
promoter	I
activity	O
was	O
lost	O
in	O
K562	O
cells	O
.	O

The	O
effects	O
of	O
Cu	B
(	I
2	I
+	I
)	I
binding	O
and	O
the	O
utilization	O
of	O
different	O
force	O
fields	O
when	O
modeling	O
the	O
structural	O
characteristics	O
of	O
alpha	B
-	I
syn12	I
peptide	I
were	O
investigated	O
.	O

Human	B
cDNAs	I
encoding	O
Kruppel	B
-	I
type	I
zinc	I
finger	I
domains	I
,	O
designated	O
KOX	B
1	I
-	I
32	I
,	O
have	O
been	O
cloned	O
from	O
human	B
T	I
lymphocyte	I
cell	I
line	I
libraries	I
.	O

The	O
myeloid	B
zinc	I
finger	I
gene	I
,	O
MZF	B
-	I
1	I
,	O
regulates	O
the	O
CD34	B
promoter	I
in	O
vitro	O
.	O

In	O
this	O
work	O
we	O
show	O
that	O
the	O
monoclonal	B
antibody	I
KN	I
382	I
/	I
EC1	I
raised	O
against	O
the	O
rabbit	B
59	I
-	I
kDa	I
protein	I
reacts	O
with	O
9S	B
,	O
untransformed	B
glucocorticoid	I
receptor	I
complexes	I
in	O
cytosol	O
prepared	O
from	O
human	O
IM	O
-	O
9	O
lymphocytes	O
but	O
not	O
with	O
4S	B
salt	I
-	I
transformed	I
receptors	I
.	O

The	O
mechanism	O
of	O
transactivation	O
by	O
BMLF1	B
proteins	I
has	O
been	O
controversial	O
but	O
SM	B
was	O
shown	O
to	O
transactivate	O
gene	O
expression	O
from	O
a	O
CAT	B
reporter	I
construct	I
by	O
increasing	O
the	O
amount	O
of	O
cytoplasmic	B
CAT	I
mRNA	I
.	O

TRAF2	B
is	O
a	O
potent	O
activator	O
of	O
a	O
95	B
-	I
kDa	I
serine	I
/	I
threonine	I
kinase	I
termed	O
germinal	B
center	I
kinase	I
related	I
(	O
GCKR	B
,	O
also	O
referred	O
to	O
as	O
KHS1	B
)	O
,	O
which	O
signals	O
activation	O
of	O
the	O
SAPK	B
pathway	O
.	O

Thyrotropin	B
-	O
induced	O
expression	O
of	O
a	O
gene	O
for	O
a	O
ribosomal	B
protein	I
related	O
to	O
the	O
trk	B
oncogene	I
.	O

Our	O
results	O
show	O
that	O
the	O
temperature	B
-	I
sensitive	I
rad54	I
-	I
3	I
allele	I
blocks	O
mitotic	O
recombination	O
between	O
tandemly	O
repeated	O
DYZ3	B
satellite	I
sequences	I
and	O
significantly	O
stabilizes	O
a	O
human	B
DYZ5	I
satellite	O
-	O
containing	O
YAC	O
clone	O
.	O

The	O
two	O
structurally	O
distinct	O
immunophilin	B
-	I
drug	I
complexes	I
bind	O
to	O
,	O
and	O
inhibit	O
,	O
the	O
phosphatase	B
activity	O
of	O
calcineurin	B
.	O

Sequence	O
analysis	O
reveals	O
that	O
the	O
DNA	O
binding	O
domain	O
of	O
ILF	B
has	O
strong	O
homology	O
to	O
the	O
recently	O
described	O
fork	B
head	I
DNA	I
binding	I
domain	I
found	O
in	O
the	O
Drosophila	B
homeotic	I
protein	I
fork	I
head	I
and	O
a	O
family	O
of	O
hepatocyte	B
nuclear	I
factors	I
,	O
HNF	B
-	I
3	I
.	O

Mutation	O
in	O
the	O
GATA	B
-	I
1	I
(	I
d	I
)	I
motif	I
,	O
which	O
exhibits	O
an	O
adult	B
erythroid	I
-	I
specific	I
genomic	I
footprint	I
,	O
decreases	O
the	O
HS	B
-	I
40	I
enhancer	I
function	O
in	O
dimethyl	O
sulfoxide	O
-	O
induced	O
MEL	O
cells	O
but	O
not	O
in	O
K562	O
cells	O
.	O

While	O
homodimerizing	B
cytokine	I
receptors	I
may	O
transmit	O
signal	O
via	O
a	O
single	O
form	O
of	O
JAK	B
(	O
i	O
.	O
e	O
.	O
growth	B
hormone	I
receptors	I
)	O
,	O
several	O
multicomponent	B
cytokine	I
receptors	I
have	O
been	O
shown	O
to	O
require	O
simultaneous	O
activation	O
of	O
pairs	O
of	O
different	O
JAK	B
kinases	I
(	O
i	O
.	O
e	O
.	O
interferon	B
receptors	I
)	O
.	O

A	O
genomic	O
DNA	O
clone	O
encoding	O
oryzacystatin	B
(	O
Oc	B
)	O
,	O
a	O
cysteine	B
proteinase	I
inhibitor	O
(	O
cystatin	B
)	O
of	O
rice	O
,	O
was	O
isolated	O
from	O
a	O
lambda	O
EMBL3	O
phage	O
library	O
constructed	O
with	O
Sau3AI	B
partial	O
digests	O
of	O
rice	O
chromosomal	O
DNA	O
,	O
by	O
screening	O
with	O
an	O
oc	B
cDNA	I
as	O
a	O
probe	O
.	O

AML1	B
(	I
CBFalpha2	I
)	I
cooperates	O
with	O
B	B
cell	I
-	I
specific	I
activating	I
protein	I
(	I
BSAP	I
/	I
PAX5	I
)	I
in	O
activation	O
of	O
the	O
B	B
cell	I
-	I
specific	I
BLK	I
gene	I
promoter	I
.	O

This	O
protein	O
,	O
termed	O
calcium	B
-	I
signal	I
modulating	I
cyclophilin	I
ligand	I
(	O
CAML	B
)	O
,	O
acts	O
downstream	O
of	O
the	O
TCR	B
and	O
upstream	O
of	O
calcineurin	B
by	O
causing	O
an	O
influx	O
of	O
calcium	O
.	O

The	O
KBF1	B
/	I
p50	I
factor	I
binds	O
as	O
a	O
homodimer	B
but	O
can	O
also	O
form	O
heterodimers	B
with	O
the	O
products	O
of	O
other	O
members	O
of	O
the	O
same	O
family	O
,	O
like	O
the	O
c	B
-	I
rel	I
and	I
v	I
-	I
rel	I
(	I
proto	I
)	I
oncogenes	I
.	O

Tandem	B
AP	I
-	I
1	I
-	I
binding	I
sites	I
within	O
the	O
human	B
beta	I
-	I
globin	I
dominant	I
control	I
region	I
function	O
as	O
an	O
inducible	B
enhancer	I
in	O
erythroid	O
cells	O
.	O

These	O
different	O
observations	O
exclude	O
a	O
heterozygosity	O
of	O
the	O
A	O
-	O
-	O
>	O
G	O
mutation	O
at	O
codon	O
beta	O
77	O
,	O
as	O
well	O
as	O
a	O
deletion	O
comparable	O
to	O
that	O
of	O
Hbs	B
Lepore	I
or	I
Kenya	I
,	O
or	O
a	O
beta	B
-	I
globin	I
gene	I
duplication	O
,	O
and	O
point	O
to	O
a	O
nontraditional	O
inheritance	O
of	O
Hb	B
Costa	I
Rica	I
.	O

Several	O
antiandrogens	O
show	O
agonistic	O
properties	O
for	O
a	O
mutated	B
androgen	I
receptor	I
(	O
LNCaP	O
cell	O
variant	O
)	O
;	O
trypsin	B
digestion	O
of	O
antiandrogen	B
-	I
bound	I
mutated	I
receptor	I
also	O
resulted	O
in	O
a	O
29	B
-	I
kDa	I
fragment	I
.	O

MEF	B
and	O
AML1B	B
synergistically	O
transactivated	O
an	O
interleukin	B
3	I
promoter	I
reporter	I
gene	I
construct	I
,	O
yet	O
the	O
activating	O
activity	O
of	O
MEF	B
was	O
abolished	O
when	O
MEF	B
was	O
coexpressed	O
with	O
AML1	B
/	O
ETO	B
.	O

The	O
DNA	B
-	I
binding	I
protein	I
GATA	B
-	I
1	I
is	O
required	O
for	O
normal	O
erythroid	O
development	O
and	O
regulates	O
erythroid	B
-	I
expressed	I
genes	I
in	O
maturing	O
erythroblasts	O
.	O

Erythropoietin	B
-	O
dependent	O
induction	O
of	O
hemoglobin	B
synthesis	O
in	O
a	O
cytokine	O
-	O
dependent	O
cell	O
line	O
M	O
-	O
TAT	O
.	O

A	O
newly	O
identified	O
motif	O
called	O
the	O
B29	B
conserved	I
sequence	I
(	O
BCS	B
)	O
,	O
found	O
upstream	O
of	O
both	O
human	B
and	I
murine	I
B29	I
promoters	I
,	O
appears	O
to	O
stimulate	O
B29	B
transcription	O
through	O
a	O
novel	O
mechanism	O
.	O

Likewise	O
,	O
rad6	B
-	I
delta	I
reduces	O
silencing	O
of	O
the	O
telomere	B
-	I
located	I
RNAP	I
II	I
-	I
transcribed	I
genes	I
URA3	I
and	O
ADE2	B
.	O

The	O
palindromic	B
site	I
(	O
site	B
B	I
)	O
recognized	O
by	O
this	O
protein	O
is	O
related	O
to	O
the	O
palindromic	B
binding	I
sites	I
of	O
members	O
of	O
the	O
steroid	B
/	I
thyroid	I
hormone	I
receptor	I
family	I
.	O

BACKGROUND	O
:	O
Defensins	B
,	O
also	O
known	O
as	O
human	B
neutrophil	I
peptides	I
,	O
are	O
antimicrobial	O
peptides	O
present	O
in	O
the	O
azurophil	O
granules	O
of	O
neutrophils	O
.	O

Human	O
recombinant	O
DNA	O
-	O
derived	O
antihemophilic	B
factor	I
(	O
factor	B
VIII	I
)	O
in	O
the	O
treatment	O
of	O
hemophilia	O
A	O
.	O
recombinant	O
Factor	B
VIII	I
Study	O
Group	O
.	O

By	O
using	O
70Z	O
/	O
3	O
-	O
derived	O
pre	O
-	O
B	O
-	O
cell	O
lines	O
either	O
lacking	O
or	O
expressing	O
human	B
CD14	I
(	O
the	O
LPS	B
receptor	I
)	O
,	O
it	O
was	O
observed	O
that	O
expression	O
of	O
human	B
CD14	I
imparted	O
responsiveness	O
to	O
LPS	O
but	O
not	O
to	O
OspA	B
or	O
spirochetal	B
lipopeptides	I
(	O
assessed	O
by	O
induction	O
of	O
NF	B
-	I
kappa	I
B	I
and	O
expression	O
of	O
surface	B
immunoglobulin	I
M	I
)	O
.	O

Here	O
,	O
we	O
show	O
that	O
v	B
-	I
erbA	I
and	O
c	B
-	I
erbA	I
bind	O
directly	O
to	O
sequences	O
within	O
the	O
promoter	B
of	O
the	O
erythrocyte	B
-	I
specific	I
carbonic	I
anhydrase	I
II	I
(	O
CAII	B
)	O
,	O
a	O
gene	O
whose	O
transcription	O
is	O
efficiently	O
suppressed	O
by	O
v	B
-	I
erbA	I
.	O

It	O
forms	O
a	O
complex	O
with	O
hematin	B
and	O
inhibits	O
beta	B
-	I
hematin	I
formation	O
,	O
suggesting	O
that	O
this	O
compound	O
act	O
on	O
a	O
heme	B
polymerization	O
target	O
.	O

The	O
translocated	B
PAX	I
-	I
5	I
gene	I
is	O
deregulated	O
by	O
the	O
insertion	O
of	O
IgH	B
regulatory	I
elements	I
into	O
its	O
5	B
'	I
region	I
,	O
which	O
may	O
contribute	O
to	O
tumorigenesis	O
by	O
interfering	O
with	O
the	O
shut	O
-	O
down	O
of	O
PAX	B
-	I
5	I
transcription	O
and	O
thus	O
with	O
the	O
completion	O
of	O
plasma	O
cell	O
differentiation	O

The	O
tryptase	B
locus	I
also	O
contains	O
at	O
least	O
four	O
tryptase	B
-	I
like	I
pseudogenes	I
,	O
including	O
mastin	B
,	O
a	O
gene	O
expressed	O
in	O
dogs	O
but	O
not	O
in	O
humans	O
.	O

An	O
NF1	B
-	I
related	I
vitellogenin	I
activator	I
element	I
mediates	O
transcription	O
from	O
the	O
estrogen	O
-	O
regulated	O
Xenopus	B
laevis	I
vitellogenin	I
promoter	I
.	O

Finally	O
,	O
we	O
show	O
that	O
one	O
of	O
the	O
isoforms	B
encodes	O
the	O
previously	O
described	O
lymphoid	B
-	I
specific	I
Oct2B	I
protein	I
which	O
has	O
been	O
suggested	O
to	O
be	O
involved	O
in	O
the	O
function	O
of	O
the	O
octamer	B
motif	I
in	O
the	O
context	O
of	O
the	O
immunoglobulin	B
heavy	I
-	I
chain	I
(	I
IgH	I
)	I
enhancer	I
.	O

Reverse	O
transcriptase	O
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
analyses	O
revealed	O
that	O
adult	O
and	O
embryonic	B
globin	I
genes	I
were	O
appropriately	O
regulated	O
,	O
with	O
the	O
exception	O
of	O
beta	B
h1	I
-	I
globin	I
,	O
which	O
continued	O
to	O
be	O
expressed	O
at	O
a	O
very	O
low	O
level	O
.	O

Previously	O
we	O
and	O
others	O
showed	O
by	O
targeted	O
gene	O
disruption	O
that	O
the	O
zinc	B
finger	I
gene	I
,	O
erythroid	B
Kruppel	I
-	I
like	I
factor	I
(	O
EKLF	B
)	O
,	O
is	O
required	O
for	O
expression	O
of	O
the	O
beta	B
-	I
globin	I
gene	I
in	O
mice	O
,	O
presumably	O
through	O
interaction	O
with	O
a	O
high	B
-	I
affinity	I
binding	I
site	I
in	O
the	O
proximal	B
promoter	I
.	O

Comparisons	O
with	O
the	O
available	O
amino	O
acid	O
residue	O
(	O
aa	O
)	O
sequence	O
information	O
from	O
the	O
complete	O
CPMV	B
RNA	I
1	I
sequence	I
and	O
the	O
partial	O
sequence	O
of	O
red	B
clover	I
mottle	I
virus	I
RNA	I
1	I
suggest	O
that	O
CPSMV	B
RNA	I
1	I
specifies	O
the	O
expected	O
set	O
of	O
five	O
mature	O
proteins	O
:	O
32K	B
proteinase	I
cofactor	I
,	O
58K	B
presumed	I
helicase	I
,	O
VPg	B
5	I
'	I
-	I
linked	I
protein	I
of	O
the	O
genomic	O
RNAs	O
,	O
24K	B
proteinase	I
,	O
and	O
87K	B
presumed	I
polymerase	I
,	O
separated	O
by	O
four	O
cleavage	O
sites	O
.	O

In	O
this	O
review	O
,	O
we	O
discuss	O
different	O
models	O
accounting	O
for	O
the	O
haploinsufficiency	O
of	O
mammalian	B
Pax	I
genes	I
,	O
provide	O
further	O
evidence	O
in	O
support	O
of	O
the	O
allele	B
-	O
specific	O
regulation	O
of	O
Pax5	B
and	O
discuss	O
the	O
implication	O
of	O
these	O
findings	O
in	O
the	O
context	O
of	O
the	O
recent	O
literature	O
describing	O
the	O
stochastic	O
and	O
monoallelic	O
activation	O
of	O
other	O
hematopoietic	B
genes	I
.	O

Conserved	B
elements	I
containing	O
NF	B
-	I
E2	I
and	I
tandem	I
GATA	I
binding	I
sites	I
are	O
required	O
for	O
erythroid	O
-	O
specific	O
chromatin	O
structure	O
reorganization	O
within	O
the	O
human	B
beta	I
-	I
globin	I
locus	I
control	I
region	I
.	O

Furthermore	O
,	O
as	O
in	O
the	O
human	O
gene	O
,	O
the	O
3	O
'	O
end	O
of	O
the	O
Cacna1f	B
gene	I
maps	O
within	O
5	O
kb	O
of	O
the	O
5	O
'	O
end	O
of	O
the	O
mouse	B
synaptophysin	I
gene	I
in	O
a	O
region	O
orthologous	O
to	O
Xp11	O
.	O
23	O
.	O

Fluorescence	O
in	O
situ	O
hybridization	O
and	O
analyses	O
of	O
a	O
yeast	O
artificial	O
chromosome	O
contig	O
revealed	O
that	O
the	O
human	B
LOX	I
-	I
1	I
gene	I
is	O
located	O
in	O
the	O
natural	B
killer	I
gene	I
complex	I
on	O
chromosome	B
12p12	I
-	I
p13	I
,	O
where	O
the	O
genes	O
of	O
the	O
natural	B
killer	I
cell	I
receptors	I
cluster	O
.	O

Following	O
TcR	B
stimulation	O
,	O
activation	O
of	O
Erk2	B
was	O
only	O
inhibited	O
by	O
a	O
previously	O
described	O
truncated	B
form	I
of	I
p85	I
that	O
can	O
not	O
bind	O
the	O
catalytic	B
subunit	I
,	O
but	O
not	O
by	O
other	O
constructs	O
of	O
p85	B
.	O

An	O
iron	B
-	I
responsive	I
element	I
(	I
IRE	I
)	I
motif	I
has	O
been	O
identified	O
in	O
the	O
5	O
'	O
-	O
untranslated	O
region	O
of	O
the	O
human	B
erythroid	I
ALAS	I
mRNA	I
,	O
but	O
is	O
not	O
present	O
in	O
the	O
housekeeping	B
ALAS	I
mRNA	I
.	O

The	O
functional	O
mature	O
domain	O
of	O
pediocin	B
AcH	I
(	I
Lys	I
+	I
1	I
to	I
Cys	I
+	I
44	I
)	I
is	O
targeted	O
into	O
the	O
E	O
.	O
coli	O
sec	O
machinery	O
and	O
secreted	O
to	O
the	O
periplasm	O
in	O
active	O
form	O
when	O
fused	O
in	O
frame	O
to	O
the	O
COOH	O
terminus	O
of	O
the	O
secretory	B
protein	I
maltose	I
-	I
binding	I
protein	I
(	O
MBP	B
)	O
.	O

Skeletal	O
myogenesis	O
is	O
regulated	O
by	O
a	O
group	O
of	O
transcription	B
factors	I
(	O
MyoD	B
,	O
myogenin	B
,	O
myf5	B
,	O
and	O
myf6	B
)	O
that	O
are	O
`	B
`	I
basic	I
helix	I
-	I
loop	I
-	I
helix	I
'	I
'	I
proteins	I
that	O
bind	O
to	O
the	O
promoters	B
of	O
muscle	B
-	I
specific	I
genes	I
and	O
promote	O
their	O
expression	O
.	O

The	O
rules	O
of	O
assembly	O
of	O
the	O
cognate	O
ligands	O
of	O
TF	B
,	O
namely	O
the	O
zymogen	B
plasma	I
factors	I
VII	I
and	O
the	O
serine	B
protease	I
factor	I
VIIa	I
,	O
with	O
the	O
soluble	B
surface	I
domain	I
of	O
TF	B
in	O
free	O
solution	O
,	O
in	O
the	O
presence	O
of	O
phospholipid	O
surfaces	O
and	O
cell	O
surface	O
and	O
of	O
the	O
anchored	B
TF	I
molecule	I
have	O
been	O
described	O
.	O

A	O
structure	O
-	O
function	O
analysis	O
demonstrated	O
that	O
induction	O
of	O
apoptosis	O
was	O
not	O
a	O
dominant	O
-	O
negative	O
effect	O
of	O
the	O
E2a	B
moiety	I
but	O
,	O
rather	O
,	O
required	O
the	O
DNA	B
-	I
binding	I
homeodomain	I
of	O
Pbx1	B
.	O

It	O
was	O
recently	O
demonstrated	O
that	O
EKLF	B
is	O
also	O
required	O
for	O
the	O
activity	O
of	O
the	O
beta	B
-	I
globin	I
locus	I
control	I
region	I
(	O
LCR	B
)	O
5	B
'	I
HS3	I
.	O

We	O
present	O
a	O
model	O
in	O
which	O
HMG	B
-	I
I	I
(	I
Y	I
)	I
alters	O
DNA	O
conformation	O
to	O
allow	O
binding	O
of	O
repressor	B
proteins	I
,	O
and	O
in	O
which	O
the	O
relative	O
amount	O
of	O
HMG	O
-	O
I	O
(	O
Y	O
)	O
helps	O
to	O
determine	O
the	O
repressive	O
state	O
of	O
the	O
beta	B
-	I
globin	I
gene	I
.	O

In	O
vitro	O
,	O
CsA	O
inhibits	O
lymphocyte	B
gene	I
activation	O
by	O
inhibiting	O
the	O
phosphatase	B
activity	O
of	O
calcineurin	B
(	O
CN	B
)	O
.	O

The	O
protein	O
encoded	O
by	O
the	O
fruA	B
transcript	I
is	O
well	O
conserved	O
with	O
the	O
D	B
.	I
melanogaster	I
type	I
A	I
protein	I
,	O
particularly	O
the	O
BTB	B
protein	I
-	O
protein	O
-	O
binding	O
domain	O
,	O
which	O
is	O
encoded	O
by	O
exons	O
I	O
and	O
II	O
and	O
is	O
100	O
%	O
conserved	O
.	O

We	O
have	O
previously	O
reported	O
the	O
presence	O
of	O
a	O
transcriptional	B
control	I
element	I
with	O
the	O
properties	O
of	O
a	O
silencer	B
extending	O
from	O
-	B
392	I
to	I
-	I
177	I
bp	I
relative	O
to	O
the	O
cap	B
site	I
of	O
the	O
human	B
epsilon	I
-	I
globin	I
-	I
encoding	I
gene	I
[	O
Cao	O
et	O
al	O
.	O
,	O
Proc	O
.	O
Natl	O
.	O
Acad	O
.	O
Sci	O
.	O
USA	O
86	O
(	O
1989	O
)	O
5306	O
-	O
5309	O
]	O
.	O

Further	O
studies	O
established	O
that	O
the	O
Ep	B
-	O
induced	O
increase	O
in	O
beta	B
-	I
globin	I
mRNA	I
could	O
be	O
inhibited	O
by	O
the	O
tyrosine	B
kinase	I
inhibitor	O
genistein	O
and	O
the	O
protein	B
kinase	I
C	I
inhibitor	O
Compound	O
3	O
.	O
(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

The	O
highly	O
specific	O
granulomonocyte	B
-	I
associated	I
lysosomal	I
proteins	I
myeloperoxidase	B
(	O
MPO	B
)	O
and	O
lysozyme	B
(	O
LZ	B
)	O
,	O
as	O
well	O
as	O
the	O
transcription	B
factor	I
PU	B
.	I
1	I
,	O
were	O
already	O
detectable	O
in	O
the	O
most	O
immature	O
CD34	O
+	O
Thy	O
-	O
1	O
+	O
subset	O
.	O

The	O
locus	B
control	I
region	I
of	O
the	O
beta	B
-	I
globin	I
cluster	I
contains	O
five	O
DNase	B
I	I
hypersensitive	I
sites	I
(	O
5	B
'	I
HS1	I
-	I
5	I
)	O
required	O
for	O
locus	O
activation	O
.	O

Following	O
Fe	B
(	I
III	I
)	I
-	O
promoted	O
coupling	O
with	O
catharanthine	B
and	O
in	O
situ	O
oxidation	O
to	O
provide	O
the	O
corresponding	O
vinblastine	B
analogues	O
,	O
their	O
evaluation	O
provided	O
unanticipated	O
insights	O
into	O
how	O
the	O
structure	O
of	O
the	O
vindoline	B
subunit	O
contributes	O
to	O
activity	O
.	O

A	O
new	O
B	B
-	I
cell	I
-	I
specific	I
enhancer	I
element	I
has	O
been	O
identified	O
3	O
'	O
of	O
E4	B
and	I
the	I
octamerlike	I
motifs	I
in	O
the	O
human	B
immunoglobulin	I
heavy	I
-	I
chain	I
gene	I
enhancer	I
.	O

Egd1p	B
is	O
homologous	O
to	O
human	B
BTF3b	I
,	O
recently	O
identified	O
as	O
the	O
beta	O
subunit	O
of	O
the	O
heterodimeric	B
nascent	I
-	I
polypeptide	I
-	I
associated	I
complex	I
(	O
NAC	B
)	O
involved	O
in	O
ensuring	O
signal	O
-	O
sequence	O
-	O
specific	O
protein	O
sorting	O
and	O
translocation	O
[	O
Wiedmann	O
et	O
al	O
.	O
,	O
Nature	O
370	O
(	O
1994	O
)	O
434	O
-	O
440	O
]	O
.	O

To	O
determine	O
whether	O
enhancer	B
elements	I
in	O
addition	O
to	O
the	O
highly	O
conserved	O
octamer	B
(	I
OCTA	I
)	I
-	I
nucleotide	I
motif	I
are	O
important	O
for	O
lymphoid	O
-	O
specific	O
expression	O
of	O
the	O
immunoglobulin	B
heavy	I
-	I
chain	I
(	I
IgH	I
)	I
gene	I
,	O
we	O
have	O
investigated	O
the	O
effect	O
of	O
mutating	O
the	O
binding	B
site	I
for	O
a	O
putative	B
additional	I
lymphoid	I
-	I
specific	I
transcription	I
factor	I
,	O
designated	O
NF	B
-	I
microB	I
,	O
in	O
the	O
murine	B
IgH	I
enhancer	I
.	O

The	O
beta	B
-	I
globin	I
promoter	I
is	O
important	O
for	O
recruitment	O
of	O
erythroid	B
Kruppel	I
-	I
like	I
factor	I
to	O
the	O
locus	B
control	I
region	I
in	O
erythroid	O
cells	O
.	O

The	O
IFN	B
-	O
dependent	O
increase	O
in	O
RAR	B
(	I
alpha	I
)	I
levels	O
and	O
the	O
enhancing	O
effect	O
of	O
the	O
cytokine	B
on	O
retinoid	B
-	I
dependent	I
granulocytic	I
markers	I
expression	O
may	O
be	O
a	O
characteristic	O
of	O
PML	O
-	O
RAR	O
positive	O
cells	O
,	O
since	O
the	O
phenomena	O
are	O
not	O
observed	O
in	O
HL	O
-	O
60	O
promyelocytes	O
.	O

One	O
63	B
-	I
kDa	I
isoform	I
,	O
termed	O
I	B
kappa	I
B	I
gamma	I
-	I
1	I
,	O
which	O
lacks	O
59	O
amino	O
acids	O
C	O
-	O
terminal	O
to	O
ankyrin	B
repeat	I
7	I
,	O
has	O
a	O
novel	O
35	B
-	I
amino	I
acid	I
C	I
terminus	I
encoded	O
by	O
an	O
alternative	B
reading	I
frame	I
of	O
the	O
p105	B
gene	I
.	O

In	O
combination	O
,	O
EBF	B
and	O
E47	B
induce	O
efficient	O
expression	O
of	O
the	O
endogenous	B
immunoglobulin	I
surrogate	I
light	I
chain	I
genes	I
,	O
lambda5	B
and	O
VpreB	B
,	O
whereas	O
other	O
pre	B
-	I
B	I
cell	I
-	I
specific	I
genes	I
remain	O
silent	O
.	O

To	O
determine	O
if	O
CYC2	B
is	O
found	O
in	O
a	O
complex	O
with	O
previously	O
identified	O
trypanosome	B
cdc2	I
-	I
related	I
kinases	I
(	O
CRKs	B
)	O
,	O
the	O
CYC2	B
gene	I
was	O
fused	O
to	O
the	O
TY	B
epitope	I
tag	O
,	O
integrated	O
into	O
the	O
trypanosome	O
genome	O
,	O
and	O
expressed	O
under	O
inducible	O
control	O
.	O

Together	O
,	O
these	O
findings	O
support	O
the	O
notion	O
that	O
chromatin	B
configuration	O
as	O
well	O
as	O
the	O
interplay	O
of	O
promoter	B
elements	I
mediate	O
proper	O
hormone	O
-	O
dependent	O
and	O
tissue	O
-	O
specific	O
expression	O
of	O
the	O
B1	B
vitellogenin	I
gene	I
.	O

A	O
human	B
putative	I
lymphocyte	I
G0	I
/	I
G1	I
switch	I
gene	I
homologous	O
to	O
a	O
rodent	B
gene	I
encoding	O
a	O
zinc	B
-	I
binding	I
potential	I
transcription	I
factor	I
.	O

The	O
distribution	O
of	O
myeloid	B
lineage	I
-	I
associated	I
cytokine	I
receptors	I
and	O
lysosomal	B
proteins	I
was	O
analyzed	O
in	O
human	O
CD34	O
+	O
cord	O
blood	O
cell	O
(	O
CB	O
)	O
subsets	O
at	O
different	O
stages	O
of	O
myeloid	O
commitment	O
by	O
reverse	O
-	O
transcriptase	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
.	O

Multifunctional	B
protein	I
kinase	I
(	O
MFPK	B
)	O
phosphorylates	O
ATP	B
-	I
citrate	I
lyase	I
on	O
peptide	B
B	I
on	O
two	O
sites	O
,	O
BT	O
and	O
BS	O
,	O
on	O
threonine	O
and	O
serine	O
,	O
respectively	O
,	O
inhibitor	B
2	I
on	O
a	O
threonyl	O
residue	O
,	O
and	O
glycogen	B
synthase	I
at	O
sites	O
2	O
and	O
3	O
.	O

DNA	O
-	O
binding	O
and	O
transcriptional	O
regulatory	O
properties	O
of	O
hepatic	B
leukemia	I
factor	I
(	O
HLF	B
)	O
and	O
the	O
t	O
(	O
17	O
;	O
19	O
)	O
acute	B
lymphoblastic	I
leukemia	I
chimera	I
E2A	I
-	I
HLF	I
.	O

To	O
assess	O
more	O
specific	O
PKA	B
-	O
dependent	O
mediation	O
of	O
LH	B
'	I
s	I
contribution	O
to	O
combined	O
hormonal	O
drive	O
,	O
the	O
LDL	B
receptor	I
(	I
-	I
1076	I
to	I
+	I
11	I
bp	I
)	I
reporter	I
plasmid	O
was	O
cotransfected	O
with	O
a	O
full	B
-	I
sequence	I
rabbit	I
muscle	I
protein	I
kinase	I
inhibitor	I
(	O
PKI	B
)	O
minigene	O
driven	O
constitutively	O
by	O
a	O
Rous	B
sarcoma	I
virus	I
promoter	I
.	O

Detailed	O
structural	O
analysis	O
of	O
the	O
first	O
12	O
cDNAs	B
(	O
HZF	B
1	I
-	I
10	I
)	O
and	O
a	O
partial	O
characterization	O
of	O
HZF	B
11	I
-	I
42	I
revealed	O
that	O
a	O
common	O
feature	O
of	O
human	B
Kruppel	I
-	I
related	I
zinc	I
finger	I
proteins	I
is	O
the	O
presence	O
of	O
tandem	O
arrays	O
of	O
zinc	B
fingers	I
ranging	O
in	O
number	O
from	O
3	O
to	O
over	O
20	O
that	O
are	O
preferentially	O
located	O
in	O
the	O
carboxy	B
-	I
terminal	I
regions	I
of	O
the	O
proteins	O
.	O

DNA	O
sequence	O
and	O
evolution	O
of	O
the	O
CPS	B
domain	I
of	O
the	O
Syrian	B
hamster	I
multifunctional	I
protein	I
CAD	I
.	O

Interaction	O
between	O
the	O
stage	B
selector	I
element	I
(	O
SSE	O
)	O
in	O
the	O
proximal	B
gamma	I
-	I
globin	I
promoter	I
and	O
hypersensitivity	B
site	I
2	I
in	O
the	O
locus	B
control	I
region	I
partly	O
mediates	O
the	O
competitive	O
silencing	O
of	O
the	O
beta	B
-	I
globin	I
promoter	I
in	O
the	O
fetal	O
developmental	O
stage	O
.	O

NE	B
and	O
PR3	B
assist	O
in	O
the	O
destruction	O
of	O
phagocytosed	O
microorganisms	O
,	O
cleave	O
the	O
important	O
connective	B
-	I
tissue	I
protein	I
elastin	I
,	O
and	O
generate	O
chemotactic	O
activities	O
by	O
forming	O
alpha	B
1	I
-	I
proteinase	I
inhibitor	I
complexes	I
and	O
elastin	B
peptides	I
.	O

High	O
-	O
resolution	O
structure	O
of	O
the	O
diphtheria	B
toxin	I
repressor	I
complexed	O
with	O
cobalt	O
and	O
manganese	O
reveals	O
an	O
SH3	B
-	I
like	I
third	O
domain	O
and	O
suggests	O
a	O
possible	O
role	O
of	O
phosphate	O
as	O
co	O
-	O
corepressor	O
.	O

The	O
CHEMR1	B
gene	I
Scya3r2	B
is	O
a	O
single	B
-	I
copy	I
gene	I
whose	O
open	O
reading	O
frame	O
may	O
be	O
in	O
a	O
single	O
exon	O
and	O
maps	O
to	O
the	O
distal	O
region	O
of	O
mouse	B
Chr	I
9	I
where	O
the	O
mouse	B
macrophage	I
inflammatory	I
protein	I
-	I
1alpha	I
(	I
MIP	I
-	I
1alpha	I
)	I
receptor	I
gene	I
Scya3r	B
and	O
two	O
related	O
C	B
-	I
C	I
chemokine	I
receptor	I
-	I
like	I
genes	I
reside	O
.	O

The	O
physiological	O
role	O
of	O
the	O
pro	B
-	I
myelocytic	I
leukaemia	I
(	I
PML	I
)	I
gene	I
product	I
is	O
poorly	O
defined	O
.	O

Activation	O
of	O
the	O
CDC42	B
effector	I
N	B
-	I
WASP	I
by	O
the	O
Shigella	B
flexneri	I
IcsA	I
protein	I
promotes	O
actin	B
nucleation	O
by	O
Arp2	B
/	I
3	I
complex	I
and	O
bacterial	O
actin	B
-	O
based	O
motility	O
.	O

We	O
identify	O
considerable	O
spatio	O
-	O
temporal	O
similarities	O
between	O
reported	O
expression	O
patterns	O
of	O
Ypr10	B
genes	I
and	O
ribonuclease	O
genes	O
,	O
which	O
,	O
together	O
with	O
the	O
significant	O
sequence	O
similarity	O
to	O
the	O
ginseng	B
ribonuclease	I
,	O
support	O
the	O
hypothesis	O
of	O
a	O
ribonuclease	O
function	O
for	O
PR	B
-	I
10	I
proteins	I
and	O
allow	O
the	O
prediction	O
of	O
possible	O
biological	O
roles	O
.	O

GATA	B
-	I
1	I
binds	O
to	O
WGATAR	B
consensus	I
motifs	I
in	O
the	O
regulatory	B
regions	I
of	O
virtually	O
all	O
erythroid	B
cell	I
-	I
specific	I
genes	I
.	O

A	O
patient	O
who	O
received	O
antithymocyte	B
globulin	I
therapy	O
for	O
aplastic	O
anemia	O
due	O
to	O
D	B
-	I
penicillamine	I
therapy	O
is	O
described	O
.	O

In	O
this	O
paper	O
,	O
I	O
described	O
the	O
characterization	O
of	O
genes	O
encoding	O
eosinophil	B
granule	I
proteins	I
and	O
the	O
mRNA	O
expression	O
of	O
GATA	B
-	I
1	I
binding	I
transcription	I
factor	I
during	O
eosinophil	O
differentiation	O
.	O

Pretreatment	O
of	O
PBMCs	O
with	O
pertussis	B
toxin	I
blocked	O
the	O
functions	O
of	O
C3a	B
and	O
C3a	B
(	I
desArg	I
)	I
,	O
indicating	O
that	O
the	O
actions	O
of	O
these	O
two	O
molecules	O
are	O
mediated	O
by	O
a	O
G	B
protein	I
-	O
coupled	O
pathway	O
.	O

In	O
the	O
course	O
of	O
screening	O
for	O
transcription	O
factors	O
which	O
interact	O
with	O
the	O
human	B
myeloperoxidase	I
(	O
MPO	B
)	O
promoter	O
we	O
,	O
for	O
the	O
first	O
time	O
,	O
identified	O
and	O
cloned	O
the	O
cDNA	O
and	O
genomic	O
DNA	O
for	O
human	B
HBP1	I
(	O
HMG	B
-	I
Box	I
containing	I
protein	I
1	I
)	O
,	O
a	O
member	O
of	O
the	O
high	B
mobility	I
group	I
of	I
non	I
-	I
histone	I
chromosomal	I
proteins	I
.	O

The	O
chimeric	B
gene	I
,	I
AML1	B
/	I
ETO	I
(	I
MTG8	I
)	I
,	O
generated	O
in	O
t	B
(	I
8	I
;	I
21	I
)	I
acute	O
myeloid	O
leukemia	O
enhances	O
the	O
expression	O
of	O
Bcl	B
-	I
2	I
.	O

(	O
iv	O
)	O
The	O
accumulation	O
of	O
cyclin	B
D3	I
protein	I
in	O
Vero	O
cells	O
infected	O
with	O
an	O
alpha0	B
deletion	I
mutant	I
was	O
reduced	O
relative	O
to	O
that	O
of	O
cells	O
infected	O
with	O
wild	O
-	O
type	O
virus	O
or	O
a	O
recombinant	O
virus	O
in	O
which	O
the	O
deleted	O
alpha0	B
sequences	I
were	O
restored	O
.	O

The	O
product	O
of	O
the	O
murine	B
homolog	I
of	O
the	O
Drosophila	B
extra	I
sex	I
combs	I
gene	I
displays	O
transcriptional	B
repressor	I
activity	O
.	O

Here	O
,	O
we	O
characterize	O
the	O
putative	B
human	I
homolog	I
of	O
NRL	B
,	O
neutrophil	B
gelatinase	I
-	I
associated	I
lipocalin	I
(	O
NGAL	B
)	O
.	O

The	O
PB1	B
sequence	O
motif	O
is	O
highly	O
conserved	O
in	O
both	O
human	B
and	I
murine	I
GM	I
-	I
CSF	I
genes	I
.	O

Our	O
results	O
suggest	O
that	O
the	O
bulk	O
of	O
protein	O
-	O
DNA	O
interactions	O
that	O
underlies	O
the	O
developmental	O
control	O
of	O
globin	B
genes	I
takes	O
place	O
in	O
the	O
gamma	B
-	I
and	I
beta	I
-	I
globin	I
gene	I
promoters	I
,	O
and	O
that	O
GT	B
motifs	I
of	O
the	O
beta	B
-	I
globin	I
locus	I
LCR	B
may	O
play	O
a	O
role	O
in	O
the	O
developmental	O
regulation	O
of	O
human	O
beta	B
-	I
globin	I
gene	I
expression	O
,	O
perhaps	O
by	O
increasing	O
the	O
probability	O
of	O
interaction	O
of	O
the	O
LCR	B
holocomplex	I
with	O
the	O
fetal	B
or	I
the	I
adult	I
globin	I
gene	I
.	O

We	O
found	O
that	O
erythropoietin	B
(	O
EPO	B
)	O
and	O
stem	B
cell	I
factor	I
(	O
SCF	B
)	O
activated	B
protein	I
kinase	I
B	I
(	O
PKB	B
/	I
Akt	I
)	O
in	O
EPO	O
-	O
dependent	O
HCD57	O
erythroid	O
cells	O
.	O

Transcriptional	O
regulation	O
of	O
the	O
beta	B
-	I
casein	I
gene	I
by	O
cytokines	B
:	O
cross	O
-	O
talk	O
between	O
STAT5	B
and	O
other	O
signaling	B
molecules	I
.	O

These	O
genes	O
were	O
expressed	O
in	O
a	O
Saccharomyces	O
cerevisiae	O
mutant	O
in	O
which	O
the	O
endogenous	B
ferrochelatase	I
gene	I
(	O
HEM15	B
)	O
had	O
been	O
deleted	O
,	O
and	O
the	O
phenotypes	O
of	O
the	O
transformants	O
were	O
characterized	O
.	O

Identification	O
of	O
upstream	B
regulatory	I
elements	I
that	O
repress	O
expression	O
of	O
adult	B
beta	I
-	I
like	I
globin	I
genes	I
in	O
a	O
primitive	O
erythroid	O
environment	O
.	O

Tyrosine	O
phosphorylation	O
STAT1	B
or	O
STAT3	B
was	O
not	O
detected	O
in	O
human	O
erythroid	O
precursors	O
after	O
stimulation	O
with	O
erythropoietin	B
.	O

Using	O
a	O
fragment	O
of	O
K	B
protein	I
as	O
bait	O
in	O
the	O
yeast	O
two	O
-	O
hybrid	O
screen	O
,	O
we	O
isolated	O
a	O
cDNA	B
that	O
encodes	O
a	O
protein	O
whose	O
primary	O
structure	O
has	O
extensive	O
similarity	O
to	O
the	O
Drosophila	B
melanogaster	I
extra	I
sex	I
combs	I
(	I
esc	I
)	I
gene	I
product	I
,	O
Esc	B
,	O
a	O
putative	O
silencer	O
of	O
homeotic	B
genes	I
.	O

In	O
UCSD	O
-	O
AML1	O
,	O
we	O
have	O
also	O
identified	O
fusion	B
transcripts	I
between	O
the	O
ecotropic	B
viral	I
insertion	I
site	I
I	I
(	I
EVI1	I
)	I
gene	I
in	O
3q26	B
and	O
GR6	B
and	O
between	O
EVI1	B
and	O
Ribophorin	B
I	I
that	O
maps	O
30	O
kb	O
telomeric	O
to	O
GR6	B
in	O
3q21	B
.	O

The	O
characterized	O
Aplysia	B
Afurin2	I
is	O
a	O
candidate	O
PC	B
that	O
may	O
play	O
an	O
important	O
role	O
in	O
the	O
processing	O
of	O
egg	B
-	I
laying	I
hormone	I
(	O
ELH	B
)	O
-	O
related	O
precursors	O
in	O
the	O
secretory	O
cells	O
of	O
the	O
atrial	O
gland	O
.	O

The	O
160	B
N	I
-	I
terminal	I
amino	I
acids	I
in	O
the	O
nonfinger	B
region	I
of	O
clone	B
18	I
are	O
highly	O
homologous	O
with	O
similar	O
regions	O
of	O
several	O
other	O
human	B
,	I
mouse	I
,	I
and	I
Drosophila	I
sequences	I
,	O
defining	O
a	O
subfamily	O
of	O
Kruppel	O
-	O
like	O
zinc	B
finger	I
proteins	I
termed	O
TAB	B
(	O
tramtrack	B
[	I
ttk	I
]	I
-	I
associated	I
box	I
)	O
here	O
.	O

Glucocorticoid	O
-	O
mediated	O
repression	O
of	O
cytokine	B
gene	I
transcription	O
in	O
human	O
arteritis	B
-	I
SCID	I
chimeras	I
.	O

After	O
the	O
recent	O
discovery	O
that	O
the	O
cyclosporin	B
A	I
-	I
binding	I
protein	I
cyclophilin	B
is	O
identical	O
to	O
peptidylprolyl	B
cis	I
-	I
trans	I
isomerase	I
,	O
a	O
cellular	B
binding	I
protein	I
for	O
FK506	O
was	O
found	O
to	O
be	O
distinct	O
from	O
cyclophilin	B
but	O
to	O
have	O
the	O
same	O
enzymatic	O
activity	O
.	O

Here	O
we	O
show	O
that	O
CaMKIV	B
/	I
Gr	I
induces	O
the	O
transcription	B
factor	I
activation	I
protein	I
1	I
(	O
AP	B
-	I
1	I
)	O
alone	O
or	O
in	O
synergy	O
with	O
T	B
cell	I
mitogens	I
and	O
with	O
the	O
p21ras	B
oncoprotein	I
.	O

The	O
functional	O
effects	O
of	O
these	O
interactions	O
are	O
that	O
CBP	B
and	O
p300	B
,	O
but	O
not	O
P	B
/	I
CAF	I
,	O
enhance	O
EKLF	B
'	O
s	O
transcriptional	O
activation	O
of	O
the	O
beta	B
-	I
globin	I
promoter	I
in	O
erythroid	O
cells	O
.	O

The	O
physical	O
linkage	O
of	O
the	O
FHR2	B
and	O
the	O
factor	B
H	I
genes	I
provides	O
additional	O
evidence	O
for	O
a	O
close	O
relatedness	O
of	O
complement	B
factor	I
H	I
and	O
the	O
factor	B
H	I
-	I
related	I
proteins	I
.	O

Transcription	O
of	O
the	O
gene	O
for	O
ivanolysin	B
O	I
and	O
expression	O
of	O
other	O
genes	O
of	O
the	O
virulence	B
gene	I
cluster	I
in	I
L	I
.	I
ivanovii	I
were	O
dependent	O
on	O
PrfA	B
.	O

The	O
GATA	B
-	I
1	I
nuclear	O
bodies	O
differed	O
from	O
previously	O
described	O
nuclear	O
structures	O
and	O
there	O
was	O
no	O
co	O
-	O
localization	O
with	O
nuclear	B
antigens	I
involved	O
in	O
RNA	O
processing	O
or	O
other	O
ubiquitous	B
(	I
Spl	I
,	I
c	I
-	I
Jun	I
and	I
TBP	I
)	I
or	I
haemopoietic	I
(	I
NF	I
-	I
E2	I
)	I
transcription	I
factors	I
.	O

We	O
studied	O
the	O
functional	O
interaction	O
between	O
human	O
embryonic	O
zeta	B
2	I
globin	I
promoter	O
and	O
the	O
alpha	B
globin	I
regulatory	I
element	I
(	O
HS	B
-	I
40	I
)	O
located	O
40	O
kb	O
upstream	O
of	O
the	O
zeta	B
2	I
globin	I
gene	I
.	O

Deletion	O
of	O
an	O
intergenic	O
DNA	O
-	O
binding	O
site	O
for	O
this	O
complex	O
from	O
a	O
human	B
beta	I
-	I
globin	I
locus	I
construct	I
results	O
in	O
delayed	O
human	B
gamma	I
-	I
to	I
beta	I
-	I
globin	I
switching	O
in	O
transgenic	O
mice	O
,	O
suggesting	O
that	O
the	O
PYR	B
complex	I
acts	O
to	O
facilitate	O
the	O
switch	O
.	O

It	O
was	O
shown	O
by	O
transient	O
expression	O
assay	O
that	O
HS	B
-	I
40	I
behaved	O
as	O
an	O
authentic	O
enhancer	O
for	O
high	O
-	O
level	O
zeta	B
2	I
globin	I
promoter	I
activity	O
in	O
K562	O
cells	O
,	O
an	O
erythroid	O
cell	O
line	O
of	O
embryonic	O
and	O
/	O
or	O
fetal	O
origin	O
.	O

How	O
does	O
GATA	B
-	I
1	I
regulate	O
red	B
cell	I
genes	I
like	O
globin	B
or	O
the	O
Epo	B
receptor	I
?	O
Once	O
we	O
identify	O
the	O
functional	O
domains	O
of	O
the	O
GATA	B
-	I
binding	I
proteins	I
,	O
we	O
hope	O
to	O
learn	O
what	O
proteins	O
GATA	B
-	I
1	I
binds	O
to	O
in	O
the	O
basic	O
transcription	O
machinery	O
or	O
in	O
chromatin	O
.	O

Use	O
of	O
antithymocyte	B
globulin	I
may	O
be	O
the	O
optimal	O
treatment	O
of	O
D	B
-	I
penicillamine	I
-	O
induced	O
aplastic	O
anemia	O
.	O

Finally	O
,	O
both	O
PU	B
.	I
1	I
and	O
Spi	B
-	I
B	I
function	O
as	O
transcriptional	O
activators	O
of	O
the	O
immunoglobulin	B
light	I
-	I
chain	I
enhancer	I
E	I
lambda	I
2	I
.	I
4	I
when	O
coexpressed	O
with	O
Pip	B
(	O
PU	B
.	I
1	I
-	I
interaction	I
partner	I
)	O
in	O
NIH	O
-	O
3T3	O
cells	O
.	O

Using	O
deletion	B
mutants	I
,	O
the	O
downstream	O
parathyroid	B
hormone	I
-	I
related	I
protein	I
(	I
PTHrP	I
)	I
promoter	I
is	O
shown	O
to	O
be	O
responsive	O
to	O
both	O
HTLV	B
-	I
I	I
and	I
HTLV	I
-	I
II	I
Tax	I
as	O
well	O
as	O
the	O
AP1	B
/	I
c	I
-	I
jun	I
proto	I
-	I
oncogene	I
.	O

Previously	O
,	O
we	O
characterized	O
a	O
DNA	O
-	O
binding	O
protein	O
,	O
HS2NF5	B
,	O
that	O
bound	O
tightly	O
to	O
a	O
conserved	O
region	O
within	O
hypersensitive	O
site	O
2	O
(	O
HS2	O
)	O
of	O
the	O
human	B
beta	I
-	I
globin	I
locus	I
control	I
region	I
(	O
LCR	O
)	O
(	O
Lam	O
,	O
L	O
.	O

Antithymocyte	B
globulin	I
in	O
the	O
treatment	O
of	O
D	B
-	I
penicillamine	I
-	O
induced	O
aplastic	O
anemia	O
.	O

We	O
now	O
show	O
that	O
the	O
BAT1	B
translation	I
product	I
is	O
the	O
homolog	O
of	O
the	O
rat	B
p47	I
nuclear	I
protein	I
,	O
the	O
WM6	B
Drosophila	I
gene	I
product	I
,	O
and	O
probably	O
also	O
Ce08102	B
of	O
Caenorhabditis	O
elegans	O
,	O
all	O
members	O
of	O
the	O
DEAD	B
protein	I
family	I
of	O
ATP	B
-	I
dependent	I
RNA	I
helicases	I
.	O

In	O
addition	O
,	O
expression	O
of	O
Fli	B
-	I
1	I
was	O
identified	O
immunohistochemicall	O
in	O
megakaryocytes	O
derived	O
from	O
CD34	O
(	O
+	O
)	O
cells	O
treated	O
with	O
the	O
megakaryocyte	B
differentiation	I
and	I
proliferation	I
factor	I
,	O
thrombopoietin	B
.	O

In	O
addition	O
,	O
we	O
show	O
that	O
erythropoietin	B
,	O
which	O
is	O
also	O
required	O
for	O
erythroid	O
cell	O
survival	O
,	O
cooperates	O
with	O
GATA	B
-	I
1	I
to	O
stimulate	O
bcl	B
-	I
xL	I
gene	O
expression	O
and	O
to	O
maintain	O
erythroid	O
cell	O
viability	O
during	O
terminal	O
maturation	O
.	O

Pterin	B
carbinolamine	I
dehydratase	I
/	I
dimerization	I
cofactor	I
of	O
HNF1	B
(	O
PCD	B
/	I
DCoH	I
)	O
is	O
a	O
dual	B
-	I
function	I
protein	I
.	O

We	O
show	O
that	O
both	O
delta383	B
and	O
delta99	B
specifically	O
enhance	O
expression	O
of	O
cat	B
for	O
plasmids	B
containing	O
a	O
human	B
adult	I
globin	I
(	I
HBB	I
)	I
promoter	I
,	O
whereas	O
expression	O
of	O
similar	O
constructs	O
using	O
human	B
fetal	I
(	I
A	I
gamma	I
-	I
)	I
globin	I
(	I
HBG1	I
)	I
or	I
simian	I
virus	I
40	I
(	I
SV40	I
)	I
promoters	I
is	O
not	O
enhanced	O
.	O

The	O
yeast	B
LPD1	I
gene	I
encoding	O
lipoamide	B
dehydrogenase	I
is	O
subject	O
to	O
the	O
general	O
control	O
of	O
amino	O
acid	O
biosynthesis	O
mediated	O
by	O
the	O
GCN4	B
transcription	I
factor	I
.	O

The	O
Sp1	B
transcription	I
factor	I
binds	O
the	O
CD11b	B
promoter	I
specifically	O
in	O
myeloid	O
cells	O
in	O
vivo	O
and	O
is	O
essential	O
for	O
myeloid	B
-	I
specific	I
promoter	I
activity	O
.	O

Specific	O
complex	O
formation	O
between	O
the	O
type	B
II	I
bare	I
lymphocyte	I
syndrome	I
-	I
associated	I
transactivators	I
CIITA	B
and	O
RFX5	B
.	O

RESULTS	O
:	O
Here	O
,	O
we	O
have	O
isolated	O
the	O
murine	B
and	I
human	I
cDNAs	I
which	O
encode	O
a	O
novel	O
form	O
of	O
MZF	B
protein	I
(	O
MZF	B
-	I
2	I
)	O
.	O

All	O
fusions	O
splice	O
the	O
5	B
'	I
ends	I
of	O
the	O
3q21	B
genes	I
into	O
exon	B
2	I
of	O
the	O
EVI1	B
gene	O
,	O
an	O
event	O
that	O
is	O
similar	O
to	O
the	O
normal	O
intergenic	O
splicing	O
of	O
MDS1	B
-	I
EVI1	I
and	O
to	O
those	O
previously	O
documented	O
in	O
leukemias	O
with	O
t	B
(	I
3	I
;	I
21	I
)	I
and	O
t	B
(	I
3	I
;	I
12	I
)	I
,	O
in	O
which	O
acute	O
myelogenous	B
leukemia	I
1	I
-	I
EVI1	I
fusions	I
and	O
ETV6	B
-	I
EVI1	I
fusions	I
,	O
respectively	O
,	O
occur	O
.	O

The	O
major	O
myosin	B
-	I
binding	I
domain	I
of	O
skeletal	B
muscle	I
MyBP	I
-	I
C	I
(	O
C	B
protein	I
)	O
resides	O
in	O
the	O
COOH	O
-	O
terminal	O
,	O
immunoglobulin	B
C2	B
motif	I
.	O

Transcriptional	O
activation	O
of	O
human	B
zeta	I
2	I
globin	I
promoter	I
by	O
the	O
alpha	B
globin	I
regulatory	I
element	I
(	O
HS	B
-	I
40	I
)	O
:	O
functional	O
role	O
of	O
specific	O
nuclear	B
factor	I
-	I
DNA	I
complexes	I
.	O

We	O
conclude	O
that	O
sodium	O
phenylacetate	O
treatment	O
of	O
K562	O
cells	O
increases	O
gamma	B
-	I
globin	I
mRNA	I
and	O
induces	O
cell	O
maturation	O
as	O
judged	O
by	O
morphology	O
without	O
affecting	O
the	O
expression	O
of	O
the	O
erythroid	B
transcription	I
factors	I
,	O
some	O
of	O
which	O
are	O
known	O
to	O
be	O
involved	O
in	O
the	O
regulation	O
of	O
beta	B
-	I
like	I
globin	I
genes	I
.	O

Recombinant	B
soluble	I
pMCP	I
that	O
lacked	O
transmembrane	O
and	O
cytoplasmic	O
domains	O
had	O
factor	B
I	I
cofactor	I
activity	O
in	O
C3b	B
cleavage	O
,	O
indicating	O
that	O
it	O
is	O
functionally	O
,	O
as	O
well	O
as	O
structurally	O
homologous	O
to	O
MCP	B
.	O

A	O
novel	O
function	O
of	O
Stat1	B
and	O
Stat3	B
proteins	O
in	O
erythropoietin	B
-	O
induced	O
erythroid	O
differentiation	O
of	O
a	O
human	O
leukemia	O
cell	O
line	O
.	O

The	O
E2A	B
-	I
HLF	I
(	I
hepatic	I
leukemia	I
factor	I
)	I
oncoprotein	I
,	O
generated	O
in	O
pro	O
-	O
B	O
lymphocytes	O
by	O
fusion	O
of	O
the	O
trans	B
-	I
activation	I
domain	I
of	O
E2A	B
to	O
the	O
basic	B
region	I
/	I
leucine	I
zipper	I
(	I
bZIP	I
)	I
domain	I
of	O
HLF	B
,	O
functions	O
as	O
an	O
anti	B
-	I
apoptotic	I
transcription	I
factor	I
in	O
leukemic	O
cell	O
transformation	O
.	O

Overexpression	O
of	O
hematopoietic	B
protein	I
-	I
tyrosine	I
phosphatase	I
(	O
HePTP	B
)	O
results	O
in	O
suppression	O
of	O
T	O
lymphocyte	O
activation	O
as	O
measured	O
by	O
T	B
cell	I
antigen	I
receptor	I
-	O
induced	O
activation	O
of	O
transcription	B
factors	I
binding	O
to	O
the	O
5	B
'	I
promoter	I
of	O
the	O
interleukin	B
-	I
2	I
gene	I
.	O

That	O
the	O
c	B
-	I
myb	I
oncogene	I
product	I
can	O
interact	O
synergistically	O
with	O
an	O
EBV	B
-	I
encoded	I
member	I
of	O
the	O
leucine	B
zipper	I
protein	I
family	I
suggests	O
c	B
-	I
myb	I
is	O
likely	O
to	O
engage	O
in	O
similar	O
interactions	O
with	O
cellularly	B
encoded	I
transcription	I
factors	I
.	O

Furthermore	O
a	O
dominant	B
negative	I
form	I
of	O
AML1	B
,	O
AML1a	B
,	O
totally	O
suppressed	O
granulocytic	O
differentiation	O
otherwise	O
induced	O
by	O
granulocyte	B
colony	I
-	I
stimulating	I
factor	I
when	O
AML1a	B
was	O
overexpressed	O
in	O
32Dc13	O
murine	O
myeloid	O
cells	O
.	O

First	O
,	O
human	O
erythroid	O
K562	O
cells	O
stably	O
integrated	O
with	O
various	O
HS	B
-	I
40	I
mutants	I
cis	O
linked	O
to	O
a	O
human	B
alpha	I
-	I
globin	I
promoter	I
-	O
growth	B
hormone	I
hybrid	O
gene	O
were	O
analyzed	O
by	O
genomic	O
footprinting	O
and	O
expression	O
analysis	O
.	O

Initiation	B
binding	I
repressor	I
[	O
corrected	O
]	O
(	O
IBR	B
)	O
is	O
a	O
chicken	B
erythrocyte	I
factor	I
(	O
apparent	O
molecular	O
mass	O
,	O
70	O
to	O
73	O
kDa	O
)	O
that	O
binds	O
to	O
the	O
sequences	O
spanning	O
the	O
transcription	B
initiation	I
site	I
of	O
the	O
histone	B
h5	I
gene	I
,	O
repressing	O
its	O
transcription	O
.	O

GATA	B
-	I
1	I
and	O
erythropoietin	B
cooperate	O
to	O
promote	O
erythroid	O
cell	O
survival	O
by	O
regulating	O
bcl	B
-	I
xL	I
expression	O
.	O

Hemoglobin	B
concentration	O
and	O
gamma	B
-	I
globin	I
and	O
erythroid	B
delta	I
-	I
aminolevulinate	I
synthase	I
mRNA	I
levels	O
were	O
significantly	O
higher	O
in	O
M	O
-	O
TAT	O
/	O
EPO	O
cells	O
than	O
in	O
M	O
-	O
TAT	O
/	O
GM	O
-	O
CSF	O
cells	O
.	O

It	O
is	O
also	O
evident	O
that	O
the	O
TF	B
.	I
VIIa	I
complex	I
is	O
proteolytically	O
active	O
and	O
can	O
activate	O
the	O
zymogen	B
plasma	I
factor	I
X	I
to	O
the	O
serine	B
protease	I
Xa	I
in	O
free	O
solution	O
,	O
inferring	O
that	O
extended	O
substrate	O
recognition	O
by	O
induced	O
structural	O
loci	O
of	O
the	O
TF	B
.	I
VIIa	I
complex	I
are	O
created	O
from	O
either	O
or	O
both	O
proteins	O
to	O
constitute	O
a	O
new	B
recognition	I
structure	I
.	O

The	O
results	O
indicate	O
that	O
DNA	O
methylation	O
,	O
chromatin	B
structure	O
,	O
and	O
transactivation	O
at	O
an	O
Sp1	B
site	I
contribute	O
to	O
the	O
highly	O
restricted	O
expression	O
of	O
this	O
myelomonocytic	B
lineage	I
specific	I
gene	I
.	O

The	O
transcript	O
was	O
initially	O
identified	O
as	O
a	O
partial	O
cDNA	O
sequence	O
in	O
the	O
course	O
of	O
constructing	O
a	O
transcript	O
map	O
of	O
the	O
region	O
between	O
markers	O
D11S1765	B
and	O
uteroglobin	B
known	O
to	O
encompass	O
the	O
gene	O
causing	O
Best	O
disease	O
.	O

Here	O
we	O
report	O
the	O
isolation	O
and	O
characterization	O
of	O
the	O
forkhead	B
homologue	I
in	I
rhabdomyosarcoma	I
(	O
FKHR	B
)	O
,	O
a	O
recently	O
described	O
member	O
of	O
the	O
hepatocyte	B
nuclear	I
factor	I
3	I
/	O
forkhead	B
homeotic	B
gene	I
family	I
,	O
as	O
a	O
nuclear	B
hormone	I
receptor	I
(	O
NR	B
)	O
intermediary	O
protein	O
.	O

Human	B
neutrophil	I
elastase	I
proteolytically	O
activates	O
the	O
platelet	B
integrin	I
alphaIIbbeta3	B
through	O
cleavage	O
of	O
the	O
carboxyl	B
terminus	I
of	O
the	O
alphaIIb	B
subunit	I
heavy	I
chain	I
.	O

Ki	B
-	I
ras4BVal	I
-	I
12	I
transfectant	O
cells	O
expressed	O
2	O
-	O
fold	O
elevated	O
protein	O
levels	O
of	O
the	O
lysosomal	B
cysteine	I
protease	I
cathepsin	B
B	I
but	O
did	O
not	O
up	O
-	O
regulate	O
cathepsin	B
B	I
mRNA	I
expression	O
.	O

Promiscuous	O
transcriptional	O
activity	O
of	O
the	O
reticuloendotheliosi	B
virus	I
(	I
REV	I
)	I
long	I
terminal	I
repeat	I
(	O
LTR	B
)	O
was	O
detected	O
in	O
transient	O
expression	O
assays	O
using	O
LTR	B
-	I
chloramphenicol	I
acetyltransferase	I
-	I
encoding	I
gene	I
chimeras	I
,	O
and	O
cells	O
of	O
diverse	O
species	O
and	O
tissue	O
type	O
;	O
levels	O
of	O
expression	O
from	O
two	O
different	O
REV	B
LTRs	I
correlate	O
with	O
reports	O
of	O
pathogenicity	O
of	O
the	O
respective	O
viruses	O
in	O
vivo	O
.	O

The	O
dimerization	B
domain	I
of	O
KBF1	B
/	I
p50	I
is	O
contained	O
between	B
amino	I
acids	I
201	I
and	I
367	I
.	O

hLH	B
-	I
2	I
was	O
mapped	O
to	O
chromosome	B
9Q33	I
-	I
34	I
.	I
1	I
,	O
in	O
the	O
same	O
region	O
as	O
the	O
reciprocal	O
translocation	O
that	O
creates	O
the	O
BCR	B
-	I
ABL	I
chimera	I
of	O
the	O
Philadelphia	O
chromosome	O
(	O
Ph	O
'	O
)	O
,	O
the	O
hallmark	O
of	O
CML	O
;	O
hLH	B
-	I
2	I
was	O
retained	O
on	O
the	O
derivative	B
9	I
chromosome	I
and	O
is	O
therefore	O
centromeric	O
of	O
c	B
-	I
ABL	I
.	O

Hemoglobin	B
switching	O
in	O
humans	O
is	O
accompanied	O
by	O
changes	O
in	O
the	O
ratio	O
of	O
the	O
transcription	B
factors	I
,	O
GATA	B
-	I
1	I
and	O
SP1	B
.	O

[	B
3H	I
]	I
S	I
-	I
desoxy	I
-	I
BTX	I
-	I
B2	I
(	O
cysteine	B
brevetoxin	I
B	I
)	O
was	O
semi	O
-	O
synthesized	O
from	O
BTX	B
-	I
B	I
by	O
conjugation	O
of	O
cysteine	B
at	O
the	O
C50	O
olefinic	B
group	O
,	O
then	O
[	B
3H	I
]	I
radiolabeled	O
by	O
C42	O
aldehyde	B
reduction	O
.	O

The	O
chimeric	B
oncoprotein	I
E2a	B
-	I
Pbx1	I
results	O
from	O
fusion	O
of	O
the	O
E2A	B
and	I
PBX1	I
genes	I
following	O
t	B
(	I
1	I
;	I
19	I
)	I
chromosomal	I
translocations	I
in	O
B	O
cell	O
precursor	O
acute	O
leukemias	O
.	O

When	O
the	O
supplemented	O
cytokine	B
was	O
switched	O
from	O
GM	B
-	I
CSF	I
to	O
EPO	B
,	O
hemoglobin	B
synthesis	O
in	O
M	O
-	O
TAT	O
/	O
GM	O
-	O
CSF	O
cells	O
increased	O
rapidly	O
(	O
within	O
5	O
h	O
)	O
,	O
and	O
the	O
level	O
of	O
GATA	B
-	I
1	I
mRNA	I
increased	O
.	O

Erythroid	B
Kruppel	I
-	I
like	I
factor	I
(	O
EKLF	B
)	O
is	O
a	O
red	B
cell	I
-	I
specific	I
transcriptional	I
activator	I
that	O
is	O
crucial	O
for	O
consolidating	O
the	O
switch	O
to	O
high	O
levels	O
of	O
adult	O
beta	B
-	I
globin	I
expression	O
during	O
erythroid	O
ontogeny	O
.	O

Functional	O
analysis	O
of	O
DNase	B
-	I
I	I
hypersensitive	O
sites	O
at	O
the	O
mouse	B
porphobilinogen	I
deaminase	I
gene	I
locus	I
.	O

A	O
novel	O
B	B
-	I
cell	I
-	I
specific	I
transcription	I
factor	I
,	O
BSAP	B
,	O
was	O
identified	O
as	O
a	O
mammalian	B
homolog	I
of	O
the	O
sea	B
urchin	I
protein	I
TSAP	B
,	O
which	O
interacts	O
with	O
the	O
promoters	B
of	O
four	O
tissue	B
-	I
specific	I
late	I
histone	I
H2A	I
-	I
2	I
and	I
H2B	I
-	I
2	I
genes	I
.	O

The	O
results	O
define	O
the	O
rhombotin	B
gene	O
family	O
as	O
a	O
class	O
of	O
T	B
-	I
cell	I
oncogenes	I
with	O
duplicated	O
cysteine	B
-	I
rich	I
LIM	I
domains	I
.	O

We	O
find	O
that	O
HMG	B
-	I
I	I
binds	O
preferentially	O
to	O
the	O
more	O
3	O
'	O
of	O
a	O
pair	O
of	O
GATA	B
motifs	I
in	O
the	O
gamma	B
-	I
globin	I
promoter	I
;	O
this	O
paired	O
motif	O
is	O
bound	O
by	O
the	O
erythroid	B
factor	I
GATA	I
-	I
1	I
.	O

The	O
Ribophorin	B
I	I
-	I
EVI1	I
fusion	I
in	O
particular	O
may	O
be	O
a	O
common	O
occurrence	O
in	O
t	B
(	I
3	I
;	I
3	I
)	I
.	O

hMSH	B
-	I
2	I
is	O
one	O
of	O
the	O
hereditary	B
non	I
-	I
polyposis	I
colorectal	I
cancer	I
(	I
HNPCC	I
)	I
tumor	I
suppressor	I
genes	I
,	O
and	O
maps	O
to	O
human	O
chromosome	O
2p16	O
.	O

Sp1	B
functions	O
in	O
a	O
chromatin	B
-	O
dependent	O
manner	O
to	O
augment	O
human	B
alpha	I
-	I
globin	I
promoter	I
activity	O
.	O

Here	O
,	O
we	O
report	O
theoretical	O
models	O
for	O
the	O
Gla	O
and	O
EGF	B
-	I
1	I
modules	I
of	O
human	B
PS	I
constructed	O
using	O
prothrombin	B
and	O
factor	B
X	I
experimental	O
structures	O
.	O

The	O
function	O
of	O
the	O
zeta	B
-	I
globin	I
promoter	I
was	O
studied	O
using	O
a	O
series	O
of	O
zeta	B
-	I
globin	I
promoter	I
deletion	I
constructs	I
to	O
drive	O
luciferase	B
expression	O
in	O
transiently	O
transfected	O
human	O
erythroleukemia	O
cells	O
.	O

One	O
of	O
these	O
,	O
designated	O
Rhom	B
-	I
2	I
,	O
is	O
located	O
on	O
human	B
chromosome	I
11	I
at	O
band	B
11p13	I
,	O
where	O
a	O
cluster	O
of	O
T	B
-	I
cell	I
leukemia	I
-	I
specific	I
translocations	I
occur	O
;	O
all	O
translocation	O
breakpoints	O
at	O
11p13	B
are	O
upstream	O
of	O
the	O
Rhom	B
-	I
2	I
gene	I
.	O

Characterization	O
of	O
FIII	B
/	O
YY1	B
,	O
a	O
Xenopus	B
laevis	I
conserved	I
zinc	I
-	I
finger	I
protein	I
binding	O
to	O
the	O
first	O
exon	O
of	O
L1	B
and	O
L14	B
ribosomal	I
protein	I
genes	I
.	O

The	O
involvement	O
of	O
p23	B
,	O
hsp90	B
,	O
and	O
immunophilins	B
in	O
the	O
assembly	O
of	O
progesterone	B
receptor	I
complexes	I
.	O

The	O
conserved	O
TRAF3	B
binding	I
sites	I
in	O
LMP1	B
and	O
the	O
CD30	B
Hodgkin	I
'	I
s	I
disease	I
marker	I
provides	O
further	O
evidence	O
that	O
a	O
TRAF3	B
-	O
mediated	O
signal	O
transduction	O
pathway	O
may	O
be	O
important	O
in	O
malignant	O
transformation	O
.	O

We	O
previously	O
detected	O
a	O
tissue	B
-	I
specific	I
promoter	I
preceding	O
the	O
exon	O
encoding	O
the	O
N	B
terminus	I
of	O
the	O
pp52	B
leukocyte	I
protein	I
.	O

EKLF	B
is	O
required	O
for	O
integrity	O
of	O
the	O
chromatin	O
structure	O
at	O
the	O
beta	B
-	I
like	I
globin	I
locus	I
,	O
and	O
it	O
interacts	O
with	O
a	O
positive	B
-	I
acting	I
factor	I
in	O
vivo	O
.	O

Inv	B
(	I
16	I
)	I
(	I
p13	I
;	I
q22	I
)	I
fuses	O
the	O
gene	O
encoding	O
the	O
beta	B
subunit	I
of	O
Pebp2	B
to	O
the	O
MYH11	B
gene	I
encoding	O
a	O
smooth	B
muscle	I
myosin	I
heavy	I
chain	I
(	O
Smmhc	B
)	O
.	O

rBPI21	B
,	O
a	O
recombinant	B
N	I
-	I
terminal	I
fragment	I
of	O
human	B
bactericidal	I
/	I
permeability	I
-	I
increasing	I
protein	I
(	O
BPI	B
)	O
,	O
inhibited	O
LPS	O
-	O
induced	O
E	B
-	I
selectin	I
expression	O
when	O
added	O
at	O
the	O
same	O
time	O
as	O
,	O
and	O
up	O
to	O
6	O
h	O
after	O
,	O
LPS	O
.	O

Erythroid	O
differentiation	O
involves	O
the	O
activation	O
of	O
a	O
number	O
of	O
erythroid	O
-	O
specific	O
genes	O
,	O
most	O
of	O
which	O
,	O
including	O
the	O
globin	B
genes	I
and	O
the	O
erythropoietin	B
receptor	I
(	I
Epo	I
-	I
R	I
)	I
gene	I
,	O
are	O
,	O
at	O
least	O
in	O
part	O
,	O
regulated	O
by	O
the	O
transcription	B
factor	I
GATA	B
-	I
1	I
.	O

HVH2	B
mRNA	I
showed	O
an	O
expression	O
pattern	O
distinct	O
from	O
CL100	B
(	O
human	B
homologue	I
of	I
mouse	I
MKP1	I
)	O
and	O
PAC1	B
,	O
two	O
previously	O
identified	O
MAP	B
kinase	I
phosphatases	I
.	O

This	O
is	O
in	O
contrast	O
to	O
the	O
result	O
that	O
as	O
many	O
as	O
20	O
copies	O
of	O
the	O
cyclophilin	B
gene	I
and	O
possible	O
pseudogenes	O
may	O
be	O
present	O
in	O
the	O
mammalian	B
genome	I
.	O

So	O
far	O
,	O
we	O
have	O
identified	O
five	O
potential	O
targets	O
for	O
Oct2	B
:	O
the	O
membrane	B
glycoprotein	I
CD36	B
,	O
the	O
cysteine	B
-	I
rich	I
secreted	I
protein	I
3	I
(	O
CRISP	B
-	I
3	I
)	O
,	O
a	O
mouse	O
homolog	O
of	O
the	O
human	B
monocyte	I
/	I
neutrophil	I
elastase	I
inhibitor	I
(	O
mEI	B
)	O
and	O
two	O
unknown	O
cDNA	B
sequences	I
Nov1	B
and	O
Nov2	B
.	O

It	O
can	O
be	O
deduced	O
that	O
the	O
erythroid	B
ALAS	I
precursor	I
protein	I
has	O
a	O
molecular	O
weight	O
of	O
64	O
.	O
6	O
kd	O
,	O
and	O
is	O
similar	O
in	O
size	O
to	O
the	O
previously	O
isolated	O
human	B
housekeeping	I
ALAS	I
precursor	I
of	O
molecular	O
weight	O
70	O
.	O
6	O
kd	O
.	O

It	O
was	O
shown	O
by	O
transient	O
expression	O
assay	O
that	O
HS	B
-	I
40	I
behaved	O
as	O
an	O
authentic	O
enhancer	B
for	O
high	O
-	O
level	O
zeta	B
2	I
globin	I
promoter	I
activity	O
in	O
K562	O
cells	O
,	O
an	O
erythroid	O
cell	O
line	O
of	O
embryonic	O
and	O
/	O
or	O
fetal	O
origin	O
.	O

The	O
t	B
(	I
17	I
;	I
19	I
)	I
translocation	O
in	O
acute	O
lymphoblastic	O
leukemias	O
results	O
in	O
creation	O
of	O
E2A	B
-	I
hepatic	I
leukemia	I
factor	I
(	O
HLF	B
)	O
chimeric	B
proteins	I
that	O
contain	O
the	O
DNA	B
-	I
binding	I
and	I
protein	I
dimerization	I
domains	I
of	O
the	O
basic	B
leucine	I
zipper	I
(	I
bZIP	I
)	I
protein	I
HLF	B
fused	O
to	O
a	O
portion	O
of	O
E2A	B
proteins	I
with	O
transcriptional	O
activation	O
properties	O
.	O

Disruption	O
of	O
a	O
GATA	B
motif	I
in	O
the	O
Duffy	B
gene	I
promoter	I
abolishes	O
erythroid	B
gene	I
expression	O
in	O
Duffy	O
-	O
negative	O
individuals	O
.	O

The	O
C	B
-	I
terminal	I
Cdk2	I
truncations	O
,	O
however	O
,	O
were	O
non	O
-	O
functional	O
in	O
these	O
strains	O
and	O
thus	O
dependent	O
for	O
activity	O
on	O
the	O
pho85	B
coding	I
region	I
which	O
remained	O
in	O
the	O
mutant	B
pho85	I
:	O
:	O
HIS3	B
chromosomal	I
locus	I
.	O

The	O
transcription	B
factors	I
c	B
-	I
myb	I
and	O
C	B
/	I
EBP	I
alpha	I
regulate	O
the	O
monocytic	B
/	I
myeloic	I
gene	I
MRP14	B
.	O

These	O
results	O
establish	O
EKLF	B
as	O
a	O
tissue	B
-	I
specific	I
transcription	I
factor	I
that	O
undergoes	O
post	O
-	O
translational	O
acetylation	O
and	O
suggest	O
a	O
mechanism	O
by	O
which	O
EKLF	B
is	O
able	O
to	O
alter	O
chromatin	B
structure	O
and	O
induce	O
beta	B
-	I
globin	I
expression	O
within	O
the	O
beta	B
-	I
like	I
globin	I
cluster	I
.	O

The	O
COOH	O
-	O
terminus	O
of	O
this	O
new	O
isoform	O
,	O
which	O
we	O
designate	O
beta	B
4	I
,	O
lacks	O
a	O
22	O
amino	O
acid	O
lysine	O
-	O
rich	O
sequence	O
common	O
to	O
both	O
the	O
human	B
red	I
cell	I
alpha	I
-	I
and	I
beta	I
-	I
adducin	I
subunits	I
and	O
homologous	O
to	O
a	O
highly	O
conserved	O
region	O
in	O
MARCKS	B
,	O
a	O
filamentous	O
actin	B
-	O
cross	O
linking	O
protein	O
regulated	O
by	O
protein	B
kinase	I
C	I
and	O
calcium	O
/	O
calmodulin	B
.	O
beta	B
4	I
-	I
adducin	I
preserves	O
a	O
previously	O
identified	O
calmodulin	B
binding	I
domain	I
.	O

The	O
mechanism	O
by	O
which	O
eosinophil	B
-	I
specific	I
genes	I
encoding	O
primary	O
and	O
secondary	B
granule	I
proteins	I
(	O
e	O
.	O
g	O
.	O
ECP	B
,	O
EDN	B
,	O
EPO	B
,	O
MBP	B
,	O
and	O
CLC	B
)	O
are	O
expressed	O
and	O
regulated	O
during	O
eosinophilopoiesis	O
is	O
also	O
unknown	O
.	O

cDNA	O
sequencing	O
revealed	O
that	O
the	O
56K	B
cDNA	I
shares	O
a	O
high	O
degree	O
of	O
homology	O
in	O
both	O
nucleotide	O
(	O
87	O
%	O
)	O
and	O
amino	O
acid	O
sequence	O
(	O
92	O
.	O
5	O
%	O
)	O
with	O
bovine	B
annexin	I
XI	I
,	O
indicating	O
that	O
the	O
56K	B
cDNA	I
encodes	O
the	O
human	B
homologue	I
of	I
annexin	I
XI	I
,	O
a	O
member	O
of	O
the	O
Ca	B
(	I
2	I
+	I
)	I
-	I
dependent	I
phospholipid	I
binding	I
protein	I
family	I
.	O

Identification	O
of	O
essential	O
GATA	B
and	O
Ets	B
binding	I
motifs	I
within	O
the	O
promoter	O
of	O
the	O
platelet	B
glycoprotein	I
Ib	I
alpha	I
gene	I
.	O

Induction	O
of	O
Mn	B
SOD	I
in	O
human	O
monocytes	O
without	O
inflammatory	B
cytokine	I
production	O
by	O
a	O
mutant	B
endotoxin	I
.	O

Although	O
sequences	O
located	O
between	O
-	O
559	O
and	O
-	O
88	O
of	O
the	O
zeta	B
2	I
globin	I
gene	I
were	O
dispensable	O
for	O
its	O
expression	O
on	O
enhancerless	B
plasmids	I
,	O
they	O
were	O
required	O
for	O
the	O
HS	B
-	I
40	I
enhancer	I
-	O
mediated	O
activity	O
of	O
the	O
zeta	B
2	I
globin	I
promoter	I
.	O

These	O
blast	O
cells	O
express	O
lineage	B
-	I
specific	I
transcription	I
factors	I
such	O
as	O
GATA	B
-	I
1	I
common	O
to	O
these	O
lineages	O
and	O
frequently	O
express	O
erythroid	B
-	I
specific	I
mRNAs	I
such	O
as	O
gamma	B
-	I
globin	I
and	O
erythroid	B
delta	I
-	I
aminolevulinate	I
synthase	I
(	O
ALAS	B
-	I
E	I
)	O
,	O
indicating	O
that	O
most	O
of	O
the	O
blasts	O
in	O
M7	O
and	O
TMD	O
cases	O
have	O
erythroid	O
and	O
megakaryocytic	O
phenotypes	O
.	O

We	O
have	O
mapped	O
the	O
human	B
STAG3	I
gene	I
to	O
the	O
7q22	O
region	O
of	O
chromosome	O
7	O
;	O
six	O
human	B
STAG3	I
-	I
related	I
genes	I
have	O
also	O
been	O
mapped	O
:	O
two	O
at	O
7q22	O
near	O
the	O
functional	O
gene	O
,	O
one	O
at	O
7q11	O
.	O
22	O
,	O
and	O
three	O
at	O
7q11	O
.	O
23	O
,	O
two	O
of	O
them	O
flanking	O
the	O
breakpoints	O
commonly	O
associated	O
with	O
the	O
Williams	B
-	I
Beuren	I
syndrome	I
(	I
WBS	I
)	I
deletion	I
.	O

Identification	O
of	O
a	O
major	O
positive	B
regulatory	I
element	I
located	O
5	O
'	O
to	O
the	O
human	B
zeta	I
-	I
globin	I
gene	I
.	O

The	O
E2A	B
-	I
HLF	I
fusion	I
gene	I
,	O
generated	O
by	O
t	B
(	I
17	I
;	I
19	I
)	I
(	I
q22	I
;	I
p13	I
)	I
in	O
acute	O
lymphoblastic	O
leukemia	O
(	O
ALL	O
)	O
,	O
encodes	O
a	O
chimeric	B
transcription	I
factor	I
in	O
which	O
the	O
trans	B
-	I
activating	I
domains	I
of	O
E2A	B
are	O
fused	O
to	O
the	O
DNA	B
-	I
binding	I
and	I
dimerization	I
domains	I
of	O
hepatic	B
leukemic	I
factor	I
(	O
HLF	B
)	O
.	O

The	O
involvement	O
of	O
members	O
of	O
the	O
PEBP2	B
/	I
CBF	I
family	I
in	O
chromosome	O
translocations	O
associated	O
with	O
acute	O
myeloid	O
leukemia	O
,	O
and	O
in	O
the	O
transcriptional	O
regulation	O
of	O
the	O
myeloid	B
-	I
specific	I
genes	I
encoding	O
for	O
myeloperoxidase	B
,	O
elastase	B
,	O
and	O
the	O
colony	B
-	I
stimulating	I
factor	I
receptor	I
,	O
highlights	O
the	O
relevance	O
of	O
the	O
regulation	O
of	O
the	O
CD36	B
gene	I
promoter	I
in	O
monocytic	O
cells	O
by	O
members	O
of	O
the	O
PEBP2	B
/	I
CBF	I
family	I
.	O

Cooperation	O
of	O
Spi	B
-	I
1	I
/	I
PU	I
.	I
1	I
with	O
an	O
activated	B
erythropoietin	I
receptor	I
inhibits	O
apoptosis	O
and	O
Epo	B
-	O
dependent	O
differentiation	O
in	O
primary	O
erythroblasts	O
and	O
induces	O
their	O
Kit	O
ligand	O
-	O
dependent	O
proliferation	O
.	O

The	O
B	B
.	I
germanica	I
cyclophilin	I
amino	I
acid	I
sequence	I
shares	O
83	O
%	O
identity	O
with	O
the	O
cytosolic	B
cyclophilin	I
isoform	I
from	I
Drosophila	I
melanogaster	I
(	O
Cyp	B
-	I
1	I
)	O
.	O

This	O
paper	O
reports	O
the	O
expression	O
of	O
IL	B
-	I
12R	I
on	O
a	O
human	O
gamma	O
delta	O
T	O
cell	O
line	O
that	O
responds	O
to	O
IL	B
-	I
12	I
with	O
enhanced	O
cytolytic	O
activity	O
and	O
increased	O
expression	O
of	O
cytolytic	B
effector	I
molecules	I
granzyme	B
B	I
and	O
perforin	B
.	O

Despite	O
this	O
drastic	O
effect	O
in	O
vivo	O
,	O
the	O
in	O
vitro	O
immortalization	O
of	O
erythropoietin	O
-	O
dependent	O
erythroid	O
progenitors	O
unexpectedly	O
occurred	O
at	O
low	O
frequency	O
,	O
and	O
all	O
four	O
cell	O
lines	O
established	O
expressed	O
both	O
erythrocytic	B
(	I
globins	I
)	I
and	I
megakaryocytic	I
markers	I
(	O
glycoprotein	B
IIb	I
,	O
platelet	B
factor	I
4	I
)	O
as	O
well	O
as	O
Spi	B
-	I
1	I
and	O
Fli	B
-	I
1	I
transcripts	I
at	O
permissive	O
temperature	O
.	O

PEBP2	B
alpha	I
B	I
is	O
the	O
murine	B
counterpart	I
of	O
human	B
AML1	I
,	O
which	O
is	O
located	O
at	O
the	O
breakpoints	O
of	O
the	O
8	B
;	I
21	I
and	I
3	I
;	I
21	I
chromosome	I
translocations	I
associated	O
with	O
acute	O
myeloid	O
leukemia	O
.	O

We	O
now	O
demonstrate	O
that	O
a	O
forced	O
exogenous	O
expression	O
of	O
the	O
four	O
different	O
isoforms	O
of	O
WT1	B
in	O
K562	O
does	O
not	O
affect	O
the	O
differentiation	O
response	O
,	O
as	O
judged	O
by	O
accumulation	O
of	O
hemoglobin	B
in	O
response	O
to	O
hemin	B
or	O
the	O
expression	O
of	O
megakaryocytic	B
cell	I
surface	I
markers	I
in	O
response	O
to	O
12	O
-	O
O	O
-	O
tetradecanoylphorbol	O
-	O
13	O
-	O
acetate	O
(	O
TPA	O
)	O
.	O

Similarly	O
,	O
expression	O
of	O
a	O
transiently	O
transfected	O
wild	B
-	I
type	I
prothymosin	I
alpha	I
gene	I
as	O
the	O
reporter	O
was	O
not	O
affected	O
by	O
a	O
repertoire	O
of	O
myc	B
-	I
derived	I
genes	I
,	O
including	O
myc	B
itself	O
and	O
dominant	O
or	O
recessive	O
negative	O
myc	B
mutants	I
.	O

The	O
HSFE	B
induced	O
an	O
area	O
of	O
enhanced	O
DNase	B
1	I
hypersensitivity	O
extending	O
from	O
the	O
transcriptional	O
start	O
site	O
to	O
-	O
300bp	O
of	O
the	O
artificial	B
promoter	I
and	O
significantly	O
increased	O
the	O
proportion	O
of	O
beta	B
-	I
globin	I
promoters	I
in	O
an	O
open	O
chromatin	O
configuration	O
.	O

We	O
have	O
previously	O
shown	O
that	O
a	O
DNA	B
-	I
binding	I
factor	I
specific	O
to	O
adult	O
hematopoietic	O
cells	O
(	O
polypryrimidine	B
-	I
binding	I
factor	I
,	O
PYBF	B
)	O
binds	O
to	O
a	O
pyrimidine	B
-	I
rich	I
region	I
1	B
kb	I
upstream	I
from	O
the	O
human	B
delta	I
-	I
globin	I
-	I
encoding	I
gene	I
(	O
HBD	B
)	O
.	O

The	O
rhombotin	B
family	I
of	O
cysteine	B
-	I
rich	I
LIM	I
-	I
domain	I
oncogenes	I
:	O
distinct	O
members	O
are	O
involved	O
in	O
T	B
-	I
cell	I
translocations	I
to	O
human	B
chromosomes	I
11p15	I
and	I
11p13	I
.	O

We	O
studied	O
the	O
functional	O
interaction	O
between	O
human	B
embryonic	I
zeta	I
2	I
globin	I
promoter	I
and	O
the	O
alpha	B
globin	I
regulatory	I
element	I
(	O
HS	B
-	I
40	I
)	O
located	O
40	B
kb	I
upstream	I
of	O
the	O
zeta	B
2	I
globin	I
gene	I
.	O

Transfection	O
experiments	O
showed	O
that	O
both	O
Stat1alpha	B
and	O
Stat3	B
inhibited	O
the	O
induction	O
by	O
EPO	B
of	O
gamma	B
-	I
globin	I
and	I
erythroid	I
-	I
specific	I
5	I
-	I
aminolevulinate	I
synthetase	I
transcripts	I
,	O
resulting	O
in	O
a	O
reduction	O
of	O
the	O
percentage	O
of	O
hemoglobin	O
-	O
positive	O
cells	O
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
effect	O
of	O
ER	B
alpha	I
(	O
referred	O
to	O
throughout	O
as	O
ER	B
)	O
on	O
DNA	O
-	O
binding	O
activities	O
of	O
transcription	B
factors	I
involved	O
in	O
regulating	O
the	O
expression	O
of	O
erythroid	B
-	I
specific	I
genes	I
,	O
and	O
,	O
in	O
particular	O
,	O
the	O
histone	B
H5	I
gene	I
.	O

Complementary	B
DNA	I
encoding	O
the	O
human	B
T	I
-	I
cell	I
FK506	I
-	I
binding	I
protein	I
,	O
a	O
peptidylprolyl	B
cis	I
-	I
trans	I
isomerase	I
distinct	O
from	O
cyclophilin	B
.	O

Functional	O
roles	O
of	O
in	B
vivo	I
footprinted	I
DNA	I
motifs	I
within	O
an	O
alpha	B
-	I
globin	I
enhancer	I
.	O

These	O
data	O
suggest	O
that	O
transcriptional	O
activation	O
of	O
human	B
embryonic	I
zeta	I
2	I
globin	I
gene	I
and	O
the	O
fetal	B
/	I
adult	I
alpha	I
globin	I
genes	I
is	O
mediated	O
by	O
erythroid	O
cell	O
-	O
specific	O
and	O
developmental	B
stage	I
-	I
specific	I
nuclear	I
factor	I
-	I
DNA	I
complexes	I
which	O
form	O
at	O
the	O
enhancer	B
(	O
HS	B
-	I
40	I
)	O
and	O
the	O
globin	B
promoters	I
.	O

Induction	O
of	O
the	O
pro	B
-	I
myelocytic	I
leukaemia	I
gene	I
by	O
type	B
I	I
and	I
type	I
II	I
interferons	I
.	O

Switching	O
the	O
cells	O
to	O
the	O
nonpermissive	O
temperature	O
led	O
to	O
a	O
marked	O
increase	O
in	O
globin	B
gene	I
expression	O
and	O
concomitant	O
decrease	O
in	O
expression	O
of	O
Spi	B
-	I
1	I
,	O
Fli	B
-	I
1	I
,	O
and	O
megakaryocytic	B
genes	I
in	O
an	O
erythropoietin	B
-	O
dependent	O
manner	O
.	O

The	O
chimeric	B
oncoprotein	I
E2A	B
-	I
HLF	I
,	O
generated	O
by	O
the	O
t	B
(	I
17	I
;	I
19	I
)	I
chromosomal	I
translocation	I
in	O
pro	O
-	O
B	O
-	O
cell	O
acute	O
lymphoblastic	O
leukemia	O
,	O
incorporates	O
the	O
transactivation	B
domains	I
of	O
E2A	B
and	O
the	O
basic	B
leucine	I
zipper	I
(	I
bZIP	I
)	I
DNA	I
-	I
binding	I
and	I
protein	I
dimerization	I
domain	I
of	O
HLF	B
(	O
hepatic	B
leukemic	I
factor	I
)	O
.	O

The	O
developmental	O
stage	O
-	O
specificity	O
of	O
PYBF	B
and	O
the	O
location	O
of	O
its	O
binding	O
site	O
between	O
the	O
fetal	B
and	I
adult	I
beta	I
-	I
globin	I
(	I
HBB	I
)	I
-	I
like	I
genes	I
suggest	O
that	O
PBYF	B
and	O
its	O
binding	O
site	O
may	O
function	O
in	O
fetal	O
-	O
to	O
-	O
adult	O
globin	B
gene	I
switching	O
.	O

By	O
using	O
run	O
-	O
on	O
assays	O
,	O
ACLA	O
was	O
shown	O
to	O
induce	O
an	O
enhancement	O
of	O
the	O
transcription	O
of	O
erythroid	B
genes	I
,	O
including	O
gamma	B
-	I
globin	I
,	O
PBGD	B
,	O
erythropoietin	B
receptor	I
,	O
and	O
GATA	B
-	I
1	I
transcription	B
factor	I
.	O

The	O
pre	O
-	O
leukemic	O
phase	O
of	O
Friend	O
erythroleukemia	O
results	O
from	O
activation	O
of	O
the	O
erythropoietin	B
receptor	I
(	O
EpoR	B
)	O
by	O
the	O
spleen	B
focus	I
forming	I
virus	I
(	I
SFFV	I
)	I
envelope	I
glycoprotein	I
,	O
followed	O
by	O
the	O
emergence	O
of	O
leukemic	O
clones	O
characterized	O
by	O
overexpression	O
of	O
Spi	B
-	I
1	I
and	O
mutation	O
of	O
the	O
p53	B
tumor	I
suppressor	I
gene	I
.	O

Binding	O
of	O
erythroid	B
and	I
non	I
-	I
erythroid	I
nuclear	I
proteins	I
to	O
the	O
silencer	B
of	O
the	O
human	B
epsilon	I
-	I
globin	I
-	I
encoding	I
gene	I
.	O

Binding	O
to	O
sulphatides	O
and	O
the	O
alpha	B
-	I
dystroglycan	I
receptor	I
was	O
much	O
stronger	O
and	O
required	O
at	O
least	O
two	O
LG	B
modules	I
.	O

The	O
Ikaros	B
gene	I
,	O
which	O
encodes	O
a	O
family	O
of	O
hemopoietic	B
-	I
specific	I
zinc	I
finger	I
proteins	I
,	O
is	O
described	O
as	O
a	O
central	O
regulator	O
of	O
lymphocyte	O
differentiation	O
.	O

Infectious	B
hypodermal	I
and	I
hematopoietic	I
necrosis	I
virus	I
(	O
IHHNV	B
)	O
is	O
an	O
important	O
shrimp	O
pathogen	O
that	O
causes	O
mortality	O
in	O
Penaeus	B
stylirostris	I
and	O
stunting	O
(	O
called	O
runt	O
deformity	O
syndrome	O
or	O
RDS	O
)	O
in	O
Penaeus	B
vannamei	I
.	O

In	O
the	O
human	B
genome	I
,	O
the	O
erythroid	B
-	I
specific	I
hypersensitive	I
site	I
HS2	I
enhancer	I
regulates	O
the	O
transcription	O
of	O
the	O
downstream	B
beta	I
-	I
like	I
globin	I
genes	I
10	B
-	I
50	I
kilobases	I
away	O
.	O

Regulation	O
of	O
the	O
megakaryocytic	B
glycoprotein	I
IX	I
promoter	I
by	O
the	O
oncogenic	B
Ets	I
transcription	I
factor	I
Fli	B
-	I
1	I
.	O

The	O
findings	O
indicate	O
that	O
MNDA	B
expression	O
is	O
regulated	O
by	O
mechanisms	O
similar	O
to	O
other	O
myelomonocytic	B
cell	I
specific	I
genes	I
and	O
genes	O
up	O
-	O
regulated	O
by	O
interferon	B
alpha	I
.	O

To	O
examine	O
the	O
role	O
of	O
EKLF	B
in	O
the	O
developmental	O
regulation	O
of	O
the	O
human	B
gamma	I
-	I
globin	I
gene	I
we	O
interbred	O
EKLF	B
heterozygotes	I
(	O
+	O
/	O
-	O
)	O
with	O
mice	O
harboring	O
a	O
human	B
beta	I
-	I
globin	I
yeast	I
artificial	I
chromosome	I
transgene	I
.	O

These	O
data	O
suggest	O
that	O
these	O
sequences	O
located	O
immediately	O
3	O
'	O
to	O
the	O
breakpoint	O
of	O
the	O
HPFH	B
-	I
3	I
deletion	I
,	O
exhibit	O
both	O
the	O
structure	O
and	O
the	O
function	O
of	O
an	O
enhancer	O
,	O
and	O
can	O
modify	O
the	O
developmental	O
specificity	O
of	O
the	O
fetal	B
gamma	I
-	I
globin	I
genes	I
,	O
resulting	O
in	O
their	O
continued	O
expression	O
during	O
adult	O
life	O
.	O

Furthermore	O
,	O
the	O
hemin	B
-	O
induced	O
accumulation	O
of	O
globin	B
,	O
known	O
as	O
a	O
marker	O
of	O
erythroid	O
differentiation	O
,	O
is	O
decreased	O
in	O
cells	O
overexpressing	O
HSF2	B
-	I
beta	I
.	O

Furthermore	O
,	O
replacement	O
of	O
the	O
gamma	B
(	I
c	I
)	I
cytoplasmic	B
domain	I
by	O
a	O
severely	B
truncated	I
erythropoeitin	I
receptor	I
does	O
not	O
affect	O
measured	O
IL	B
-	I
7R	I
signaling	O
events	O
.	O

Altered	B
DNA	I
-	I
binding	I
specificity	I
mutants	I
of	O
EKLF	B
and	O
Sp1	O
show	O
that	O
EKLF	B
is	O
an	O
activator	O
of	O
the	O
beta	B
-	I
globin	I
locus	I
control	I
region	I
in	O
vivo	O
.	O

Activation	O
of	O
the	O
erythropoietin	B
receptor	I
caused	O
specific	O
DNA	O
-	O
binding	O
of	O
Stat	B
5b	I
,	O
but	O
failed	O
to	O
induce	O
reporter	B
gene	I
transcription	O
.	O

Erythropoietin	B
stimulates	O
transcription	O
of	O
the	O
TAL1	B
/	I
SCL	I
gene	I
and	O
phosphorylation	O
of	O
its	O
protein	B
products	I
.	O

Transcriptional	O
regulation	O
of	O
the	O
human	B
alpha	I
-	I
like	I
globin	I
genes	I
,	O
embryonic	B
zeta	I
2	I
and	O
adult	B
alpha	I
,	O
during	O
erythroid	O
development	O
is	O
mediated	O
by	O
a	O
distal	B
enhancer	I
,	O
HS	B
-	I
40	I
.	O

Structural	O
organization	O
and	O
developmental	O
expression	O
pattern	O
of	O
the	O
mouse	B
WD	I
-	I
repeat	I
gene	I
DMR	I
-	I
N9	I
immediately	O
upstream	O
of	O
the	O
myotonic	B
dystrophy	I
locus	I
.	O

